Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers


  Free Subscription

Articles published in Vaccine

Retrieve available abstracts of 1182 articles:
HTML format

Single Articles

    November 2021
  1. BETTENCOURT PJG, Joosten SA, Lindestam Arlehamn CS, Behr MA, et al
    100 years of the Bacillus Calmette-Guerin vaccine.
    Vaccine. 2021 Nov 22. pii: S0264-410X(21)01483.

  2. SUN P, Jani V, Johnson A, Cheng Y, et al
    T cell and memory B cell responses in tetravalent DNA, tetravalent inactivated and tetravalent live-attenuated prime-boost dengue vaccines in rhesus macaques.
    Vaccine. 2021 Nov 22. pii: S0264-410X(21)01325.
    PubMed     Abstract available

  3. AREGA SM, Knobel DL, Toka FN, Conan A, et al
    Non-specific effects of veterinary vaccines: a systematic review.
    Vaccine. 2021 Nov 20. pii: S0264-410X(21)01479.
    PubMed     Abstract available

  4. HARA M, Koshida R, Nakano T
    Parents' views on mumps, mumps vaccine, and the factors associated with vaccination in Japan.
    Vaccine. 2021 Nov 20. pii: S0264-410X(21)01449.
    PubMed     Abstract available

  5. YE K, Shi D, Zhang Z, Bian L, et al
    A chemiluminescence immunoassay for precise automatic quality control of glycoprotein in human rabies vaccine.
    Vaccine. 2021 Nov 20. pii: S0264-410X(21)01393.
    PubMed     Abstract available

  6. BELLIZZI S, Aidyralieva C, Al-Shaikh A, Muthu N, et al
    Inclusiveness of prisons in COVID-19 vaccination deployment: Evidence from Jordan.
    Vaccine. 2021 Nov 18. pii: S0264-410X(21)01468.

  7. ORTEGA-SANCHEZ IR, Mott JA, Kittikraisak W, Khanthamaly V, et al
    Cost-effectiveness of seasonal influenza vaccination in pregnant women, healthcare workers and adults >= 60 years of age in Lao People's Democratic Republic.
    Vaccine. 2021 Nov 18. pii: S0264-410X(21)01445.
    PubMed     Abstract available

  8. IRVING SA, Ball SW, Booth SM, Regan AK, et al
    A multi-country investigation of influenza vaccine coverage in pregnant individuals, 2010-2016.
    Vaccine. 2021 Nov 18. pii: S0264-410X(21)01463.
    PubMed     Abstract available

  9. HAFNER-GIESSAUF H, Horn S, Schwantzer G, Sprenger-Mahr H, et al
    Cholecalciferol supplementation to improve the hepatitis B vaccination response in hemodialysis patients: A first randomized open label pilot study (DeVitaHep).
    Vaccine. 2021 Nov 18. pii: S0264-410X(21)01474.
    PubMed     Abstract available

  10. BLAIN AE, Reese HE, Marjuki H, Topaz N, et al
    Serogroup A, C, W, and Y meningococcal disease in persons previously vaccinated with a serogroup ACWY meningococcal vaccine - United States, 2014-2018.
    Vaccine. 2021 Nov 18. pii: S0264-410X(21)01480.
    PubMed     Abstract available

  11. WANG W, Wang Y, Wang Y, Yan F, et al
    Vaccine bidding, procurement and distribution management practices in mainland China: A nationwide study.
    Vaccine. 2021 Nov 18. pii: S0264-410X(21)01465.
    PubMed     Abstract available

  12. KITRO A, Sirikul W, Piankusol C, Rirermsoonthorn P, et al
    Acceptance, attitude, and factors affecting the intention to accept COVID-19 vaccine among Thai people and expatriates living in Thailand.
    Vaccine. 2021 Nov 17. pii: S0264-410X(21)01476.
    PubMed     Abstract available

  13. HOFF NA, Bratcher A, Mukadi P, Ahuka S, et al
    Increasing Ebola transmission behaviors 6 months post-vaccination: Comparing vaccinated and unvaccinated populations near 2018 Mbandaka Ebola outbreak in the Democratic Republic of Congo.
    Vaccine. 2021 Nov 16. pii: S0264-410X(21)01404.
    PubMed     Abstract available

  14. VOSS G, Jacquet JM, Tornieporth N, Kampmann B, et al
    Meeting report: CEPI consultation on accelerating access to novel vaccines against emerging infectious diseases for pregnant and lactating women, London, 12-13 February 2020.
    Vaccine. 2021 Nov 16. pii: S0264-410X(21)01382.
    PubMed     Abstract available

  15. VOHRA P, Chintoan-Uta C, Bremner A, Mauri M, et al
    Evaluation of a Campylobacter jejuni N-glycan-ExoA glycoconjugate vaccine to reduce C. jejuni colonisation in chickens.
    Vaccine. 2021 Nov 16. pii: S0264-410X(21)01434.
    PubMed     Abstract available

  16. BOBO FT, Asante A, Woldie M, Dawson A, et al
    Child vaccination in sub-Saharan Africa: Increasing coverage addresses inequalities.
    Vaccine. 2021 Nov 15. pii: S0264-410X(21)01439.
    PubMed     Abstract available

  17. ESPARZA J, Damaso CR
    Searching for the origin of the smallpox vaccine: Edward Jenner and his little-known horsepox hypothesis.
    Vaccine. 2021 Nov 15. pii: S0264-410X(21)01441.

  18. AMEND KL, Turnbull B, Zhou L, Marks MA, et al
    Vaccine initiation and 3-dose series completion of 4vHPV vaccine among US insured males 2012-2016.
    Vaccine. 2021 Nov 15. pii: S0264-410X(21)01403.
    PubMed     Abstract available

  19. SILAS J, Jones A, Weiss-Cohen L, Ayton P, et al
    The seductive allure of technical language and its effect on covid-19 vaccine beliefs and intentions.
    Vaccine. 2021 Nov 15. pii: S0264-410X(21)01472.
    PubMed     Abstract available

  20. CHOKEPHAIBULKIT K, Puthanakit T, Bhat N, Mansouri S, et al
    A phase 2 randomized controlled dose-ranging trial of recombinant pertussis booster vaccines containing genetically inactivated pertussis toxin in women of childbearing age.
    Vaccine. 2021 Nov 14. pii: S0264-410X(21)01425.
    PubMed     Abstract available

  21. BURKE RM, Shih S, Hsiung CA, Yen C, et al
    Impact of rotavirus vaccination on rotavirus hospitalizations in Taiwanese children.
    Vaccine. 2021 Nov 14. pii: S0264-410X(21)01397.
    PubMed     Abstract available

  22. REESE HE, McNamara LA, Vianzon V, Blain A, et al
    Serogroup B meningococcal disease in persons previously vaccinated with a serogroup B meningococcal vaccine - United States, 2014-2019.
    Vaccine. 2021 Nov 13. pii: S0264-410X(21)01438.
    PubMed     Abstract available

  23. ROSENTHAL S, Cummings CL
    Influence of rapid COVID-19 vaccine development on vaccine hesitancy.
    Vaccine. 2021 Nov 13. pii: S0264-410X(21)01448.
    PubMed     Abstract available

  24. HARMON SHE, Faour DE, MacDonald NE
    Mandatory immunization and vaccine injury support programs: A survey of 28 GNN countries.
    Vaccine. 2021 Nov 12. pii: S0264-410X(21)01390.
    PubMed     Abstract available

  25. CHHABRIA S, Stanford FC
    A long shot: The importance of needle length in vaccinating patients with obesity against COVID-19.
    Vaccine. 2021 Nov 11. pii: S0264-410X(21)01442.

  26. VIZCARRA P, Haemmerle J, Velasco H, Velasco T, et al
    BNT162b2 mRNA COVID-19 vaccine Reactogenicity: The key role of immunity.
    Vaccine. 2021 Nov 11. pii: S0264-410X(21)01417.
    PubMed     Abstract available

  27. AW R, Ashik MR, Islam AAZM, Khan I, et al
    Production and purification of an active CRM197 in Pichia pastoris and its immunological characterization using a Vi-typhoid antigen vaccine.
    Vaccine. 2021 Nov 10. pii: S0264-410X(21)01432.
    PubMed     Abstract available

  28. COLOMBATTI OLIVIERI MA, Moyano RD, Mon ML, Gravisaco MJ, et al
    Evaluation of a virulent strain of Mycobacterium avium subsp. Paratuberculosis used as a heat-killed vaccine.
    Vaccine. 2021 Nov 10. pii: S0264-410X(21)01433.
    PubMed     Abstract available

  29. MCLEAN HQ, Levine MZ, King JP, Flannery B, et al
    Serologic response to sequential vaccination with enhanced influenza vaccines: Open label randomized trial among adults aged 65-74 years.
    Vaccine. 2021 Nov 10. pii: S0264-410X(21)01415.
    PubMed     Abstract available

  30. BABUADZE GG, Echanove J, Lamarre C, deLaVega MA, et al
    A novel DNA platform designed for vaccine use with high transgene expression and immunogenicity.
    Vaccine. 2021 Nov 10. pii: S0264-410X(21)01315.
    PubMed     Abstract available

  31. RODRIGUES CMC, Plotkin SA
    The influence of interval between doses on response to vaccines.
    Vaccine. 2021 Nov 10. pii: S0264-410X(21)01381.

  32. RADWAN NF, Abu-Sheasha GA, Bedwani RN, Yassine OG, et al
    Vaccine wastage and cost saving after multi-dose vial policy implementation in Egypt: A success story.
    Vaccine. 2021 Nov 9. pii: S0264-410X(21)01400.
    PubMed     Abstract available

  33. SHAH SFA, Ginossar T, Bentley JM, Zimet G, et al
    Using the Theory of Planned behavior to identify correlates of HPV vaccination uptake among college students attending a rural university in Alabama.
    Vaccine. 2021 Nov 9. pii: S0264-410X(21)01431.
    PubMed     Abstract available

  34. SVENNERHOLM AM, Qadri F, Lundgren A, Kaim J, et al
    Induction of mucosal and systemic immune responses against the common O78 antigen of an oral inactivated ETEC vaccine in Bangladeshi children and infants.
    Vaccine. 2021 Nov 9. pii: S0264-410X(21)01389.
    PubMed     Abstract available

  35. THULUVA S, Matur R, Tsa K, Gv SR, et al
    A single blind randomized phase 3 study to evaluate safety and immunogenicity of inactivated hepatitis A vaccine (HAPIBEV(TM)) in 1-15 years-old healthy hepatitis A vaccine-naive children.
    Vaccine. 2021 Nov 8. pii: S0264-410X(21)01326.
    PubMed     Abstract available

  36. HOSANGADI D, Martin EK, Watson M, Bruns R, et al
    Supporting use of thermostable vaccines during public health emergencies: Considerations and recommendations for the future.
    Vaccine. 2021 Nov 8. pii: S0264-410X(21)01398.

  37. MCKINNON B, Quach C, Dube E, Tuong Nguyen C, et al
    Social inequalities in COVID-19 vaccine acceptance and uptake for children and adolescents in Montreal, Canada.
    Vaccine. 2021 Nov 8. pii: S0264-410X(21)01426.
    PubMed     Abstract available

  38. WU K, Choi A, Koch M, Elbashir S, et al
    Variant SARS-CoV-2 mRNA vaccines confer broad neutralization as primary or booster series in mice.
    Vaccine. 2021 Nov 8. pii: S0264-410X(21)01435.
    PubMed     Abstract available

  39. VILLANUEVA-UY MET, Lam HY, Aldaba JG, Uy TMZ, et al
    Cost-effectiveness of rotavirus vaccination in the Philippines: A modeling study.
    Vaccine. 2021 Nov 6. pii: S0264-410X(21)01290.
    PubMed     Abstract available

  40. CUEVAS-JUAREZ E, Pando-Robles V, Palomares LA
    Flavivirus vaccines: Virus-like particles and single-round infectious particles as promising alternatives.
    Vaccine. 2021 Nov 6. pii: S0264-410X(21)01383.
    PubMed     Abstract available

  41. SHARUN K, Tiwari R, Saied AA, Dhama K, et al
    SARS-CoV-2 vaccine for domestic and captive animals: An effort to counter COVID-19 pandemic at the human-animal interface.
    Vaccine. 2021 Nov 6. pii: S0264-410X(21)01386.
    PubMed     Abstract available

  42. GOODE JR, Cook P, Cuttino S, Gatewood SBS, et al
    Early experience with COVID-19 vaccine in a Federally-Qualified Healthcare Center for the homeless.
    Vaccine. 2021 Nov 6. pii: S0264-410X(21)01388.

  43. DE HAAS TDJ, Yeung KHT, Hutubessy R, van der Putten IM, et al
    Programme costs for introducing age/gestation-based universal influenza vaccine schedules for young children and pregnant women in Hong Kong.
    Vaccine. 2021;39:6762-6780.
    PubMed     Abstract available

  44. LAU CL, Mayfield HJ, Sinclair JE, Brown SJ, et al
    Risk-benefit analysis of the AstraZeneca COVID-19 vaccine in Australia using a Bayesian network modelling framework.
    Vaccine. 2021 Nov 4. pii: S0264-410X(21)01428.
    PubMed     Abstract available

  45. SANZ-ROJO S, Jimenez-Garcia R, Lopez-de-Andres A, de Miguel-Diez J, et al
    Influenza vaccination uptake among high-risk target groups and health care workers in Spain and change from 2017 to 2020.
    Vaccine. 2021 Nov 3. pii: S0264-410X(21)01392.
    PubMed     Abstract available

  46. VASUDEVAN L, Ostermann J, Wang Y, Harrison SE, et al
    Predictors of HPV vaccination in the southern US: A survey of caregivers from 13 states.
    Vaccine. 2021 Nov 3. pii: S0264-410X(21)01356.
    PubMed     Abstract available

  47. RIBERA-CANO A, Dupont M, Houze-Cerfon CH, Houze-Cerfon V, et al
    Evaluation of a prototype decontamination mobile unit (UMDEO) for COVID-19 vaccination: A cross-sectional survey in France.
    Vaccine. 2021 Nov 3. pii: S0264-410X(21)01429.
    PubMed     Abstract available

  48. MIYA TV, Groome MJ, de Assis Rosa D
    TLR genetic variation is associated with Rotavirus-specific IgA seroconversion in South African Black infants after two doses of Rotarix vaccine.
    Vaccine. 2021 Nov 2. pii: S0264-410X(21)01384.
    PubMed     Abstract available

  49. PIERRON A, Bozon F, Berceanu A, Fontan J, et al
    Vaccination coverage in hematological patients undergoing chemotherapy: Should we move towards personalized vaccination?
    Vaccine. 2021 Nov 2. pii: S0264-410X(21)01369.
    PubMed     Abstract available

    Vaccination of healthcare personnel in the COVID-19 era: A call for actions.
    Vaccine. 2021 Nov 2. pii: S0264-410X(21)01427.

  51. CASSONE A, Cauda R
    Multicomponent vaccines to fight SARS-CoV-2 variants of concern.
    Vaccine. 2021 Nov 1. pii: S0264-410X(21)01402.

  52. WAGNER A, Jasinska J, Tomosel E, Zielinski CC, et al
    Absent antibody production following COVID19 vaccination with mRNA in patients under immunosuppressive treatments.
    Vaccine. 2021 Nov 1. pii: S0264-410X(21)01401.
    PubMed     Abstract available

    October 2021
  53. LIU H, Zhou C, An J, Song Y, et al
    Development of recombinant COVID-19 vaccine based on CHO-produced, prefusion spike trimer and alum/CpG adjuvants.
    Vaccine. 2021 Oct 30. pii: S0264-410X(21)01399.
    PubMed     Abstract available

  54. MALTEZOU HC, Panagopoulos P, Sourri F, Giannouchos TV, et al
    COVID-19 vaccination significantly reduces morbidity and absenteeism among healthcare personnel: A prospective multicenter study.
    Vaccine. 2021 Oct 30. pii: S0264-410X(21)01387.
    PubMed     Abstract available

  55. KHOURY J, Najjar-Debbiny R, Hanna A, Jabbour A, et al
    COVID-19 vaccine - Long term immune decline and breakthrough infections.
    Vaccine. 2021 Oct 30. pii: S0264-410X(21)01370.
    PubMed     Abstract available

  56. GORDON SF, Clothier HJ, Morgan H, Buttery JP, et al
    Immune thrombocytopenia following immunisation with Vaxzevria ChadOx1-S (AstraZeneca) vaccine, Victoria, Australia.
    Vaccine. 2021 Oct 29. pii: S0264-410X(21)01350.
    PubMed     Abstract available

  57. GARCIA-GRIMSHAW M, Ceballos-Liceaga SE, Michel-Chavez A, Garcia-Alanis M, et al
    Transient sensory symptoms among first-dose recipients of the BNT162b2 mRNA COVID-19 vaccine: A case-control study.
    Vaccine. 2021 Oct 29. pii: S0264-410X(21)01391.
    PubMed     Abstract available

  58. MAZUR A, Benitez S, Chuffart-Finsterwald S, La Rotta R, et al
    COVAX no fault compensation program for COVID-19 vaccine injuries in 92 low and middle income countries.
    Vaccine. 2021 Oct 28. pii: S0264-410X(21)01380.

  59. MARTIN S, Vanderslott S
    "Any idea how fast 'It's just a mask!' can turn into 'It's just a vaccine!'": From mask mandates to vaccine mandates during the COVID-19 pandemic.
    Vaccine. 2021 Oct 28. pii: S0264-410X(21)01351.
    PubMed     Abstract available

  60. NOWALK MP, D'Agostino HEA, Zimmerman RK, Saul SG, et al
    Agreement among sources of adult influenza vaccination in the age of immunization information systems.
    Vaccine. 2021 Oct 26. pii: S0264-410X(21)01372.
    PubMed     Abstract available

  61. JEON S, Kelly M, Yun J, Lee B, et al
    Scalable production and immunogenicity of a cholera conjugate vaccine.
    Vaccine. 2021 Oct 26. pii: S0264-410X(21)01312.
    PubMed     Abstract available

  62. CAPPOZZO F, Dal Zotto A, Scollo M, Bernardini D, et al
    dTap vaccination uptake during pregnancy: Pregnant women-focused and health professionals-focused predictors in the Veneto Region (Italy).
    Vaccine. 2021 Oct 25. pii: S0264-410X(21)01321.
    PubMed     Abstract available

  63. HUANG J, Bai Y, Ding H, Wang B, et al
    Acceptance of pneumococcal vaccination in older adults: A general population-based survey.
    Vaccine. 2021 Oct 25. pii: S0264-410X(21)01344.
    PubMed     Abstract available

  64. CHANTHAVANICH P, Versage E, Van Twuijver E, Hohenboken M, et al
    Antibody responses against heterologous A/H5N1 strains for an MF59-adjuvanted cell culture-derived A/H5N1 (aH5N1c) influenza vaccine in healthy pediatric subjects.
    Vaccine. 2021 Oct 25. pii: S0264-410X(21)01317.
    PubMed     Abstract available

  65. OLANIPEKUN T, Abe T, Effoe V, Westney G, et al
    Changes in COVID-19 vaccine acceptance rate among recovered critically Ill patients: A 12-month follow-up study.
    Vaccine. 2021 Oct 25. pii: S0264-410X(21)01324.
    PubMed     Abstract available

  66. OPRIESSNIG T, Rawal G, McKeen L, Filippsen Favaro P, et al
    Evaluation of the intranasal route for porcine reproductive and respiratory disease modified-live virus vaccination.
    Vaccine. 2021 Oct 24. pii: S0264-410X(21)01353.
    PubMed     Abstract available

  67. LOEB M, Russell ML, Kelly-Stradiotto C, Fuller N, et al
    Adjuvanted trivalent influenza vaccine versus quadrivalent inactivated influenza vaccine in Hutterite Children: A randomized clinical trial.
    Vaccine. 2021 Oct 23. pii: S0264-410X(21)01355.
    PubMed     Abstract available

  68. MYAT TW, Thu HM, Tate JE, Burnett E, et al
    Rotavirus infection among children under five years of age hospitalized with acute gastroenteritis in Myanmar during 2018-2020 - Multicentre surveillance before rotavirus vaccine introduction.
    Vaccine. 2021 Oct 23. pii: S0264-410X(21)01323.
    PubMed     Abstract available

  69. FAN X, Li X, Wan K, Zhao X, et al
    Construction and immunogenicity of a T cell epitope-based subunit vaccine candidate against Mycobacterium tuberculosis.
    Vaccine. 2021 Oct 23. pii: S0264-410X(21)01354.
    PubMed     Abstract available

  70. SHACHOR-MEYOUHAS Y, Hussein K, Szwarcwort-Cohen M, Weissman A, et al
    Single BNT162b2 vaccine dose produces seroconversion in under 60 s cohort.
    Vaccine. 2021 Oct 23. pii: S0264-410X(21)01327.
    PubMed     Abstract available

  71. TRAN VN, Nguyen HA, Le TTA, Truong TT, et al
    Factors influencing adverse events following immunization with AZD1222 in Vietnamese adults during first half of 2021.
    Vaccine. 2021;39:6485-6491.
    PubMed     Abstract available

    Covid-19 vaccine hesitancy, conspiracist beliefs, paranoid ideation and perceived ethnic discrimination in a sample of University students in Venezuela.
    Vaccine. 2021 Oct 22. pii: S0264-410X(21)01371.
    PubMed     Abstract available

  73. SHUBITZ LF, Robb EJ, Powell DA, Bowen RA, et al
    Deltacps1 vaccine protects dogs against experimentally induced coccidioidomycosis.
    Vaccine. 2021 Oct 22. pii: S0264-410X(21)01349.
    PubMed     Abstract available

  74. VAN BEEK LF, Langereis JD, van den Berg van Saparoea HB, Gillard J, et al
    Intranasal vaccination with protein bodies elicit strong protection against Streptococcus pneumoniae colonization.
    Vaccine. 2021 Oct 22. pii: S0264-410X(21)01313.
    PubMed     Abstract available

  75. DAR SA, Kole S, Shin SM, Jeong HJ, et al
    Comparative study on antigen persistence and immunoprotective efficacy of intramuscular and intraperitoneal injections of squalene - aluminium hydroxide (Sq + Al) adjuvanted viral hemorrhagic septicaemia virus vaccine in olive flounder (Paralichthys o
    Vaccine. 2021 Oct 22. pii: S0264-410X(21)01345.
    PubMed     Abstract available

  76. ABU-RAYA B, Maertens K, Munoz FM, Zimmermann P, et al
    Factors affecting antibody responses to immunizations in infants born to women immunized against pertussis in pregnancy and unimmunized women: Individual-Participant Data Meta-analysis.
    Vaccine. 2021;39:6545-6552.
    PubMed     Abstract available

  77. FAN S, Li D, Zhao H, Yu L, et al
    Ameliorated immunity elicited by intradermal inoculation in individuals vaccinated with inactivated SARS-CoV-2 vaccine.
    Vaccine. 2021 Oct 22. pii: S0264-410X(21)01375.
    PubMed     Abstract available

  78. MAKOVITZKI A, Lerer E, Kafri Y, Adar Y, et al
    Evaluation of a downstream process for the recovery and concentration of a Cell-Culture-Derived rVSV-Spike COVID-19 vaccine candidate.
    Vaccine. 2021 Oct 22. pii: S0264-410X(21)01376.
    PubMed     Abstract available

  79. WANG J, Wagner AL, Chen Y, Jaime E, et al
    Would COVID-19 vaccination willingness increase if mobile technologies prohibit unvaccinated individuals from public spaces? A nationwide discrete choice experiment from China.
    Vaccine. 2021 Oct 22. pii: S0264-410X(21)01340.
    PubMed     Abstract available

  80. JAMES EK, Bokemper SE, Gerber AS, Omer SB, et al
    Persuasive messaging to increase COVID-19 vaccine uptake intentions.
    Vaccine. 2021 Oct 22. pii: S0264-410X(21)01368.
    PubMed     Abstract available

  81. NETANEL C, Ben-Aharon O, Ben-Ari Z, Chodick G, et al
    Evaluation of a universal hepatitis B vaccination program and antenatal screening for hepatitis B surface antigen: Results from a real-world study 2015-2016.
    Vaccine. 2021 Oct 20. pii: S0264-410X(21)01287.
    PubMed     Abstract available

  82. DANKWA EA, Donnelly CA, Brouwer AF, Zhao R, et al
    Estimating vaccination threshold and impact in the 2017-2019 hepatitis A virus outbreak among persons experiencing homelessness or who use drugs in Louisville, Kentucky, United states.
    Vaccine. 2021 Oct 19. pii: S0264-410X(21)01308.
    PubMed     Abstract available

  83. KIM D, Pekgun P, Yildirim I, Keskinocak P, et al
    Resource allocation for different types of vaccines against COVID-19: Tradeoffs and synergies between efficacy and reach.
    Vaccine. 2021 Oct 18. pii: S0264-410X(21)01346.
    PubMed     Abstract available

  84. DANG TKNS, Rivero Cabrera R, Yeung KHT, van der Putten IM, et al
    Feasibility of age- and gestation-based routine universal influenza vaccines schedules for children aged 6 months - 2 years and pregnant women.
    Vaccine. 2021 Oct 18. pii: S0264-410X(21)01291.
    PubMed     Abstract available

  85. CHEN AT, Stacey HD, Marzok A, Singh P, et al
    Effect of inactivated influenza vaccination on human coronavirus infection: Secondary analysis of a randomized trial in Hutterite colonies.
    Vaccine. 2021 Oct 18. pii: S0264-410X(21)01341.
    PubMed     Abstract available

  86. MAKI Y, Kashiwagi S, Kimizuka Y
    Laser vaccine adjuvants: Light-augmented immune responses.
    Vaccine. 2021 Oct 16. pii: S0264-410X(21)01233.
    PubMed     Abstract available

  87. CHAPIN-BARDALES J, Myers T, Gee J, Shay DK, et al
    Reactogenicity within 2 weeks after mRNA COVID-19 vaccines: Findings from the CDC v-safe surveillance system.
    Vaccine. 2021 Oct 16. pii: S0264-410X(21)01339.
    PubMed     Abstract available

  88. ALI SAHRAIAN M, Ghadiri F, Azimi A, Naser Moghadasi A, et al
    Adverse events reported by Iranian patients with multiple sclerosis after the first dose of Sinopharm BBIBP-CorV.
    Vaccine. 2021;39:6347-6350.
    PubMed     Abstract available

  89. AYAZ S, Dibben O, Chapman D
    Presence of defective viral genes in H1N1 live attenuated influenza vaccine strains is not associated with reduced human cell fitness or vaccine effectiveness.
    Vaccine. 2021 Oct 15. pii: S0264-410X(21)01320.
    PubMed     Abstract available

  90. SILVER MC, Neumann PJ, Ma S, Kim DD, et al
    Frequency and impact of the inclusion of broader measures of value in economic evaluations of vaccines.
    Vaccine. 2021 Oct 13. pii: S0264-410X(21)01285.
    PubMed     Abstract available

  91. MOGHNIEH R, Mekdashi R, El-Hassan S, Abdallah D, et al
    Immunogenicity and reactogenicity of BNT162b2 booster in BBIBP-CorV-vaccinated individuals compared with homologous BNT162b2 vaccination: Results of a pilot prospective cohort study from Lebanon.
    Vaccine. 2021 Oct 13. pii: S0264-410X(21)01314.
    PubMed     Abstract available

  92. LALWANI SK, Ramanan PV, Sapru A, Sundaram B, et al
    Safety and immunogenicity of a multidose vial formulation of 13-valent pneumococcal conjugate vaccine administered with routine pediatric vaccines in healthy infants in India: A phase 4, randomized, open-label study.
    Vaccine. 2021 Oct 13. pii: S0264-410X(21)01208.
    PubMed     Abstract available

  93. BUUS M, da Silva I, Nielsen S, Thysen SM, et al
    Coverage and factors associated with receiving campaign polio vaccines in an urban population in Guinea-Bissau.
    Vaccine. 2021 Oct 12. pii: S0264-410X(21)01150.
    PubMed     Abstract available

  94. PARK WJ, Yoon YK, Kim Y, Park JS, et al
    Development of a bivalent conjugate vaccine candidate against rotaviral diarrhea and tuberculosis using polysaccharide from Mycobacterium tuberculosis conjugated to DeltaVP8* protein from rotavirus.
    Vaccine. 2021 Oct 9. pii: S0264-410X(21)01282.
    PubMed     Abstract available

  95. MCNAY LA, Arnoczy G, Martell M, Mock P, et al
    Community-based hospitals: New partners for government-sponsored clinical research during public health emergencies.
    Vaccine. 2021;39:6183-6185.
    PubMed     Abstract available

  96. HART P, Farrar J
    The influenza vaccines roadmap - A better future through improved influenza vaccines.
    Vaccine. 2021 Oct 8. pii: S0264-410X(21)01286.

  97. VERBERK JDM, van Dongen JAP, van de Kassteele J, Andrews NJ, et al
    Impact analysis of rotavirus vaccination in various geographic regions in Western Europe.
    Vaccine. 2021 Oct 8. pii: S0264-410X(21)01262.
    PubMed     Abstract available

  98. BRYDEN GM, Rockloff M, Browne M, Unsworth C, et al
    Effect of contamination and purity priming on attitudes to vaccination and other health interventions: A randomised controlled experiment.
    Vaccine. 2021 Oct 8. pii: S0264-410X(21)01278.
    PubMed     Abstract available

  99. VANDERMEULEN C, Leroux-Roels I, Vandeleur J, Staniscia T, et al
    A new fully liquid presentation of MenACWY-CRM conjugate vaccine: Results from a multicentre, randomised, controlled, observer-blind study.
    Vaccine. 2021 Oct 8. pii: S0264-410X(21)01283.
    PubMed     Abstract available

  100. FU LY, Torres R, Caleb S, Cheng YI, et al
    Vaccination coverage among young homeless children compared to US national immunization survey data.
    Vaccine. 2021 Oct 8. pii: S0264-410X(21)01288.
    PubMed     Abstract available

  101. MOTTELSON A, Vandeweerdt C, Atchapero M, Luong T, et al
    A self-administered virtual reality intervention increases COVID-19 vaccination intention.
    Vaccine. 2021 Oct 8. pii: S0264-410X(21)01311.
    PubMed     Abstract available

  102. HUMBLE RM, Sell H, Dube E, MacDonald NE, et al
    Canadian parents' perceptions of COVID-19 vaccination and intention to vaccinate their children: Results from a cross-sectional national survey.
    Vaccine. 2021 Oct 8. pii: S0264-410X(21)01309.
    PubMed     Abstract available

  103. BYRNE T, Patel P, Shrotri M, Beale S, et al
    Trends, patterns and psychological influences on COVID-19 vaccination intention: Findings from a large prospective community cohort study in England and Wales (Virus Watch).
    Vaccine. 2021 Oct 8. pii: S0264-410X(21)01281.
    PubMed     Abstract available

  104. MULLER-PEBODY B, Sinnathamby MA, Warburton F, Rooney G, et al
    Impact of the childhood influenza vaccine programme on antibiotic prescribing rates in primary care in England.
    Vaccine. 2021 Oct 6. pii: S0264-410X(21)01284.
    PubMed     Abstract available

  105. GIERSING B, Shah N, Kristensen D, Amorij JP, et al
    Strategies for vaccine-product innovation: Creating an enabling environment for product development to uptake in low- and middle-income countries.
    Vaccine. 2021 Oct 6. pii: S0264-410X(21)00996.
    PubMed     Abstract available

  106. REIDENBERG BE, Hirsch K, Costello CM, Russo M, et al
    Drive through COVID19 vaccination for developmentally disabled persons.
    Vaccine. 2021 Oct 6. pii: S0264-410X(21)01279.

  107. ALLEVA DG, Delpero AR, Scully MM, Murikipudi S, et al
    Development of an IgG-Fc fusion COVID-19 subunit vaccine, AKS-452.
    Vaccine. 2021 Oct 5. pii: S0264-410X(21)01294.
    PubMed     Abstract available

  108. LAZAROS G, Anastassopoulou C, Hatziantoniou S, Kalos T, et al
    A case series of acute pericarditis following COVID-19 vaccination in the context of recent reports from Europe and the United States.
    Vaccine. 2021 Oct 5. pii: S0264-410X(21)01295.
    PubMed     Abstract available

  109. DRAPER M, Stergiopoulos S
    Shingles vaccination uptake in Massachusetts adults aged 50 years and older.
    Vaccine. 2021 Oct 5. pii: S0264-410X(21)01223.
    PubMed     Abstract available

  110. BRUCE YU Y, Taraban MB, Briggs KT
    All vials are not the same: Potential role of vaccine quality in vaccine adverse reactions.
    Vaccine. 2021 Oct 5. pii: S0264-410X(21)01280.

  111. VADREVU KM, Raju D, Rani S, Reddy S, et al
    Persisting antibody responses to Vi polysaccharide-tetanus toxoid conjugate (Typbar TCV(R)) vaccine up to 7years following primary vaccination of children<2years of age with, or without, a booster vaccination.
    Vaccine. 2021 Oct 5. pii: S0264-410X(21)00966.
    PubMed     Abstract available

  112. CORCORAN KE, Scheitle CP, DiGregorio BD
    Christian nationalism and COVID-19 vaccine hesitancy and uptake.
    Vaccine. 2021 Oct 2. pii: S0264-410X(21)01289.
    PubMed     Abstract available

  113. SRICHAN P, Thohinung U, Kodyee S, Apidechkul T, et al
    Vaccine serocoverage under the expanded program on immunization among hill tribe children in Thailand: A cross-sectional study.
    Vaccine. 2021 Oct 1. pii: S0264-410X(21)01264.
    PubMed     Abstract available

    September 2021
  114. NIEUWENHUIZEN NE, Zyla J, Zedler U, Bandermann S, et al
    Weaker protection against tuberculosis in BCG-vaccinated male 129 S2 mice compared to females.
    Vaccine. 2021 Sep 30. pii: S0264-410X(21)01230.
    PubMed     Abstract available

  115. LEWIS G, Lazzaro T, Crawford NW
    Recurrent lipoatrophy following multiple vaccinations: A case study.
    Vaccine. 2021 Sep 30. pii: S0264-410X(21)01237.

  116. KHAIMOVA R, Fischetti B, Cope R, Berkowitz L, et al
    Serological response with Heplisav-B(R) in prior Hepatitis B vaccine non-responders living with HIV.
    Vaccine. 2021 Sep 29. pii: S0264-410X(21)01251.
    PubMed     Abstract available

  117. FRANCIS-OLIVIERO F, Bozoki S, Micsik A, Kieny MP, et al
    Research priorities to increase vaccination coverage in Europe (EU joint action on vaccination).
    Vaccine. 2021 Sep 28. pii: S0264-410X(21)01224.
    PubMed     Abstract available

  118. YACOUB MR, Cucca V, Asperti C, Ramirez GA, et al
    Efficacy of a rational algorithm to assess allergy risk in patients receiving the BNT162b2 vaccine.
    Vaccine. 2021 Sep 28. pii: S0264-410X(21)01239.
    PubMed     Abstract available

  119. ROMANO CJ, Hall C, Khodr ZG, Bukowinski AT, et al
    History of pandemic H1N1-containing influenza vaccination and risk for spontaneous abortion and birth defects.
    Vaccine. 2021 Sep 28. pii: S0264-410X(21)01171.
    PubMed     Abstract available

  120. HOFMEISTER MG, Weng MK, Thoroughman D, Thomasson ED, et al
    Prevalence of indications for adult hepatitis A vaccination among hepatitis A outbreak-associated cases, Three US States, 2016-2019.
    Vaccine. 2021 Sep 28. pii: S0264-410X(21)01254.
    PubMed     Abstract available

  121. MOON JE, Greenleaf ME, Regules JA, Debois M, et al
    A phase IIA extension study evaluating the effect of booster vaccination with a fractional dose of RTS,S/AS01E in a controlled human malaria infection challenge.
    Vaccine. 2021 Sep 27. pii: S0264-410X(21)01203.
    PubMed     Abstract available

  122. CASEY RM, Adrien N, Badiane O, Diallo A, et al
    National introduction of HPV vaccination in Senegal-Successes, challenges, and lessons learned.
    Vaccine. 2021 Sep 27. pii: S0264-410X(21)01075.
    PubMed     Abstract available

  123. VIEIRA REZENDE RP, Braz AS, Guimaraes MFB, Ribeiro SLE, et al
    Characteristics associated with COVID-19 vaccine hesitancy: A nationwide survey of 1000 patients with immune-mediated inflammatory diseases.
    Vaccine. 2021 Sep 25. pii: S0264-410X(21)01260.
    PubMed     Abstract available

  124. BLEICHER I, Kadour-Peero E, Sagi-Dain L, Sagi S, et al
    Early exploration of COVID-19 vaccination safety and effectiveness during pregnancy: interim descriptive data from a prospective observational study.
    Vaccine. 2021 Sep 25. pii: S0264-410X(21)01234.
    PubMed     Abstract available

  125. SHEVZOV-ZEBRUN N, Caplan A
    Parental consent for vaccination of minors against COVID-19.
    Vaccine. 2021 Sep 25. pii: S0264-410X(21)01250.

  126. FISHER KA, Nguyen N, Crawford S, Fouayzi H, et al
    Preferences for COVID-19 vaccination information and location: Associations with vaccine hesitancy, race and ethnicity.
    Vaccine. 2021 Sep 25. pii: S0264-410X(21)01261.
    PubMed     Abstract available

  127. MOLODECKY NA, Jafari H, Safdar RM, Ahmed JA, et al
    Modelling the spread of serotype-2 vaccine derived-poliovirus outbreak in Pakistan and Afghanistan to inform outbreak control strategies in the context of the COVID-19 pandemic.
    Vaccine. 2021 Sep 25. pii: S0264-410X(21)01228.
    PubMed     Abstract available

  128. ZENG W, Cui Y, Jarawan E, Avila C, et al
    Optimizing immunization schedules in endemic cholera regions: cost-effectiveness assessment of vaccination strategies for cholera control in Bangladesh.
    Vaccine. 2021 Sep 24. pii: S0264-410X(21)01235.
    PubMed     Abstract available

  129. AKSNES BN, Walldorf JA, Nkwenkeu SF, Zoma RL, et al
    Vaccination information, motivations, and barriers in the context of meningococcal serogroup A conjugate vaccine introduction: A qualitative assessment among caregivers in Burkina Faso, 2018.
    Vaccine. 2021 Sep 24. pii: S0264-410X(21)01229.
    PubMed     Abstract available

  130. FADLYANA E, Rusmil K, Tarigan R, Rahmadi AR, et al
    A phase III, observer-blind, randomized, placebo-controlled study of the efficacy, safety, and immunogenicity of SARS-CoV-2 inactivated vaccine in healthy adults aged 18-59 years: An interim analysis in Indonesia.
    Vaccine. 2021 Sep 24. pii: S0264-410X(21)01255.
    PubMed     Abstract available

  131. SINGH AK, Phatak SR, Singh R, Bhattacharjee K, et al
    Antibody response after first and second-dose of ChAdOx1-nCOV (Covishield(TM)(R)) and BBV-152 (Covaxin(TM)(R)) among health care workers in India: The final results of cross-sectional coronavirus vaccine-induced antibody titre (COVAT) study.
    Vaccine. 2021 Sep 24. pii: S0264-410X(21)01258.
    PubMed     Abstract available

  132. YAMAZAKI Y, Ikeda M, Imada T, Furuno K, et al
    A phase 3, multicenter, single-arm, open-label study to assess the safety, tolerability, and immunogenicity of a single dose of 13-valent pneumococcal conjugate vaccine in Japanese participants aged 6-64 years who are considered to be at increased ris
    Vaccine. 2021 Sep 23. pii: S0264-410X(21)01168.
    PubMed     Abstract available

  133. MOORE KA, Ostrowsky JT, Kraigsley AM, Mehr AJ, et al
    A Research and Development (R&D) roadmap for influenza vaccines: Looking toward the future.
    Vaccine. 2021 Sep 23. pii: S0264-410X(21)01028.
    PubMed     Abstract available

  134. CHOWDHURY F, Akter A, Rahman Bhuiyan T, Tauheed I, et al
    A non-inferiority trial comparing two recombinant vaccines (Hepa-B vs. Engerix-B) for hepatitis B among adults in Dhaka, Bangladesh.
    Vaccine. 2021 Sep 21. pii: S0264-410X(21)01222.
    PubMed     Abstract available

  135. MELGAARD A, Krogsgaard LW, Randrup T, Plana-Ripoll O, et al
    Pre-vaccination vulnerability and suspected adverse events following HPV vaccination. A case-control study nested in the Danish national birth cohort.
    Vaccine. 2021 Sep 21. pii: S0264-410X(21)01232.
    PubMed     Abstract available

  136. LIU CH, Huang WT, Chie WC, Arnold Chan K, et al
    Safety surveillance of varicella vaccine using tree-temporal scan analysis.
    Vaccine. 2021 Sep 21. pii: S0264-410X(21)01226.
    PubMed     Abstract available

  137. GIESE H, Neth H, Gaissmaier W
    Determinants of information diffusion in online communication on vaccination: The benefits of visual displays.
    Vaccine. 2021 Sep 21. pii: S0264-410X(21)01195.
    PubMed     Abstract available

  138. MAHAPATRA SR, Dey J, Kaur T, Sarangi R, et al
    Immunoinformatics and molecular docking studies reveal a novel Multi-Epitope peptide vaccine against pneumonia infection.
    Vaccine. 2021 Sep 20. pii: S0264-410X(21)01204.
    PubMed     Abstract available

  139. PARK SJ, Kang YM, Cho HK, Kim DY, et al
    Cross-protective efficacy of inactivated whole influenza vaccines against Korean Y280 and Y439 lineage H9N2 viruses in mice.
    Vaccine. 2021 Sep 20. pii: S0264-410X(21)01207.
    PubMed     Abstract available

  140. ANGSUWATCHARAKON P, Puthanakit T, Bunjoungmanee P, Anugulruengkitt S, et al
    High seroprevalence of rubella in Thai children with a 2-dose MMR national immunization policy.
    Vaccine. 2021 Sep 20. pii: S0264-410X(21)01127.
    PubMed     Abstract available

  141. SCHNEIDER JC, Chen HC, Bautista E, Retallack D, et al
    Safety and immunogenicity of Px563L, a recombinant anthrax vaccine candidate, in a two-dose regimen for post-exposure prophylaxis in healthy adults.
    Vaccine. 2021 Sep 17. pii: S0264-410X(21)01123.
    PubMed     Abstract available

  142. WILEY KE, Levy D, Shapiro GK, Dube E, et al
    A user-centered approach to developing a new tool measuring the behavioural and social drivers of vaccination.
    Vaccine. 2021 Sep 17. pii: S0264-410X(21)01186.
    PubMed     Abstract available

  143. ELBASHA EH, Choi Y, Daniels V, Goveia MG, et al
    Cost-effectiveness of routine catch-up hepatitis a vaccination in the United States: Dynamic transmission modeling study.
    Vaccine. 2021 Sep 17. pii: S0264-410X(21)01147.
    PubMed     Abstract available

  144. MANSUY JM, Sagna AS, Laurent M, Izopet J, et al
    COVID-19 diagnosis in a Senegalese company: A model for COVID-19 vaccination?
    Vaccine. 2021 Sep 17. pii: S0264-410X(21)01227.

  145. RAINA MACINTYRE C, Costantino V, Chanmugam A
    The use of face masks during vaccine roll-out in New YorkCity and impact on epidemic control.
    Vaccine. 2021 Sep 16. pii: S0264-410X(21)01164.
    PubMed     Abstract available

  146. WANG J, Wu QS, Lu J, Ni YH, et al
    Low vaccination coverage of pneumococcal conjugate vaccines (PCVs) in Shanghai, China: A database analysis based on birth cohorts from 2012 to 2020.
    Vaccine. 2021 Sep 16. pii: S0264-410X(21)01190.
    PubMed     Abstract available

  147. OZAWA S, Chen HH, Rao GG, Eguale T, et al
    Value of pneumococcal vaccination in controlling the development of antimicrobial resistance (AMR): Case study using DREAMR in Ethiopia.
    Vaccine. 2021 Sep 16. pii: S0264-410X(21)00471.
    PubMed     Abstract available

  148. CHARD AN, Martinez M, Matanock A, Kassem AM, et al
    Estimation of oral poliovirus vaccine effectiveness in Afghanistan, 2010-2020.
    Vaccine. 2021 Sep 16. pii: S0264-410X(21)01199.
    PubMed     Abstract available

  149. MOSINA L, Kulper-Schiek W, Jacques-Carroll L, Earnshaw A, et al
    Supporting National Immunization Technical Advisory Groups in the WHO European Region in developing national COVID-19 vaccination recommendations through online communication platform.
    Vaccine. 2021 Sep 16. pii: S0264-410X(21)01225.
    PubMed     Abstract available

  150. AUGUSTO HERNANDES ROCHA T, Grapiuna de Almeida D, Shankar Kozhumam A, Cristina da Silva N, et al
    Microplanning for designing vaccination campaigns in low-resource settings: A geospatial artificial intelligence-based framework.
    Vaccine. 2021 Sep 15. pii: S0264-410X(21)01197.
    PubMed     Abstract available

  151. ABAYNEH T, Getachew B, Gelaye E, Traxler R, et al
    Viability evaluation of freeze dried and suspension anthrax spore vaccine formulations stored at different temperatures.
    Vaccine. 2021 Sep 15. pii: S0264-410X(21)01202.
    PubMed     Abstract available

  152. LEE SI, Jeong CG, Ul Salam Mattoo S, Nazki S, et al
    Protective immunity induced by concurrent intradermal injection of porcine circovirus type 2 and Mycoplasma hyopneumoniae inactivated vaccines in pigs.
    Vaccine. 2021 Sep 15. pii: S0264-410X(21)00921.
    PubMed     Abstract available

  153. SULIMAN S, Pelzer PT, Shaku M, Rozot V, et al
    Meeting report: Virtual Global Forum on Tuberculosis Vaccines, 20-22 April 2021.
    Vaccine. 2021 Sep 15. pii: S0264-410X(21)01154.
    PubMed     Abstract available

  154. KOSHAL SS, Ray A, Mehra R, Kaur A, et al
    Partnering for rotavirus vaccine introduction in India: A retrospective analysis.
    Vaccine. 2021 Sep 15. pii: S0264-410X(21)01193.
    PubMed     Abstract available

  155. KIM DY, Kang YM, Cho HK, Park SJ, et al
    Development of a recombinant H9N2 influenza vaccine candidate against the Y280 lineage field virus and its protective efficacy.
    Vaccine. 2021 Sep 14. pii: S0264-410X(21)01149.
    PubMed     Abstract available

    Influenza vaccination at the workplace.
    Vaccine. 2021 Sep 14. pii: S0264-410X(21)01188.

  157. BENJAMIN-CHUNG J, Arnold BF, Mishra K, Kennedy CJ, et al
    City-wide school-located influenza vaccination: A retrospective cohort study.
    Vaccine. 2021 Sep 14. pii: S0264-410X(21)01161.
    PubMed     Abstract available

  158. KNUF M, Haas H, Garcia-Corbeira P, Turriani E, et al
    Hexavalent vaccines: What can we learn from head-to-head studies?
    Vaccine. 2021 Sep 13. pii: S0264-410X(21)01146.
    PubMed     Abstract available

  159. MKOPI A, Mtenga S, Festo C, Mhalu G, et al
    Factors affecting non-coverage of measles-rubella vaccination among children aged 9-59 months in Tanzania.
    Vaccine. 2021 Sep 13. pii: S0264-410X(21)01196.
    PubMed     Abstract available

  160. PALACHE A, Rockman S, Taylor B, Akcay M, et al
    Vaccine complacency and dose distribution inequities limit the benefits of seasonal influenza vaccination, despite a positive trend in use.
    Vaccine. 2021 Sep 11. pii: S0264-410X(21)01157.
    PubMed     Abstract available

    Third-generation smallpox vaccine strain-based recombinant vaccines for viral hemorrhagic fevers.
    Vaccine. 2021 Sep 11. pii: S0264-410X(21)01169.
    PubMed     Abstract available

  162. PARADOWSKA-STANKIEWICZ I, Rumik A, Bogusz J, Zbrzezniak J, et al
    Duration of protection against Bordetella pertussis infection elicited by whole-cell and acellular vaccine priming in Polish children and adolescents.
    Vaccine. 2021 Sep 9. pii: S0264-410X(21)01167.
    PubMed     Abstract available

  163. FUJISAWA S, Murata S, Takehara M, Aoyama J, et al
    In vitro characterization of adipocyte plasma membrane-associated protein from poultry red mites, Dermanyssus gallinae, as a vaccine antigen for chickens.
    Vaccine. 2021 Sep 8. pii: S0264-410X(21)01166.
    PubMed     Abstract available

  164. THOMPSON MG, Soto G, Perez A, Newes-Adeyim G, et al
    Influenza vaccine effectiveness within prospective cohorts of healthcare personnel in Israel and Peru 2016-2019.
    Vaccine. 2021 Sep 8. pii: S0264-410X(21)00982.
    PubMed     Abstract available

  165. PERRY M, Akbari A, Cottrell S, Gravenor MB, et al
    Inequalities in coverage of COVID-19 vaccination: A population register based cross-sectional study in Wales, UK.
    Vaccine. 2021 Sep 8. pii: S0264-410X(21)01198.
    PubMed     Abstract available

  166. PLATT HL, Cardona JF, Haranaka M, Schwartz HI, et al
    A phase 3 trial of safety, tolerability, and immunogenicity of V114, 15-valent pneumococcal conjugate vaccine, compared with 13-valent pneumococcal conjugate vaccine in adults 50 years of age and older (PNEU-AGE).
    Vaccine. 2021 Sep 7. pii: S0264-410X(21)01097.
    PubMed     Abstract available

  167. ABREU E SILVA HB, Correa HP, Ribeiro IA, Nascimento VAM, et al
    Impact of six years of routine varicella vaccination on the disease-related hospitalizations at Minas Gerais, Brazil.
    Vaccine. 2021 Sep 7. pii: S0264-410X(21)01009.
    PubMed     Abstract available

  168. KUNITOKI K, Funato M, Mitsunami M, Kinoshita T, et al
    Access to HPV vaccination in Japan: Increasing social trust to regain vaccine confidence.
    Vaccine. 2021 Sep 7. pii: S0264-410X(21)01145.
    PubMed     Abstract available

  169. MOLL K, Wong HL, Fingar K, Ke Zhou C, et al
    Vaccine exposure during pregnancy among privately and publicly insured women in the United States, 2016-2018.
    Vaccine. 2021 Sep 7. pii: S0264-410X(21)01151.
    PubMed     Abstract available

  170. VAN DONGEN JAP, Rouers EDM, Bonten MJM, Bruijning-Verhagen PCJ, et al
    Evaluation of non-specific effects of human rotavirus vaccination in medical risk infants.
    Vaccine. 2021 Sep 7. pii: S0264-410X(21)01115.
    PubMed     Abstract available

  171. JACOBI CJ, Vaidyanathan B
    Racial differences in anticipated COVID-19 vaccine acceptance among religious populations in the US.
    Vaccine. 2021 Sep 7. pii: S0264-410X(21)01184.
    PubMed     Abstract available

  172. MOORE DCBC, Nehab MF, Camacho KG, Reis AT, et al
    Low COVID-19 vaccine hesitancy in Brazil.
    Vaccine. 2021 Sep 7. pii: S0264-410X(21)01192.
    PubMed     Abstract available

  173. EBERHARDT J, Ling J
    Predicting COVID-19 vaccination intention using protection motivation theory and conspiracy beliefs.
    Vaccine. 2021 Sep 7. pii: S0264-410X(21)01189.
    PubMed     Abstract available

  174. WAINSTOCK T, Yoles I, Sergienko R, Sheiner E, et al
    Prenatal maternal COVID-19 vaccination and pregnancy outcomes.
    Vaccine. 2021 Sep 7. pii: S0264-410X(21)01191.
    PubMed     Abstract available

  175. SULIMAN DM, Nawaz FA, Mohanan P, Modber MAKA, et al
    UAE efforts in promoting COVID-19 vaccination and building vaccine confidence.
    Vaccine. 2021 Sep 7. pii: S0264-410X(21)01194.
    PubMed     Abstract available

  176. BHAT S, Caldera F, Farraye FA
    Standardizing shared vaccination responsibilities among specialists to improve vaccination rates of immunosuppressed patients.
    Vaccine. 2021 Sep 4. pii: S0264-410X(21)01121.

  177. RANE MS, Rohani P, Halloran ME
    Durability of protection after 5 doses of acellular pertussis vaccine among 5-9 year old children in King County, Washington.
    Vaccine. 2021 Sep 4. pii: S0264-410X(21)01118.
    PubMed     Abstract available

  178. SISNOWSKI J, Vujovich-Dunn C, Gidding H, Brotherton J, et al
    Differences in school factors associated with adolescent HPV vaccination initiation and completion coverage in three Australian states.
    Vaccine. 2021 Sep 4. pii: S0264-410X(21)01124.
    PubMed     Abstract available

  179. LEVIN D, Shimon G, Fadlon-Derai M, Gershovitz L, et al
    Myocarditis following COVID-19 vaccination - A case series.
    Vaccine. 2021 Sep 4. pii: S0264-410X(21)01172.
    PubMed     Abstract available

  180. BOZORGI A, Fahimnia B
    Micro array patch (MAP) for the delivery of thermostable vaccines in Australia: A cost/benefit analysis.
    Vaccine. 2021 Sep 3. pii: S0264-410X(21)01036.
    PubMed     Abstract available

  181. BOZORGI A, Fahimnia B
    Transforming the vaccine supply chain in Australia: Opportunities and challenges.
    Vaccine. 2021 Sep 3. pii: S0264-410X(21)01066.
    PubMed     Abstract available

  182. SONG JY, Chang CJ, Andrews C, Diez-Domingo J, et al
    Safety, tolerability, and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, followed by sequential PPSV23 vaccination in healthy adults aged>/=50years: A randomized phase III trial (PNEU-PATH).
    Vaccine. 2021 Sep 3. pii: S0264-410X(21)01071.
    PubMed     Abstract available

  183. LAWRENCE J, Kitchin N, Anderson AS, Pride MW, et al
    Safety and immunogenicity of different Clostridioides (Clostridium) difficile vaccine formulations in two early phase randomized studies of healthy adults aged 50-85 years.
    Vaccine. 2021 Sep 3. pii: S0264-410X(21)00592.
    PubMed     Abstract available

  184. ZHOU Z, Zhang X, Li Q, Fu L, et al
    Unmethylated CpG motif-containing genomic DNA fragments of bacillus calmette-guerin improves immune response towards a DNA vaccine for COVID-19.
    Vaccine. 2021 Sep 3. pii: S0264-410X(21)01165.
    PubMed     Abstract available

  185. VOORMAN A, O'Reilly K, Lyons H, Goel AK, et al
    Real-time prediction model of cVDPV2 outbreaks to aid outbreak response vaccination strategies.
    Vaccine. 2021 Sep 2. pii: S0264-410X(21)01112.
    PubMed     Abstract available

  186. KARAFILLAKIS E, Peretti-Watel P, Verger P, Chantler T, et al
    The role of maturity in adolescent decision-making around HPV vaccination in France.
    Vaccine. 2021 Sep 2. pii: S0264-410X(21)01156.
    PubMed     Abstract available

  187. ALI A, Dwyer D, Wu Q, Wang Q, et al
    Characterization of humoral response to COVID mRNA vaccines in multiple sclerosis patients on disease modifying therapies.
    Vaccine. 2021 Sep 2. pii: S0264-410X(21)01126.
    PubMed     Abstract available

  188. MCCLAIN JB, Chuang A, Reid C, Moore SM, et al
    Rabies virus neutralizing activity, pharmacokinetics, and safety of the monoclonal antibody mixture SYN023 in combination with rabies vaccination: Results of a phase 2, randomized, blinded, controlled trial.
    Vaccine. 2021 Sep 2. pii: S0264-410X(21)01114.
    PubMed     Abstract available

  189. DRUEDAHL LC, Minssen T, Price WN
    Collaboration in times of crisis: A study on COVID-19 vaccine R&D partnerships.
    Vaccine. 2021 Sep 2. pii: S0264-410X(21)01163.
    PubMed     Abstract available

  190. ZAMAN K, Kovacs SD, Vanderende K, Aziz A, et al
    Assessing the immunogenicity of three different inactivated polio vaccine schedules for use after oral polio vaccine cessation, an open label, phase IV, randomized controlled trial.
    Vaccine. 2021 Sep 1. pii: S0264-410X(21)01113.
    PubMed     Abstract available

  191. BARRY M, Temsah MH, Aljamaan F, Saddik B, et al
    COVID-19 vaccine uptake among healthcare workers in the fourth country to authorize BNT162b2 during the first month of rollout.
    Vaccine. 2021 Sep 1. pii: S0264-410X(21)01131.
    PubMed     Abstract available

  192. KOTLER L, Greenberg D, Givon-Lavi N, van der Beek BA, et al
    Decline in pneumococcal nasopharyngeal carriage in children 6-23 months with respiratory illnesses following pneumococcal conjugate vaccine implementation.
    Vaccine. 2021 Sep 1. pii: S0264-410X(21)01130.
    PubMed     Abstract available

  193. CLAYTON K, Finley C, Flynn DJ, Graves M, et al
    Evaluating the effects of vaccine messaging on immunization intentions and behavior: Evidence from two randomized controlled trials in Vermont.
    Vaccine. 2021 Sep 1. pii: S0264-410X(21)01095.
    PubMed     Abstract available

  194. AZAM JM, Saitta B, Bonner K, Ferrari MJ, et al
    Modelling the relative benefits of using the measles vaccine outside cold chain for outbreak response.
    Vaccine. 2021 Sep 1. pii: S0264-410X(21)01101.
    PubMed     Abstract available

    August 2021
  195. PRIVOR-DUMM LA, Poland GA, Barratt J, Durrheim DN, et al
    A global agenda for older adult immunization in the COVID-19 era: A roadmap for action.
    Vaccine. 2021;39:5240-5250.
    PubMed     Abstract available

  196. TROGSTAD L, Robertson AH, Mjaaland S, Magnus P, et al
    Association between ChAdOx1 nCoV-19 vaccination and bleeding episodes: Large population-based cohort study.
    Vaccine. 2021 Aug 31. pii: S0264-410X(21)01103.
    PubMed     Abstract available

  197. CANTARELLI P, Belle N, Quattrone F
    Nudging influenza vaccination among health care workers.
    Vaccine. 2021 Aug 31. pii: S0264-410X(21)01073.
    PubMed     Abstract available

  198. ALBANI VVL, Loria J, Massad E, Zubelli JP, et al
    The impact of COVID-19 vaccination delay: A data-driven modeling analysis for Chicago and New York City.
    Vaccine. 2021 Aug 31. pii: S0264-410X(21)01158.
    PubMed     Abstract available

  199. FOWLER A, Sampson M, Remaley AT, Chackerian B, et al
    A VLP-based vaccine targeting ANGPTL3 lowers plasma triglycerides in mice.
    Vaccine. 2021 Aug 30. pii: S0264-410X(21)01125.
    PubMed     Abstract available

  200. BROSH-NISSIMOV T, Sorek N, Yeshayahu M, Zherebovich I, et al
    Oropharyngeal shedding of herpesviruses before and after BNT162b2 mRNA vaccination against COVID-19.
    Vaccine. 2021 Aug 30. pii: S0264-410X(21)01148.
    PubMed     Abstract available

  201. BATOOL R, Tahir Yousafzai M, Qureshi S, Ali M, et al
    Effectiveness of typhoid conjugate vaccine against culture-confirmed typhoid in a peri-urban setting in Karachi: A case-control study.
    Vaccine. 2021 Aug 28. pii: S0264-410X(21)01099.
    PubMed     Abstract available

  202. CAMPBELL JD, Pasetti MF, Oot L, Adam Z, et al
    Linked vaccination coverage surveys plus serosurveys among Ethiopian toddlers undertaken three years apart to compare coverage and serologic evidence of protection in districts implementing the RED-QI approach.
    Vaccine. 2021 Aug 28. pii: S0264-410X(21)01119.
    PubMed     Abstract available

  203. BAQUI AH, Koffi AK, McCollum ED, Roy AD, et al
    Impact of national introduction of ten-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in Bangladesh: Case-control and time-trend studies.
    Vaccine. 2021 Aug 28. pii: S0264-410X(21)01116.
    PubMed     Abstract available

  204. PRELOG M, Almanzar G, Stern R, Robrade K, et al
    Humoral and cellular immune response to tick-borne-encephalitis (TBE) vaccination depends on booster doses in patients with Juvenile Idiopathic Arthritis (JIA).
    Vaccine. 2021 Aug 27. pii: S0264-410X(21)01049.
    PubMed     Abstract available

  205. O'LORCAIN P, Cotter S, Walsh C
    Influenza vaccine uptake among healthcare workers and residents in public health care facilities in Ireland over nine influenza seasons (2011-2012 to 2019-2020).
    Vaccine. 2021 Aug 27. pii: S0264-410X(21)00987.
    PubMed     Abstract available

  206. MALTEZOU HC, Effraimidou E, Cassimos DC, Medic S, et al
    Vaccination programs for pregnant women in Europe, 2021.
    Vaccine. 2021 Aug 27. pii: S0264-410X(21)01122.
    PubMed     Abstract available

  207. GORANDER S, Honda-Okubo Y, Backstrom M, Baldwin J, et al
    A truncated glycoprotein G vaccine formulated with Advax-CpG adjuvant provides protection of mice against genital herpes simplex virus 2 infection.
    Vaccine. 2021 Aug 26. pii: S0264-410X(21)01098.
    PubMed     Abstract available

  208. SILCOCK R, Moghimi A, Perrett K, Crawford N, et al
    Subcutaneous nodule at the vaccine injection site - A case of mistaken identity.
    Vaccine. 2021 Aug 26. pii: S0264-410X(21)01069.

  209. NOWAK SA, Gidengil CA, Parker AM, Matthews LJ, et al
    Association among trust in health care providers, friends, and family, and vaccine hesitancy.
    Vaccine. 2021 Aug 26. pii: S0264-410X(21)01068.
    PubMed     Abstract available

  210. HARPAZ R
    COVID-19 vaccine safety monitoring: Might differential healthcare seeking introduce detection bias into rates of medical events and cause false safety signals?
    Vaccine. 2021 Aug 25. pii: S0264-410X(21)00712.

  211. AZIZ AB, Zaman K, Kim DR, Park JY, et al
    Re-evaluation of population-level protection conferred by a rotavirus vaccine using the 'fried-egg' approach in a rural setting in Bangladesh.
    Vaccine. 2021 Aug 25. pii: S0264-410X(21)01096.
    PubMed     Abstract available

  212. DECKER MD, Garman PM, Hughes H, Yacovone MA, et al
    Enhanced safety surveillance study of ACAM2000 smallpox vaccine among US military service members.
    Vaccine. 2021 Aug 25. pii: S0264-410X(21)01074.
    PubMed     Abstract available

  213. KUROKAWA N, Robinson MK, Bernard C, Kawaguchi Y, et al
    Safety and immunogenicity of a plant-derived rotavirus-like particle vaccine in adults, toddlers and infants.
    Vaccine. 2021 Aug 25. pii: S0264-410X(21)01100.
    PubMed     Abstract available

  214. LEWIN BJ, Rodriguez J, Yang SJ, Tartof SY, et al
    Predictors of hepatitis A immunity in adults in California in order to better utilize hepatitis A vaccine.
    Vaccine. 2021 Aug 25. pii: S0264-410X(21)01104.
    PubMed     Abstract available

  215. XU X, Rodgers MD, Guo WG
    A hub-and-spoke design for ultra-cold COVID-19 vaccine distribution.
    Vaccine. 2021 Aug 25. pii: S0264-410X(21)01117.
    PubMed     Abstract available

  216. ODUWOLE EO, Mahomed H, Laurenzi CA, Larson HJ, et al
    Point-of-care vaccinators' perceptions of vaccine hesitancy drivers: A qualitative study from the cape metropolitan district, South Africa.
    Vaccine. 2021 Aug 24. pii: S0264-410X(21)01102.
    PubMed     Abstract available

  217. ROTENBERG S, Downer MB, Cooper J
    Making COVID-19 vaccinations accessible for people with disabilities.
    Vaccine. 2021 Aug 24. pii: S0264-410X(21)01110.

  218. MORAIS E, El Mouaddin N, Schuurman S, De A, et al
    Landscape assessment for gender neutral human papillomavirus vaccination recommendations including head and neck cancer burden data.
    Vaccine. 2021 Aug 24. pii: S0264-410X(21)01076.
    PubMed     Abstract available

  219. MORIKAWA Y, Sakakibara H, Kimiya T, Obonai T, et al
    Live attenuated vaccine efficacy six months after intravenous immunoglobulin therapy for Kawasaki disease.
    Vaccine. 2021 Aug 24. pii: S0264-410X(21)01011.
    PubMed     Abstract available

  220. SUZUKI H, Noguchi T, Ogawa K, Miyazato P, et al
    Fusion of parvovirus B19 receptor-binding domain and pneumococcal surface protein A induces protective immunity against parvovirus B19 and Streptococcus pneumoniae.
    Vaccine. 2021;39:5146-5152.
    PubMed     Abstract available

  221. AHMED D, VanderEnde K, Harvey P, Bhatnagar P, et al
    Human papillomavirus (HPV) vaccine introduction in Sikkim state: Best practices from the first statewide multiple-age cohort HPV vaccine introduction in India-2018-2019.
    Vaccine. 2021 Aug 21. pii: S0264-410X(21)00901.
    PubMed     Abstract available

  222. HAUSI H, Nicks P, Mzengeza T, Tsega A, et al
    The challenge of identifying eligible girls for HPV vaccination: HPV mapping data verification in Malawi.
    Vaccine. 2021 Aug 20. pii: S0264-410X(21)00902.
    PubMed     Abstract available

  223. NIKOLAY B, Ribeiro Dos Santos G, Lipsitch M, Rahman M, et al
    Assessing the feasibility of Nipah vaccine efficacy trials based on previous outbreaks in Bangladesh.
    Vaccine. 2021 Aug 20. pii: S0264-410X(21)01047.
    PubMed     Abstract available

  224. DUDLEY MZ, Bernier R, Brewer J, Salmon DA, et al
    Walking the Tightrope: Reevaluating science communication in the era of COVID-19 vaccines.
    Vaccine. 2021 Aug 19. pii: S0264-410X(21)01070.
    PubMed     Abstract available

  225. JUNG Y, Min JY, Kim HJ, Min KB, et al
    Disparities in infant mortality from all-infectious, vaccine-preventable, and non-vaccine preventable diseases in relation to parental education.
    Vaccine. 2021 Aug 19. pii: S0264-410X(21)01012.
    PubMed     Abstract available

  226. VENEGAS-VARGAS C, Taylor LP, Foss DL, Godbee TK, et al
    Cellular and humoral immunity following vaccination with two different PCV2 vaccines (containing PCV2a or PCV2a/PCV2b) and challenge with virulent PCV2d.
    Vaccine. 2021 Aug 19. pii: S0264-410X(21)01033.
    PubMed     Abstract available

  227. ZHANG N, Zheng T, Chen Y, Zhu H, et al
    Coxsackievirus B5 virus-like particle vaccine exhibits greater immunogenicity and immunoprotection than its inactivated counterpart in mice.
    Vaccine. 2021 Aug 19. pii: S0264-410X(21)01007.
    PubMed     Abstract available

  228. WIEMKEN TL, Salas J, Hoft DF, Jacobs C, et al
    Dementia risk following influenza vaccination in a large veteran cohort running head: Influenza vaccination and dementia.
    Vaccine. 2021 Aug 19. pii: S0264-410X(21)01079.
    PubMed     Abstract available

  229. BRAEYE T, Cornelissen L, Catteau L, Haarhuis F, et al
    Vaccine effectiveness against infection and onwards transmission of COVID-19: Analysis of Belgian contact tracing data, January-June 2021.
    Vaccine. 2021 Aug 19. pii: S0264-410X(21)01108.
    PubMed     Abstract available

  230. LEE T, Gutierrez RL, Maciel M, Poole S, et al
    Safety and immunogenicity of intramuscularly administered CS6 subunit vaccine with a modified heat-labile enterotoxin from enterotoxigenic Escherichia coli.
    Vaccine. 2021 Aug 18. pii: S0264-410X(21)01065.
    PubMed     Abstract available

  231. HUANG XX, Bose AS, Gupta BP, Rai P, et al
    Vaccine preventable diseases surveillance in Nepal: How much does it cost?
    Vaccine. 2021 Aug 18. pii: S0264-410X(21)00915.
    PubMed     Abstract available

  232. KARAFILLAKIS E, Paterson P, Larson HJ
    'My primary purpose is to protect the unborn child': Understanding pregnant women's perceptions of maternal vaccination and vaccine trials in Europe.
    Vaccine. 2021 Aug 18. pii: S0264-410X(21)01014.
    PubMed     Abstract available

  233. BEDFORD H, Firman N, Waller J, Marlow L, et al
    Which young women are not being vaccinated against HPV? Cross-sectional analysis of a UK national cohort study.
    Vaccine. 2021 Aug 18. pii: S0264-410X(21)01005.
    PubMed     Abstract available

  234. KOHL-HECKL WK, Schroter M, Dobos G, Cramer H, et al
    Complementary medicine use and flu vaccination - A nationally representative survey of US adults.
    Vaccine. 2021 Aug 18. pii: S0264-410X(21)01037.
    PubMed     Abstract available

  235. NACIUTE M, Kiwitt T, Kemp RA, Hook S, et al
    Bacteria biohybrid oral vaccines for colorectal cancer treatment reduce tumor growth and increase immune infiltration.
    Vaccine. 2021 Aug 18. pii: S0264-410X(21)01048.
    PubMed     Abstract available

  236. LIU S, Liu J
    Public attitudes toward COVID-19 vaccines on English-language Twitter: A sentiment analysis.
    Vaccine. 2021 Aug 17. pii: S0264-410X(21)01106.
    PubMed     Abstract available

  237. MVUNDURA M, Frivold C, Janik Osborne A, Soni P, et al
    Vaccine innovation prioritisation strategy: Findings from three country-stakeholder consultations on vaccine product innovations.
    Vaccine. 2021 Aug 16. pii: S0264-410X(21)01044.
    PubMed     Abstract available

  238. JIANG Y, Li X, Yu L, Tong W, et al
    Immune efficacy of a candidate porcine reproductive and respiratory syndrome vaccine rHN-NP49 administered by a Needle-free intradermal delivery system in comparison with intramuscular injection.
    Vaccine. 2021 Aug 16. pii: S0264-410X(21)01043.
    PubMed     Abstract available

  239. HASSAN AS, Perera DJ, Ward BJ, Ndao M, et al
    Therapeutic activity of a Salmonella-vectored Schistosoma mansoni vaccine in a mouse model of chronic infection.
    Vaccine. 2021 Aug 16. pii: S0264-410X(21)01051.
    PubMed     Abstract available

  240. LAIGLE V, Postma MJ, Pavlovic M, Cadeddu C, et al
    Vaccine market access pathways in the EU27 and the United Kingdom-analysis and recommendations for improvements.
    Vaccine. 2021 Aug 14. pii: S0264-410X(21)00918.
    PubMed     Abstract available

  241. JANSSEN RS, Bruxvoort K, Jacobsen SJ, Slezak J, et al
    Considerations for estimating real-world outcomes and value in vaccination: A case study with adult hepatitis B virus vaccination.
    Vaccine. 2021 Aug 14. pii: S0264-410X(21)01015.
    PubMed     Abstract available

  242. HAGAN LM, Dusseau C, Crockett M, Rodriguez T, et al
    COVID-19 vaccination in the Federal Bureau of Prisons, December 2020-April 2021.
    Vaccine. 2021 Aug 14. pii: S0264-410X(21)01078.
    PubMed     Abstract available

  243. PRESTON KB, Wong TAS, To A, Tashiro TE, et al
    Single-vial filovirus glycoprotein vaccines: Biophysical characteristics and immunogenicity after co-lyophilization with adjuvant.
    Vaccine. 2021 Aug 13. pii: S0264-410X(21)01002.
    PubMed     Abstract available

  244. LI L, Hessell AJ, Kong XP, Haigwood NL, et al
    A large repertoire of B cell lineages targeting one cluster of epitopes in a vaccinated rhesus macaque.
    Vaccine. 2021 Aug 13. pii: S0264-410X(21)01035.
    PubMed     Abstract available

  245. RODRIGUES DE OLIVEIRA N, Jorge S, Andrade Colares Maia M, Thurow Bunde T, et al
    Protective efficacy of whole-cell inactivated Leptospira vaccines made using virulent or avirulent strains in a hamster model.
    Vaccine. 2021 Aug 13. pii: S0264-410X(21)01034.
    PubMed     Abstract available

  246. CIAPPONI A, Bardach A, Mazzoni A, Alconada T, et al
    Safety of components and platforms of COVID-19 vaccines considered for use in pregnancy: A rapid review.
    Vaccine. 2021 Aug 13. pii: S0264-410X(21)01067.
    PubMed     Abstract available

  247. SCHLEISS MR, John CC, Permar SR
    Children are the key to the Endgame: A case for routine pediatric COVID vaccination.
    Vaccine. 2021 Aug 12. pii: S0264-410X(21)01004.

  248. ROBERTSON RC, Church JA, Edens TJ, Mutasa K, et al
    The fecal microbiome and rotavirus vaccine immunogenicity in rural Zimbabwean infants.
    Vaccine. 2021 Aug 12. pii: S0264-410X(21)00981.
    PubMed     Abstract available

  249. WEBSTER H, Valencia S, Kumar A, Chan C, et al
    Pre-existing immunity to cytomegalovirus in macaques influences human CMV vaccine responses in preclinical models.
    Vaccine. 2021 Aug 12. pii: S0264-410X(21)01029.
    PubMed     Abstract available

  250. IWAMOTO M, Hickman CJ, Colley H, Arciuolo RJ, et al
    Measles infection in persons with secondary vaccine failure, New York City, 2018-19.
    Vaccine. 2021 Aug 12. pii: S0264-410X(21)00983.
    PubMed     Abstract available

  251. PALLADINO G, Ferrari A, Music N, Settembre EC, et al
    Improved immunologic responses to heterologous influenza strains in children with low preexisting antibody response vaccinated with MF59-adjuvanted influenza vaccine.
    Vaccine. 2021 Aug 12. pii: S0264-410X(21)01041.
    PubMed     Abstract available

  252. GRUPEL D, Gazit S, Schreiber L, Nadler V, et al
    Kinetics of SARS-CoV-2 anti-S IgG after BNT162b2 vaccination.
    Vaccine. 2021 Aug 11. pii: S0264-410X(21)01045.
    PubMed     Abstract available

  253. STINSON JA, Boopathy AV, Cieslewicz BM, Zhang Y, et al
    Enhancing influenza vaccine immunogenicity and efficacy through infection mimicry using silk microneedles.
    Vaccine. 2021 Aug 11. pii: S0264-410X(21)00957.
    PubMed     Abstract available

  254. OKAMURA S, Ebina H
    Could live attenuated vaccines better control COVID-19?
    Vaccine. 2021 Aug 11. pii: S0264-410X(21)01038.
    PubMed     Abstract available

  255. KANJI JN, Bailey A, Fenton J, Ling SH, et al
    Detection of SARS-CoV-2 antibodies formed in response to the BNT162b2 and mRNA-1237 mRNA vaccine by commercial antibody tests.
    Vaccine. 2021 Aug 11. pii: S0264-410X(21)01042.
    PubMed     Abstract available

  256. RIZK JG, Barr CE, Rizk Y, Lewin JC, et al
    The next frontier in vaccine safety and VAERS: Lessons from COVID-19 and ten recommendations for action.
    Vaccine. 2021 Aug 10. pii: S0264-410X(21)01006.

  257. GALOR I, Hartal M, Perry Markovich M, Avramovich E, et al
    Population seroprotection against hepatitis a virus in Israel 18 years after introduction of inactivated vaccine into the routine childhood vaccination schedule: Response letter, to letter to the editor.
    Vaccine. 2021;39:4777.

  258. HERZOG C
    Immune memory persistence is well documented for hepatitis A vaccines.
    Vaccine. 2021;39:4775-4776.

  259. STAPLES JN, Nelamangala SL, Morris S, Wells K, et al
    Exploring socio-demographic and geospatial variation in human papillomavirus vaccination uptake in Virginia.
    Vaccine. 2021 Aug 9. pii: S0264-410X(21)00984.
    PubMed     Abstract available

  260. GOUD R, Thompson D, Welsh K, Lu M, et al
    ICD-10 anaphylaxis algorithm and the estimate of vaccine-attributable anaphylaxis incidence in Medicare.
    Vaccine. 2021 Aug 9. pii: S0264-410X(21)01003.
    PubMed     Abstract available

  261. PETRIE JG, Fligiel H, Lamerato L, Martin ET, et al
    Agreement between state registry, health record, and self-report of influenza vaccination.
    Vaccine. 2021 Aug 9. pii: S0264-410X(21)00995.
    PubMed     Abstract available

  262. KRISTINSDOTTIR I, Haraldsson A, Love A, Asgeirsdottir TL, et al
    Burden of rotavirus disease in young children in Iceland - Time to vaccinate?
    Vaccine. 2021 Aug 9. pii: S0264-410X(21)00944.
    PubMed     Abstract available

  263. BRITTON KJ, Pickering JL, Pomat WS, de Gier C, et al
    Lack of effectiveness of 13-valent pneumococcal conjugate vaccination against pneumococcal carriage density in Papua New Guinean infants.
    Vaccine. 2021 Aug 9. pii: S0264-410X(21)00990.
    PubMed     Abstract available

  264. ILLOUZ T, Madar R, Hirsh T, Biragyn A, et al
    Induction of an effective anti-Amyloid-beta humoral response in aged mice.
    Vaccine. 2021;39:4817-4829.
    PubMed     Abstract available

  265. PHILLIPS A, Carlson S, Danchin M, Beard F, et al
    From program suspension to the pandemic: A qualitative examination of Australia's vaccine pharmacovigilance system over 10 years.
    Vaccine. 2021 Aug 7. pii: S0264-410X(21)00950.
    PubMed     Abstract available

  266. LYTLE KL, Collins SP, Feldstein LR, Baughman AH, et al
    Influenza vaccine acceptance and hesitancy among adults hospitalized with severe acute respiratory illnesses, United States 2019-2020.
    Vaccine. 2021 Aug 7. pii: S0264-410X(21)00948.
    PubMed     Abstract available

  267. YLADE M, Agrupis KA, Daag JV, Crisostomo MV, et al
    Effectiveness of a single-dose mass dengue vaccination in Cebu, Philippines: A case-control study.
    Vaccine. 2021 Aug 7. pii: S0264-410X(21)00920.
    PubMed     Abstract available

    Implementing vaccination policies based upon scientific evidence in Japan.
    Vaccine. 2021 Aug 7. pii: S0264-410X(21)00968.
    PubMed     Abstract available

  269. ELDRIDGE JH, Egan MA, Matassov D, Hamm S, et al
    A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for a soluble glycoprotein vaccine to prevent disease caused by Nipah or Hendra viruses.
    Vaccine. 2021 Aug 7. pii: S0264-410X(21)00907.
    PubMed     Abstract available

  270. BORGHI L, Riva E
    Was Aldo Castellani the inventor of combined and polyvalent vaccines?
    Vaccine. 2021 Aug 6. pii: S0264-410X(21)00955.
    PubMed     Abstract available

  271. FENG J, Li Q
    How to ensure vaccine safety: An evaluation of China's vaccine regulation system.
    Vaccine. 2021 Aug 6. pii: S0264-410X(21)00986.
    PubMed     Abstract available

  272. MILLER CN, Kemp TJ, Abrahamsen M, Isaacs-Soriano K, et al
    Increases in HPV-16/18 antibody avidity and HPV-specific memory B-cell response in mid-adult aged men post-dose three of the quadrivalent HPV vaccine.
    Vaccine. 2021 Aug 6. pii: S0264-410X(21)00962.
    PubMed     Abstract available

  273. TAYLOR SC, Hurst B, Martiszus I, Hausman MS, et al
    Semi-quantitative, high throughput analysis of SARS-CoV-2 neutralizing antibodies: Measuring the level and duration of immune response antibodies post infection/vaccination.
    Vaccine. 2021 Aug 6. pii: S0264-410X(21)01013.
    PubMed     Abstract available

  274. JOHM P, Nkoum N, Ceesay A, Mbaye EH, et al
    Erratum to 'Factors influencing acceptance of vaccination during pregnancy in The Gambia and Senegal' [Vaccine 39 (2021) 3926-3934].
    Vaccine. 2021 Aug 5. pii: S0264-410X(21)00991.

  275. WILSON R
    HPV vaccine acceptance in West Africa: A systematic literature review.
    Vaccine. 2021 Aug 5. pii: S0264-410X(21)00835.
    PubMed     Abstract available

  276. CHHATWAL J, Sapru A, Sundaram B, Shenoy B, et al
    A phase 4 study of the safety of the 13-valent pneumococcal conjugate vaccine in children 6 to 17 years of age in India.
    Vaccine. 2021 Aug 5. pii: S0264-410X(21)00946.
    PubMed     Abstract available

  277. DODD RH, Pickles K, Cvejic E, Cornell S, et al
    Perceived public health threat a key factor for willingness to get the COVID-19 vaccine in Australia.
    Vaccine. 2021 Aug 5. pii: S0264-410X(21)01008.
    PubMed     Abstract available

  278. FRIEDENSOHN L, Zur M, Timofeyev M, Burshtein S, et al
    Sub-cutaneous Pfizer/BioNTech COVID-19 vaccine administration results in seroconversion among young adults.
    Vaccine. 2021 Aug 5. pii: S0264-410X(21)01010.
    PubMed     Abstract available

  279. HVASS AMF, Norredam M, Sodemann M, Thomsen MK, et al
    Corrigendum to 'Are refugees arriving in Denmark an under-immunised group for measles? A cross-sectional serology study' [Vaccine 38 (2020) 2788-2794].
    Vaccine. 2021 Aug 4. pii: S0264-410X(21)00993.

  280. HAYMAN B, Dennehy M
    Developing-country vaccine manufacturers' technical capabilities can make a difference in global immunization.
    Vaccine. 2021 Aug 3. pii: S0264-410X(21)00922.
    PubMed     Abstract available

  281. SAKALA IG, Honda-Okubo Y, Li L, Baldwin J, et al
    A M2 protein-based universal influenza vaccine containing Advax-SM adjuvant provides newborn protection via maternal or neonatal immunization.
    Vaccine. 2021 Aug 3. pii: S0264-410X(21)00914.
    PubMed     Abstract available

  282. HAUPT RE, Harberts EM, Kitz RJ, Strohmeier S, et al
    Novel TLR4 adjuvant elicits protection against homologous and heterologous Influenza A infection.
    Vaccine. 2021 Aug 3. pii: S0264-410X(21)00847.
    PubMed     Abstract available

  283. SUN J, Zheng Z, Li M, Liu Z, et al
    Development of a novel ZIKV vaccine comprised of immunodominant CD4+ and CD8+ T cell epitopes identified through comprehensive epitope mapping in Zika virus infected mice.
    Vaccine. 2021 Aug 2. pii: S0264-410X(21)00913.
    PubMed     Abstract available

  284. LEIDNER AJ, Tang Z, Guo A, Anderson TC, et al
    Insurance reimbursements for recombinant zoster vaccine in the private sector.
    Vaccine. 2021 Aug 2. pii: S0264-410X(21)00928.
    PubMed     Abstract available

    July 2021
  285. LITWIN C, Smith L, Donken R, Krajden M, et al
    High-risk HPV prevalence among women undergoing cervical cancer screening: Findings a decade after HPV vaccine implementation in British Columbia, Canada.
    Vaccine. 2021 Jul 31. pii: S0264-410X(21)00868.
    PubMed     Abstract available

  286. ROSENTHAL EM, Hall EW, Rosenberg ES, Harris A, et al
    Corrigendum to "Assessing the cost-utility of preferentially administering Heplisav-B vaccine to certain populations" [Vaccine 38(51) (2020) 8206-8215].
    Vaccine. 2021 Jul 31. pii: S0264-410X(21)00963.

  287. REDONDO E, Drago G, Lopez-Belmonte JL, Guillen JM, et al
    Cost-utility analysis of influenza vaccination in a population aged 65 years or older in Spain with a high-dose vaccine versus an adjuvanted vaccine.
    Vaccine. 2021 Jul 31. pii: S0264-410X(21)00926.
    PubMed     Abstract available

  288. KONTOPOULOU K, Ainatzoglou A, Nakas CT, Ifantidou A, et al
    Second dose of the BNT162b2 mRNA vaccine: Value of timely administration but questionable necessity among the seropositive.
    Vaccine. 2021 Jul 31. pii: S0264-410X(21)00958.
    PubMed     Abstract available

  289. SIDDIQUI A, Ahmed A, Tanveer M, Saqlain M, et al
    An overview of procurement, pricing, and uptake of COVID-19 vaccines in Pakistan.
    Vaccine. 2021 Jul 31. pii: S0264-410X(21)00965.

  290. MAHAJAN A, Kaur J, Sidana C, Shivam S, et al
    Geo-prioritization framework for COVID-19 vaccine allocation in India.
    Vaccine. 2021 Jul 31. pii: S0264-410X(21)00989.
    PubMed     Abstract available

  291. LUCINDE RK, Ong'ayo G, Houlihan C, Bottomley C, et al
    Pneumococcal conjugate vaccine dose-ranging studies in humans: A systematic review.
    Vaccine. 2021 Jul 30. pii: S0264-410X(21)00910.
    PubMed     Abstract available

  292. JONES A, Kawesa-Newell N
    Using branded behaviour change communication to create demand for the HPV vaccine among girls in Malawi: An evaluation of Girl Effect's Zathu mini magazine.
    Vaccine. 2021 Jul 30. pii: S0264-410X(21)00870.
    PubMed     Abstract available

  293. DOI H, Kanto T
    Factors influencing the durability of hepatitis B vaccine responses.
    Vaccine. 2021 Jul 30. pii: S0264-410X(21)00876.
    PubMed     Abstract available

  294. RAGHUNANDAN R, Higgins D, Hosken N
    RSV neutralization assays - Use in immune response assessment.
    Vaccine. 2021;39:4591-4597.
    PubMed     Abstract available

  295. VELANDIA-GONZALEZ M, Vilajeliu A, Contreras M, Trumbo SP, et al
    Monitoring progress of maternal and neonatal immunization in Latin America and the Caribbean.
    Vaccine. 2021;39 Suppl 2:B55-B63.
    PubMed     Abstract available

  296. KOBAYASHI M, Abdul-Karim A, Milucky JL, Zakariah A, et al
    Estimating the economic burden of pneumococcal meningitis and pneumonia in northern Ghana in the African meningitis belt post-PCV13 introduction.
    Vaccine. 2021;39:4685-4699.
    PubMed     Abstract available

  297. LIM H, In HJ, Kim YJ, Jang S, et al
    Development of an attenuated smallpox vaccine candidate: The KVAC103 strain.
    Vaccine. 2021 Jul 29. pii: S0264-410X(21)00810.
    PubMed     Abstract available

  298. CARRICO J, Talbird SE, La EM, Poston S, et al
    Cost-benefit analysis of vaccination against four preventable diseases in older adults: Impact of an aging population.
    Vaccine. 2021 Jul 29. pii: S0264-410X(21)00906.
    PubMed     Abstract available

  299. DALON F, Majed L, Belhassen M, Jacoud F, et al
    Human papillomavirus (HPV) vaccine coverage rates (VCRs) in France: A French claims data study.
    Vaccine. 2021 Jul 29. pii: S0264-410X(21)00945.
    PubMed     Abstract available

  300. DIACO M, Yin K, Seet B, Samson S, et al
    Author response to a Letter to the Editor on "Introductory paper: High dose influenza vaccine".
    Vaccine. 2021 Jul 28. pii: S0264-410X(21)00917.

  301. GARLASCO J, Bordino V, Marengo N, Rainero E, et al
    Pertussis immunisation during pregnancy: Antibody levels and the impact of booster vaccine.
    Vaccine. 2021 Jul 27. pii: S0264-410X(21)00930.
    PubMed     Abstract available

  302. YU VG, Lasco G, David CC
    Fear, mistrust, and vaccine hesitancy: Narratives of the dengue vaccine controversy in the Philippines.
    Vaccine. 2021 Jul 27. pii: S0264-410X(21)00929.
    PubMed     Abstract available

  303. GEORGIADIS GP, Georgiadis MC
    Optimal planning of the COVID-19 vaccine supply chain.
    Vaccine. 2021 Jul 27. pii: S0264-410X(21)00961.
    PubMed     Abstract available

  304. VINK M, Upadhaya N, Amin HA, Liwal MG, et al
    Does support to Private Health Practitioners increase childhood vaccination coverage? Findings from a comparative study in Afghanistan.
    Vaccine. 2021 Jul 26. pii: S0264-410X(21)00877.
    PubMed     Abstract available

  305. KHAN SA, Choudhury P, Kakati S, Doley R, et al
    Effectiveness of a single dose of Japanese encephalitis vaccine among adults, Assam, India, 2012-2018.
    Vaccine. 2021 Jul 26. pii: S0264-410X(21)00919.
    PubMed     Abstract available

  306. KUROKAWA N, Lavoie PO, D'Aoust MA, Couture MM, et al
    Development and characterization of a plant-derived rotavirus-like particle vaccine.
    Vaccine. 2021 Jul 26. pii: S0264-410X(21)00916.
    PubMed     Abstract available

  307. KLEIN NP, Peyrani P, Yacisin K, Caldwell N, et al
    A phase 3, randomized, double-blind study to evaluate the immunogenicity and safety of 3 lots of 20-valent pneumococcal conjugate vaccine in pneumococcal vaccine-naive adults 18 through 49 years of age.
    Vaccine. 2021 Jul 24. pii: S0264-410X(21)00863.
    PubMed     Abstract available

  308. RAJAN S, Akhtar N, Sharma S, Chakrabarti D, et al
    COVID-19 vaccination for cancer patients: Evidence, priority, and practice.
    Vaccine. 2021 Jul 24. pii: S0264-410X(21)00956.

  309. MICHOS A, Tatsi EB, Filippatos F, Dellis C, et al
    Association of total and neutralizing SARS-CoV-2 spike -receptor binding domain antibodies with epidemiological and clinical characteristics after immunization with the 1(st) and 2(nd) doses of the BNT162b2 vaccine.
    Vaccine. 2021 Jul 24. pii: S0264-410X(21)00960.
    PubMed     Abstract available

  310. ALVES MLF, Ferreira MRA, Donassolo RA, Rodrigues RR, et al
    Clostridium septicum: A review in the light of alpha-toxin and development of vaccines.
    Vaccine. 2021 Jul 23. pii: S0264-410X(21)00878.
    PubMed     Abstract available

  311. BURKE PF, Masters D, Massey G
    Enablers and barriers to COVID-19 vaccine uptake: An international study of perceptions and intentions.
    Vaccine. 2021 Jul 23. pii: S0264-410X(21)00947.
    PubMed     Abstract available

  312. TEASDALE CA, Borrell LN, Shen Y, Kimball S, et al
    Parental plans to vaccinate children for COVID-19 in New York city.
    Vaccine. 2021 Jul 23. pii: S0264-410X(21)00949.
    PubMed     Abstract available

  313. SUNDARAM M, Nasreen S, Calzavara A, He S, et al
    Background rates of all-cause mortality, hospitalizations, and emergency department visits among nursing home residents in Ontario, Canada to inform COVID-19 vaccine safety assessments.
    Vaccine. 2021 Jul 23. pii: S0264-410X(21)00951.
    PubMed     Abstract available

  314. CALLAHAN AG, Coleman-Cowger VH, Schulkin J, Power ML, et al
    Racial disparities in influenza immunization during pregnancy in the United States: A narrative review of the evidence for disparities and potential interventions.
    Vaccine. 2021 Jul 23. pii: S0264-410X(21)00905.
    PubMed     Abstract available

  315. SCHEIBLHOFER S, Drothler S, Braun W, Braun R, et al
    Laser-facilitated epicutaneous immunization of mice with SARS-CoV-2 spike protein induces antibodies inhibiting spike/ACE2 binding.
    Vaccine. 2021;39:4399-4403.
    PubMed     Abstract available

  316. TISSOT N, Brunel AS, Bozon F, Rosolen B, et al
    Patients with history of covid-19 had more side effects after the first dose of covid-19 vaccine.
    Vaccine. 2021 Jul 22. pii: S0264-410X(21)00925.
    PubMed     Abstract available

    Will COVID-19 vaccine equity be possible in India?
    Vaccine. 2021 Jul 22. pii: S0264-410X(21)00927.

  318. HERVE PL, Dhelft V, Zuniga A, Ghasparian A, et al
    Epicutaneous immunization using synthetic virus-like particles efficiently boosts protective immunity to respiratory syncytial virus.
    Vaccine. 2021;39:4555-4563.
    PubMed     Abstract available

  319. VODICKA E, Nonvignon J, Antwi-Agyei KO, Bawa J, et al
    The projected cost-effectiveness and budget impact of HPV vaccine introduction in Ghana.
    Vaccine. 2021 Jul 21. pii: S0264-410X(21)00904.
    PubMed     Abstract available

  320. JACKSON B, Harvey Y, Perez-Martin E, Wilsden G, et al
    The selection of naturally stable candidate foot-and-mouth disease virus vaccine strains for East Africa.
    Vaccine. 2021 Jul 21. pii: S0264-410X(21)00860.
    PubMed     Abstract available

  321. PAUL E, Brown GW, Kalk A, Ridde V, et al
    Playing vaccine roulette: Why the current strategy of staking everything on Covid-19 vaccines is a high-stakes wager.
    Vaccine. 2021 Jul 20. pii: S0264-410X(21)00923.

  322. CHUA H, Kwan MYW, Chan ELY, Wong JSC, et al
    Influenza vaccine effectiveness against influenza-associated hospitalization in children in Hong Kong, 2010-2020.
    Vaccine. 2021 Jul 20. pii: S0264-410X(21)00873.
    PubMed     Abstract available

  323. HECHT J, Suliman S, Wegiel B
    Bacillus Calmette-Guerin (BCG) vaccination to treat endometriosis.
    Vaccine. 2021 Jul 20. pii: S0264-410X(21)00879.
    PubMed     Abstract available

  324. INGROLE RSJ, Tao W, Joshi G, Gill HS, et al
    M2e conjugated gold nanoparticle influenza vaccine displays thermal stability at elevated temperatures and confers protection to ferrets.
    Vaccine. 2021 Jul 20. pii: S0264-410X(21)00909.
    PubMed     Abstract available

  325. CORCORAN M, Mereckiene J, Cotter S, Murchan S, et al
    Using genomics to examine the persistence of Streptococcus pneumoniae serotype 19A in Ireland and the emergence of a sub-clade associated with vaccine failures.
    Vaccine. 2021 Jul 20. pii: S0264-410X(21)00741.
    PubMed     Abstract available

  326. COLTON H, Greenfield DM, Snowden JA, Miller PDE, et al
    Long-term survivors following autologous haematopoetic stem cell transplantation have significant defects in their humoral immunity against vaccine preventable diseases, years on from transplant.
    Vaccine. 2021 Jul 19. pii: S0264-410X(21)00881.
    PubMed     Abstract available

  327. MADHIVANAN P, Krupp K, Coudray M, Colbert B, et al
    Longitudinal assessment of nonavalent vaccine HPV types in a sample of sexually active African American women from ten U.S. Cities.
    Vaccine. 2021 Jul 19. pii: S0264-410X(21)00903.
    PubMed     Abstract available

  328. HANLY M, Churches T, Fitzgerald O, MacIntyre CR, et al
    Vaccinating Australia: How long will it take?
    Vaccine. 2021 Jul 17. pii: S0264-410X(21)00865.
    PubMed     Abstract available

  329. SHILLING H, Garland SM, Atchison S, Cornall AM, et al
    Human papillomavirus prevalence and risk factors among Australian women 9-12 years after vaccine program introduction.
    Vaccine. 2021 Jul 16. pii: S0264-410X(21)00864.
    PubMed     Abstract available

  330. FLUCKIGER AC, Ontsouka B, Bozic J, Diress A, et al
    An enveloped virus-like particle vaccine expressing a stabilized prefusion form of the SARS-CoV-2 spike protein elicits highly potent immunity.
    Vaccine. 2021 Jul 16. pii: S0264-410X(21)00911.
    PubMed     Abstract available

  331. INSERRA F, Tajer C, Antonietti L, Mariani J, et al
    Vitamin D supplementation: An alternative to enhance the effectiveness of vaccines against SARS-CoV-2?
    Vaccine. 2021 Jul 16. pii: S0264-410X(21)00908.

  332. PATHIRANA J, Kwatra G, Maposa I, Groome MJ, et al
    Effect of cytomegalovirus infection on humoral immune responses to select vaccines administered during infancy.
    Vaccine. 2021 Jul 15. pii: S0264-410X(21)00661.
    PubMed     Abstract available

  333. LAMONTAGNE DS, Manangazira P, Marembo J, Chigodo C, et al
    HPV vaccination coverage in three districts in ZIMBABWE following national introduction of 0,12 month schedule among 10 to 14 year old girls.
    Vaccine. 2021 Jul 15. pii: S0264-410X(21)00871.
    PubMed     Abstract available

  334. ELAS M, Villatoro N, Pezzoli L
    Disproportionality analysis of reported drug adverse events to assess a potential safety signal for pentavalent vaccine in 2019 in El Salvador.
    Vaccine. 2021 Jul 15. pii: S0264-410X(21)00869.
    PubMed     Abstract available

  335. MOGAJI E
    Marketing the COVID-19 vaccine and the implications for public health.
    Vaccine. 2021 Jul 13. pii: S0264-410X(21)00874.
    PubMed     Abstract available

  336. O'DELL FJ, Williams AN, Poland A
    The contributions of William Money MRCS to smallpox vaccination and control - A little-known story.
    Vaccine. 2021 Jul 13. pii: S0264-410X(21)00844.
    PubMed     Abstract available

  337. HAYMAN B, Suri R, Prasad SD
    COVID-19 vaccine capacity: Challenges and mitigation - The DCVMN perspective.
    Vaccine. 2021 Jul 13. pii: S0264-410X(21)00866.
    PubMed     Abstract available

  338. LAZAROS G, Klein AL, Hatziantoniou S, Tsioufis C, et al
    The Novel Platform of mRNA COVID-19 Vaccines and Myocarditis: Clues into the Potential Underlying Mechanism.
    Vaccine. 2021 Jul 13. pii: S0264-410X(21)00875.

  339. WANG X, Xia A, Wang C, Tian H, et al
    Clinical and molecular characterization of the first culture-confirmed pediatric fulminant meningococcemia case caused by a serogroup Y clonal complex 23 strain in China.
    Vaccine. 2021;39:4261-4265.
    PubMed     Abstract available

  340. TONG L, Jia Q, Li B, Li Z, et al
    Investigation of the baseline tetanus antibody level and its persistence in a military unit.
    Vaccine. 2021;39:4328-4334.
    PubMed     Abstract available

  341. CLARKE M, Goodchild LM, Evans S, Giles LC, et al
    Body mass index and vaccine responses following influenza vaccination during pregnancy.
    Vaccine. 2021 Jul 12. pii: S0264-410X(21)00826.
    PubMed     Abstract available

  342. GOMEZ M, McCollum J, Wang H, Bachchhav S, et al
    Evaluation of the stability of a spray-dried tuberculosis vaccine candidate designed for dry powder respiratory delivery.
    Vaccine. 2021 Jul 10. pii: S0264-410X(21)00861.
    PubMed     Abstract available

  343. MACINTYRE CR, Veness B, Berger D, Hamad N, et al
    Thrombosis with Thrombocytopenia Syndrome (TTS) following AstraZeneca ChAdOx1 nCoV-19 (AZD1222) COVID-19 vaccination - A risk-benefit analysis for people < 60 years in Australia.
    Vaccine. 2021 Jul 10. pii: S0264-410X(21)00872.
    PubMed     Abstract available

  344. GUKTUR RE, Nep EI, Asala O, Olorunfemi PO, et al
    Carboxymethylated and acetylated xerogel derivatives of Plectranthus esculentus starch protect Newcastle disease vaccines against cold chain failure.
    Vaccine. 2021 Jul 9. pii: S0264-410X(21)00812.
    PubMed     Abstract available

  345. ZHANG T, Zhang J, Shao X, Feng S, et al
    Effectiveness of 13-valent pneumococcal conjugate vaccine against community acquired pneumonia among children in China, an observational cohort study.
    Vaccine. 2021 Jul 9. pii: S0264-410X(21)00836.
    PubMed     Abstract available

  346. FONGWEN N, Delrieu I, Ham LH, Gubler DJ, et al
    Implementation strategies for the first licensed dengue vaccine: A meeting report.
    Vaccine. 2021 Jul 9. pii: S0264-410X(21)00845.
    PubMed     Abstract available

  347. TERNA RICHARD M, Taiwo L, Jean Baptiste AE, Bawa S, et al
    Planning for supplemental immunization activities using the readiness assessment dashboard: Experience from 2017/2018 Measles vaccination campaign, Nigeria.
    Vaccine. 2021 Jul 8. pii: S0264-410X(21)00831.
    PubMed     Abstract available

  348. MATEO-URDIALES A, Del Manso M, Andrianou X, Spuri M, et al
    Initial impact of SARS-Cov-2 vaccination on healthcare workers in Italy- Update on the 28th of March 2021.
    Vaccine. 2021 Jul 7. pii: S0264-410X(21)00862.
    PubMed     Abstract available

  349. DING Y, Luo L, Luo Y, Zhao D, et al
    A novel combined vaccine against classical swine fever and porcine epidemic diarrhea viruses elicits a significant Th2-favored humoral response in mice.
    Vaccine. 2021 Jul 7. pii: S0264-410X(21)00846.
    PubMed     Abstract available

  350. AT THOBARI J, Damayanti W, Haposan JH, Nirwati H, et al
    Safety and immunogenicity of human neonatal RV3 rotavirus vaccine (Bio Farma) in adults, children, and neonates in Indonesia: Phase I Trial.
    Vaccine. 2021 Jul 6. pii: S0264-410X(21)00832.
    PubMed     Abstract available

  351. GESSNER BD, Theilacker C, Mendez C, Jodar L, et al
    Comment on "Vila-Corcoles et al., Clinical effectiveness of 13-valent and 23-valent pneumococcal vaccination in middle-aged and older adults: The EPIVAC cohort study, 2015-2016."
    Vaccine. 2021;39:4032-4033.

  352. BELLIER L, Petitjean A, Sarazu T, Tresierra J, et al
    Cost-effectiveness analysis of switching from a trivalent to a quadrivalent inactivated influenza vaccine in the Peruvian immunisation programme.
    Vaccine. 2021;39:4144-4152.
    PubMed     Abstract available

  353. OZAWA S, Yemeke TT, Mitgang E, Wedlock PT, et al
    Systematic review of the costs for vaccinators to reach vaccination sites: Incremental costs of reaching hard-to-reach populations.
    Vaccine. 2021 Jul 5. pii: S0264-410X(21)00581.
    PubMed     Abstract available

  354. GENTILE A, Pacchiotti AC, Giglio N, Nolte MF, et al
    Vaccine hesitancy in Argentina: Validation of WHO scale for parents.
    Vaccine. 2021 Jul 5. pii: S0264-410X(21)00842.
    PubMed     Abstract available

  355. MARTIN C, Marinova D, Aguilo N, Gonzalo-Asensio J, et al
    MTBVAC, a live TB vaccine poised to initiate efficacy trials 100 years after BCG.
    Vaccine. 2021 Jul 5. pii: S0264-410X(21)00799.
    PubMed     Abstract available

  356. GOSSET A, Diallo MY, Betsem E, Schaeffer L, et al
    Cost-effectiveness of adding a birth dose of hepatitis B vaccine in the Dafra district of the Hauts-Bassins Region in Burkina Faso (NeoVac Study).
    Vaccine. 2021 Jul 5. pii: S0264-410X(21)00809.
    PubMed     Abstract available

  357. KURITA J, Uematsu T, Sakurai N, Sugawara T, et al
    Attenuation of antibody titer of measles and rubella virus among university students of department of healthcare providers during 2015-2018 in Japan.
    Vaccine. 2021;39:4203-4209.
    PubMed     Abstract available

  358. LUO J, Huo C, Qin H, Hu J, et al
    Chimeric enterovirus 71 virus-like particle displaying conserved coxsackievirus A16 epitopes elicits potent immune responses and protects mice against lethal EV71 and CA16 infection.
    Vaccine. 2021;39:4135-4143.
    PubMed     Abstract available

  359. SIMAS C, Paterson P, Lees S, J Larson H, et al
    "From my phone, I could rule the world": Critical engagement with maternal vaccine information, vaccine confidence builders and post-Zika outbreak rumours in Brazil.
    Vaccine. 2021 Jul 3. pii: S0264-410X(21)00775.
    PubMed     Abstract available

  360. LI AJ, Manzi F, Kyesi F, Makame Y, et al
    Tanzania's human papillomavirus (HPV) vaccination program: Community awareness, feasibility, and acceptability of a national HPV vaccination program, 2019.
    Vaccine. 2021 Jul 3. pii: S0264-410X(21)00797.
    PubMed     Abstract available

  361. HUANG Y, Seaton KE, Casapia M, Polakowski L, et al
    AIDSVAX protein boost improves breadth and magnitude of vaccine-induced HIV-1 envelope-specific responses after a 7-year rest period.
    Vaccine. 2021 Jul 3. pii: S0264-410X(21)00827.
    PubMed     Abstract available

  362. SCHALTZ-BUCHHOLZER F, Roth A, de Bree LCJ, Biering-Sorensen S, et al
    Neonatal Bacille Calmette-Guerin vaccination and tuberculin skin test reactions at 2- and 6-months: Effects on mortality up to 1 year of age.
    Vaccine. 2021 Jul 2. pii: S0264-410X(21)00839.
    PubMed     Abstract available

  363. LO CY, Misplon JA, Li X, Price GE, et al
    Universal influenza vaccine based on conserved antigens provides long-term durability of immune responses and durable broad protection against diverse challenge virus strains in mice.
    Vaccine. 2021 Jul 2. pii: S0264-410X(21)00833.
    PubMed     Abstract available

  364. RAHAMIMOV N, Baturov V, Shani A, Ben Zoor I, et al
    Inadequate deltoid muscle penetration and concerns of improper COVID mRNA vaccine administration can be avoided by injection technique modification.
    Vaccine. 2021 Jul 2. pii: S0264-410X(21)00843.
    PubMed     Abstract available

  365. THIEM VD, Anh DD, Ha VH, Hien ND, et al
    Safety and immunogenicity of two formulations of rotavirus vaccine in Vietnamese infants.
    Vaccine. 2021 Jul 1. pii: S0264-410X(21)00806.
    PubMed     Abstract available

  366. CHOWDHURY F, Ali Syed K, Akter A, Rahman Bhuiyan T, et al
    A phase I/II study to evaluate safety, tolerability and immunogenicity of Hillchol(R), an inactivated single Hikojima strain based oral cholera vaccine, in a sequentially age descending population in Bangladesh.
    Vaccine. 2021 Jul 1. pii: S0264-410X(21)00830.
    PubMed     Abstract available

  367. YEMEKE TT, Mitgang E, Wedlock PT, Higgins C, et al
    Promoting, seeking, and reaching vaccination services: A systematic review of costs to immunization programs, beneficiaries, and caregivers.
    Vaccine. 2021 Jul 1. pii: S0264-410X(21)00670.
    PubMed     Abstract available

    June 2021
  368. MWABA J, Chisenga CC, Xiao S, Ng'ombe H, et al
    Serum vibriocidal responses when second doses of oral cholera vaccine are delayed 6 months in Zambia.
    Vaccine. 2021 Jun 30. pii: S0264-410X(21)00770.
    PubMed     Abstract available

  369. SORENSEN MK, Schaltz-Buchholzer F, Jensen AM, Nielsen S, et al
    Retesting the hypothesis that early Diphtheria-Tetanus-Pertussis vaccination increases female mortality: An observational study within a randomised trial.
    Vaccine. 2021 Jun 30. pii: S0264-410X(21)00720.
    PubMed     Abstract available

  370. HINES AM, Murphy N, Mullin C, Barillas J, et al
    Henoch-Schonlein purpura presenting post COVID-19 vaccination.
    Vaccine. 2021 Jun 30. pii: S0264-410X(21)00841.

  371. FISCHER P, Pawlowski A, Cao D, Bell D, et al
    Safety and immunogenicity of a prototype recombinant alpha-like protein subunit vaccine (GBS-NN) against Group B Streptococcus in a randomised placebo-controlled double-blind phase 1 trial in healthy adult women.
    Vaccine. 2021 Jun 29. pii: S0264-410X(21)00796.
    PubMed     Abstract available

  372. OSTERGAARD L, Vesikari T, Senders SD, Flodmark CE, et al
    Persistence of hSBA titers elicited by the meningococcal serogroup B vaccine menB-FHbp for up to 4 years after a 2- or 3-dose primary series and immunogenicity, safety, and tolerability of a booster dose through 26 months.
    Vaccine. 2021 Jun 29. pii: S0264-410X(21)00717.
    PubMed     Abstract available

  373. PLUTZER E, Warner SB
    A potential new front in health communication to encourage vaccination: Health education teachers.
    Vaccine. 2021 Jun 29. pii: S0264-410X(21)00800.
    PubMed     Abstract available

  374. KAUR R, Pham M, Pichichero M
    Serum antibody levels to pneumococcal polysaccharides 22F, 33F, 19A and 6A that correlate with protection from colonization and acute otitis media in children.
    Vaccine. 2021;39:3900-3906.
    PubMed     Abstract available

  375. KELLY SM, Larsen KR, Darling R, Petersen AC, et al
    Single-dose combination nanovaccine induces both rapid and durable humoral immunity and toxin neutralizing antibody responses against Bacillus anthracis.
    Vaccine. 2021;39:3862-3870.
    PubMed     Abstract available

  376. AL-SHAIKH A, Muthu N, Aidyralieva C, Profili MC, et al
    COVID-19 vaccine roll-out in middle-income countries: Lessons learned from the Jordan experience.
    Vaccine. 2021 Jun 29. pii: S0264-410X(21)00840.

  377. BANKS C, Portnoy A, Moi F, Boonstoppel L, et al
    Cost of vaccine delivery strategies in low- and middle-income countries during the COVID-19 pandemic.
    Vaccine. 2021 Jun 29. pii: S0264-410X(21)00838.
    PubMed     Abstract available

  378. VERGER P, Duale C, Lenzi N, Scronias D, et al
    Vaccine hesitancy among hospital staff physicians: A cross-sectional survey in France in 2019.
    Vaccine. 2021 Jun 28. pii: S0264-410X(21)00803.
    PubMed     Abstract available

  379. BURNETT E, Juin S, Esona MD, Desormeaux AM, et al
    Effectiveness of monovalent rotavirus vaccine against hospitalizations due to all rotavirus and equine-like G3P[8] genotypes in Haiti 2014-2019.
    Vaccine. 2021 Jun 26. pii: S0264-410X(21)00805.
    PubMed     Abstract available

  380. SARHAN AT, Bahey-El-Din M, Zaghloul TI
    Recombinant Ax21 protein is a promising subunit vaccine candidate against Stenotrophomonas maltophilia in a murine infection model.
    Vaccine. 2021 Jun 26. pii: S0264-410X(21)00801.
    PubMed     Abstract available

  381. FUJIMOTO AB, Keskinocak P, Yildirim I
    Significance of SARS-CoV-2 specific antibody testing during COVID-19 vaccine allocation.
    Vaccine. 2021 Jun 26. pii: S0264-410X(21)00828.
    PubMed     Abstract available

  382. FELIX S, Handem S, Nunes S, Paulo AC, et al
    Impact of private use of the 13-valent pneumococcal conjugate vaccine (PCV13) on pneumococcal carriage among Portuguese children living in urban and rural regions.
    Vaccine. 2021 Jun 25. pii: S0264-410X(21)00771.
    PubMed     Abstract available

  383. CARNALLA M, Torres-Ibarra L, Barrientos-Gutierrez T, Cruz-Valdez A, et al
    Reduction of HPV16/18 prevalence in young women after eight years of three- and two-dose vaccination schemes.
    Vaccine. 2021 Jun 25. pii: S0264-410X(21)00776.
    PubMed     Abstract available

  384. MYLES IA, Vinciguerra JS, Premus RT
    Specialist confirmed allergic reactions to COVID-19 mRNA vaccines at a mass vaccination site.
    Vaccine. 2021 Jun 25. pii: S0264-410X(21)00811.
    PubMed     Abstract available

  385. TUO W, Feng X, Cao L, Vinyard B, et al
    Vaccination with Neospora caninum-cyclophilin and -profilin confers partial protection against experimental neosporosis-induced abortion in sheep.
    Vaccine. 2021 Jun 24. pii: S0264-410X(21)00768.
    PubMed     Abstract available

  386. DESAI AP, Desai AP, Loomis GJ
    Relationship between pre-existing allergies and anaphylactic reactions post mRNA COVID-19 vaccine administration.
    Vaccine. 2021 Jun 23. pii: S0264-410X(21)00808.
    PubMed     Abstract available

  387. BALDOLLI A, Michon J, Appia F, Galimard C, et al
    Tolerance of BNT162b2 mRNA COVI-19 vaccine in patients with a medical history of COVID-19 disease: A case control study.
    Vaccine. 2021 Jun 23. pii: S0264-410X(21)00804.
    PubMed     Abstract available

  388. FURUYA-KANAMORI L, Xu C, Doi SAR, Clark J, et al
    Comparison of immunogenicity and safety of licensed Japanese encephalitis vaccines: A systematic review and network meta-analysis.
    Vaccine. 2021 Jun 23. pii: S0264-410X(21)00759.
    PubMed     Abstract available

  389. DASSAH S, Adu B, Sirima SB, Mordmuller B, et al
    Extended follow-up of children in a phase2b trial of the GMZ2 malaria vaccine.
    Vaccine. 2021 Jun 23. pii: S0264-410X(21)00760.
    PubMed     Abstract available

  390. MARTIN-MERINO E, Castillo-Cano B, Martin-Perez M, Llorente-Garcia A, et al
    Papillomavirus vaccination and Guillain-Barre Syndrome among girls: A cohort study in Spain.
    Vaccine. 2021 Jun 23. pii: S0264-410X(21)00765.
    PubMed     Abstract available

  391. KRISTENSEN D, Giersing B, Hickling J, Kazi F, et al
    A global collaboration to advance vaccine product innovations - The Vaccine Innovation Prioritisation Strategy.
    Vaccine. 2021 Jun 23. pii: S0264-410X(21)00711.

  392. PHILLIP K, Nair N, Samanta K, Azevedo JF, et al
    Maternal transfer of neutralizing antibodies to B. burgdorferi OspA after oral vaccination of the rodent reservoir.
    Vaccine. 2021 Jun 23. pii: S0264-410X(21)00761.
    PubMed     Abstract available

  393. OOSTDIJK C, Van Zoonen K, Ruijs WLM, Mollema L, et al
    Household decision-making for the MenACWY vaccination: How parents and adolescents deal with an adolescent vaccination decision.
    Vaccine. 2021 Jun 23. pii: S0264-410X(21)00772.
    PubMed     Abstract available

  394. TRENT M, Seale H, Chughtai AA, Salmon D, et al
    Trust in government, intention to vaccinate and COVID-19 vaccine hesitancy: A comparative survey of five large cities in the United States, United Kingdom, and Australia.
    Vaccine. 2021 Jun 23. pii: S0264-410X(21)00798.
    PubMed     Abstract available

  395. JAYARAMAN Y, Veeraraghavan B, Girish Kumar CP, Sukumar B, et al
    Hospital-based sentinel surveillance for bacterial meningitis in under-five children prior to the introduction of the PCV13 in India.
    Vaccine. 2021;39:3737-3744.
    PubMed     Abstract available

  396. MBAEYI C, Moran T, Wadood Z, Ather F, et al
    Stopping a polio outbreak in the midst of war: Lessons from Syria.
    Vaccine. 2021;39:3717-3723.
    PubMed     Abstract available

  397. GOOCH KE, Smith TRF, Salguero FJ, Fotheringham SA, et al
    One or two dose regimen of the SARS-CoV-2 synthetic DNA vaccine INO-4800 protects against respiratory tract disease burden in nonhuman primate challenge model.
    Vaccine. 2021 Jun 23. pii: S0264-410X(21)00807.
    PubMed     Abstract available

  398. LUNDBERG L, Bygdell M, Stukat von Feilitzen G, Woxenius S, et al
    Recent MMR vaccination in health care workers and Covid-19: A test negative case-control study.
    Vaccine. 2021 Jun 22. pii: S0264-410X(21)00795.
    PubMed     Abstract available

  399. CHEN IH, Ahorsu DK, Ko NY, Yen CF, et al
    Adapting the Motors of Influenza Vaccination Acceptance Scale into the Motors of COVID-19 Vaccination Acceptance Scale: Psychometric evaluation among mainland Chinese university students.
    Vaccine. 2021 Jun 22. pii: S0264-410X(21)00794.
    PubMed     Abstract available

  400. WANG Z, Zhou C, Gao F, Zhu Q, et al
    Preclinical evaluation of recombinant HFMD vaccine based on enterovirus 71 (EV71) virus-like particles (VLP): Immunogenicity, efficacy and toxicology.
    Vaccine. 2021 Jun 21. pii: S0264-410X(21)00767.
    PubMed     Abstract available

  401. RADHAKRISHNAN L, Stein Z, DeVies J, Smith A, et al
    Syndromic surveillance of vaccine-associated adverse events in U.S. emergency departments.
    Vaccine. 2021 Jun 21. pii: S0264-410X(21)00766.
    PubMed     Abstract available

  402. SMITH KJ, Wateska AR, Nowalk MP, Lin CJ, et al
    Should older adult pneumococcal vaccination recommendations change due to decreased vaccination in children during the pandemic? A cost-effectiveness analysis.
    Vaccine. 2021 Jun 21. pii: S0264-410X(21)00773.
    PubMed     Abstract available

  403. WEDLOCK PT, Cox SN, Bartsch SM, Randall SL, et al
    Should countries switch to using five- or ten-dose rotavirus vaccines now that they are available?
    Vaccine. 2021 Jun 19. pii: S0264-410X(21)00757.
    PubMed     Abstract available

  404. FOGEL B, Schaefer EW, Hicks SD
    Early influenza vaccination rates decline in children during the COVID-19 pandemic.
    Vaccine. 2021 Jun 17. pii: S0264-410X(21)00777.
    PubMed     Abstract available

  405. BROWN CC, Young SG, Pro GC
    COVID-19 vaccination rates vary by community vulnerability: A county-level analysis.
    Vaccine. 2021 Jun 17. pii: S0264-410X(21)00774.
    PubMed     Abstract available

  406. LILES E, Irving SA, Dandamudi P, Belongia EA, et al
    Incidence of pediatric inflammatory bowel disease within the Vaccine Safety Datalink network and evaluation of association with rotavirus vaccination.
    Vaccine. 2021;39:3614-3620.
    PubMed     Abstract available

  407. FENG Y, Yao T, Chang Y, Gao L, et al
    Immunogenicity and persistence of high-dose recombinant hepatitis B vaccine in adults infected with human immunodeficiency virus in China: A randomized, double-blind, parallel controlled trial.
    Vaccine. 2021;39:3582-3589.
    PubMed     Abstract available

  408. VAILLANT L, Oster P, McMillan B, Velin D, et al
    Gastric eosinophils are detrimental for Helicobacter pylori vaccine efficacy.
    Vaccine. 2021;39:3590-3601.
    PubMed     Abstract available

  409. JETHWA H, Wong R, Abraham S
    Covid-19 vaccine trials: Ethnic diversity and immunogenicity.
    Vaccine. 2021;39:3541-3543.

  410. PRASAD N, Read JM, Jewell C, Waite B, et al
    Modelling the impact of respiratory syncytial virus (RSV) vaccine and immunoprophylaxis strategies in New Zealand.
    Vaccine. 2021 Jun 16. pii: S0264-410X(21)00708.
    PubMed     Abstract available

  411. FRADICO JRB, Campi-Azevedo AC, Peruhype-Magalhaes V, Coelho-Dos-Reis JGA, et al
    CCL3, CCL5, IL-15, IL-1Ra and VEGF compose a reliable algorithm to discriminate classes of adverse events following 17DD-YF primary vaccination according to cause-specific definitions.
    Vaccine. 2021 Jun 16. pii: S0264-410X(21)00709.
    PubMed     Abstract available

  412. YITBAREK K, Tilahun T, Debela T, Abdena D, et al
    Measles epidemiology and vaccination coverage in Oromia Region, Ethiopia: Evidence from surveillance, 2011-2018.
    Vaccine. 2021 Jun 16. pii: S0264-410X(21)00739.
    PubMed     Abstract available

  413. MOSS WJ, Shendale S, Lindstrand A, O'Brien KL, et al
    Feasibility assessment of measles and rubella eradication.
    Vaccine. 2021;39:3544-3559.
    PubMed     Abstract available

  414. ANDRE GO, Borges MT, Assoni L, Ferraz LFC, et al
    Protective role of PhtD and its amino and carboxyl fragments against pneumococcal sepsis.
    Vaccine. 2021;39:3626-3632.
    PubMed     Abstract available

  415. GARON JR, Mukavhi A, Rupfutse M, Bright S, et al
    Multiple cohort HPV vaccination in Zimbabwe: 2018-2019 program feasibility, awareness, and acceptability among health, education, and community stakeholders.
    Vaccine. 2021 Jun 15. pii: S0264-410X(21)00669.
    PubMed     Abstract available

    Helping patients with ethical concerns about COVID-19 vaccines in light of fetal cell lines used in some COVID-19 vaccines.
    Vaccine. 2021 Jun 15. pii: S0264-410X(21)00763.
    PubMed     Abstract available

  417. SMITH LE, Hodson A, Rubin GJ
    Parental attitudes towards mandatory vaccination; a systematic review.
    Vaccine. 2021 Jun 14. pii: S0264-410X(21)00742.
    PubMed     Abstract available

  418. IVANOV V, Oomens AGP, Papin JF, Staats R, et al
    Intranasal and intrapulmonary vaccination with an M protein-deficient respiratory syncytial virus (RSV) vaccine improves clinical signs and reduces viral replication in infant baboons after an RSV challenge infection.
    Vaccine. 2021 Jun 14. pii: S0264-410X(21)00737.
    PubMed     Abstract available

  419. KOCHHAR GS, Desai A, Caldera DO F, El Hachem S, et al
    Effectiveness of recombinant zoster vaccine (RZV) in patients with inflammatory bowel disease.
    Vaccine. 2021 Jun 14. pii: S0264-410X(21)00615.
    PubMed     Abstract available

  420. POLAND GA, Ovsyannikova IG, Kennedy RB
    The need for broadly protective COVID-19 vaccines: Beyond S-only approaches.
    Vaccine. 2021 Jun 14. pii: S0264-410X(21)00764.

  421. SCHALTZ-BUCHHOLZER F, Kjaer Sorensen M, Benn CS, Aaby P, et al
    The introduction of BCG vaccination to neonates in Northern Sweden, 1927-31: Re-analysis of historical data to understand the lower mortality among BCG-vaccinated children.
    Vaccine. 2021 Jun 13. pii: S0264-410X(21)00718.
    PubMed     Abstract available

  422. LIPSITCH M, Kahn R
    Interpreting vaccine efficacy trial results for infection and transmission.
    Vaccine. 2021 Jun 12. pii: S0264-410X(21)00735.
    PubMed     Abstract available

  423. FERRARI D, Di Resta C, Tomaiuolo R, Sabetta E, et al
    Long-term antibody persistence and exceptional vaccination response on previously SARS-CoV-2 infected subjects.
    Vaccine. 2021 Jun 12. pii: S0264-410X(21)00756.
    PubMed     Abstract available

  424. MCFADDEN K, Heywood A, Dyda A, Kaufman J, et al
    Minimising missed opportunities to promote and deliver immunization services to middle and older age adults: Can hospital-based programs be a solution?
    Vaccine. 2021;39:3467-3472.
    PubMed     Abstract available

  425. DAVIES C, Stoney T, Hutton H, Parrella A, et al
    School-based HPV vaccination positively impacts parents' attitudes toward adolescent vaccination.
    Vaccine. 2021 Jun 11. pii: S0264-410X(21)00637.
    PubMed     Abstract available

  426. BEAU RENEER Z, Abreu RB, Jamal US, Corn MR, et al
    Seasonal influenza vaccination does not effectively expand H2 cross-reactive antibodies in humans.
    Vaccine. 2021 Jun 11. pii: S0264-410X(21)00659.
    PubMed     Abstract available

  427. MESHER D, Thomas SL, Linley E, Edmundson C, et al
    Post-vaccination HPV seroprevalence among female sexual health clinic attenders in England.
    Vaccine. 2021 Jun 11. pii: S0264-410X(21)00580.
    PubMed     Abstract available

  428. OH SH, Kim SH, Jeon JH, Kim EB, et al
    Cytoplasmic expression of a model antigen with M Cell-Targeting moiety in lactic acid bacteria and implication of the mechanism as a mucosal vaccine via oral route.
    Vaccine. 2021 Jun 11. pii: S0264-410X(21)00734.
    PubMed     Abstract available

  429. HSIA J, Zhao G, Lu PJ, Town M, et al
    Estimating bias from internet non-use for a hybrid web vaccination survey - 2013-2017 Behavioral Risk Factor Surveillance System.
    Vaccine. 2021 Jun 11. pii: S0264-410X(21)00675.
    PubMed     Abstract available

  430. ODITA CI, Conan A, Smith-Antony M, Battice J, et al
    Non-specific effects of rabies vaccine on the incidence of self-reported common infectious disease episodes: A randomized controlled trial.
    Vaccine. 2021 Jun 11. pii: S0264-410X(21)00719.
    PubMed     Abstract available

  431. CHEN Y, Wang Y, Robertson ID, Hu C, et al
    Key issues affecting the current status of infectious diseases in Chinese cattle farms and their control through vaccination.
    Vaccine. 2021 Jun 11. pii: S0264-410X(21)00673.
    PubMed     Abstract available

  432. RAHMAN T, de Gier C, Orami T, Seppanen EJ, et al
    PCV10 elicits Protein D IgG responses in Papua New Guinean children but has no impact on NTHi carriage in the first two years of life.
    Vaccine. 2021;39:3486-3492.
    PubMed     Abstract available

  433. SORG AL, Obermeier V, Liese JG, von Kries R, et al
    Incidence trends of parapneumonic pleural effusions/empyema in children 2009 to 2018 from health insurance data: Only temporal reduction after the introduction of PCV13.
    Vaccine. 2021;39:3516-3519.
    PubMed     Abstract available

  434. CHAUHAN AS, Kapoor I, Rana SK, Kumar D, et al
    Cost effectiveness of typhoid vaccination in India.
    Vaccine. 2021 Jun 10. pii: S0264-410X(21)00713.
    PubMed     Abstract available

  435. VANDERSLOTT S, Marks T
    Charting mandatory childhood vaccination policies worldwide.
    Vaccine. 2021 Jun 10. pii: S0264-410X(21)00547.
    PubMed     Abstract available

  436. LUTZ CS, Biggerstaff M, Rolfes MA, Lafond KE, et al
    Estimating the number of averted illnesses and deaths as a result of vaccination against an influenza pandemic in nine low- and middle-income countries.
    Vaccine. 2021 Jun 9. pii: S0264-410X(21)00557.
    PubMed     Abstract available

  437. MUHI S, Stinear TP
    Systematic review of M. Bovis BCG and other candidate vaccines for Buruli ulcer prophylaxis.
    Vaccine. 2021 Jun 9. pii: S0264-410X(21)00700.
    PubMed     Abstract available

  438. GUNTUKU SC, Buttenheim AM, Sherman G, Merchant RM, et al
    Twitter discourse reveals geographical and temporal variation in concerns about COVID-19 vaccines in the United States.
    Vaccine. 2021 Jun 9. pii: S0264-410X(21)00738.
    PubMed     Abstract available

  439. HOEHL S, Ciesek S, Graf J, Wicker S, et al
    A new group at increased risk of a SARS-CoV-2 infection emerges: The recently vaccinated.
    Vaccine. 2021 Jun 8. pii: S0264-410X(21)00736.

  440. DE VRIES LM, Kellerborg KM, Brouwer WBF, van Baal PHM, et al
    Don't forget about the future: The impact of including future costs on the cost-effectiveness of adult pneumococcal conjugate vaccination with PCV13 in the Netherlands.
    Vaccine. 2021 Jun 8. pii: S0264-410X(21)00699.
    PubMed     Abstract available

  441. STOECKEL F, Carter C, Lyons BA, Reifler J, et al
    Association of vaccine hesitancy and immunization coverage rates in the European Union.
    Vaccine. 2021 Jun 8. pii: S0264-410X(21)00657.
    PubMed     Abstract available

  442. SUN Y, Jackson K, Dalmon CA, Shapiro BL, et al
    Effectiveness of the recombinant zoster vaccine among Kaiser Permanente Hawaii enrollees aged 50 and older: A retrospective cohort study.
    Vaccine. 2021 Jun 8. pii: S0264-410X(21)00642.
    PubMed     Abstract available

  443. DIAZ-MITOMA F, Popovic V, Spaans JN
    Assessment of immunogenicity and safety across two manufacturing lots of a 3-antigen hepatitis B vaccine, Sci-B-Vac(R), compared with Engerix-B(R) in healthy Asian adults: A phase 3 randomized clinical trial.
    Vaccine. 2021 Jun 8. pii: S0264-410X(21)00662.
    PubMed     Abstract available

  444. ANDAYI F, Emukule GO, Osoro E, Ndegwa LK, et al
    Knowledge and attitude of Kenyan healthcare workers towards pandemic influenza disease and vaccination: 9 years after the last influenza pandemic.
    Vaccine. 2021 Jun 7. pii: S0264-410X(21)00643.
    PubMed     Abstract available

  445. RAZ A, Keshet Y, Popper-Giveon A, Karkabi MS, et al
    One size does not fit all: Lessons from Israel's Covid-19 vaccination drive and hesitancy.
    Vaccine. 2021 Jun 5. pii: S0264-410X(21)00714.

  446. CHUA JV, Davis C, Husson JS, Nelson A, et al
    Safety and immunogenicity of an HIV-1 gp120-CD4 chimeric subunit vaccine in a phase 1a randomized controlled trial.
    Vaccine. 2021 Jun 4. pii: S0264-410X(21)00685.
    PubMed     Abstract available

  447. NOGUERA M, Vela A, Kraft C, Chevalier M, et al
    Effects of three commercial vaccines against porcine parvovirus 1 in pregnant gilts.
    Vaccine. 2021 Jun 4. pii: S0264-410X(21)00614.
    PubMed     Abstract available

  448. KARAFILLAKIS E, Francis MR, Paterson P, Larson HJ, et al
    Trust, emotions and risks: Pregnant women's perceptions, confidence and decision-making practices around maternal vaccination in France.
    Vaccine. 2021 Jun 4. pii: S0264-410X(21)00704.
    PubMed     Abstract available

  449. WOLFE LS, Smedley JG 3rd, Bubna N, Hussain A, et al
    Development of a platform-based approach for the clinical production of HIV gp120 envelope glycoprotein vaccine candidates.
    Vaccine. 2021 Jun 4. pii: S0264-410X(21)00668.
    PubMed     Abstract available

  450. DAL-RE R, Launay O
    Public trust on regulatory decisions: The European Medicines Agency and the AstraZeneca COVID-19 vaccine label.
    Vaccine. 2021 Jun 4. pii: S0264-410X(21)00703.

  451. ITO N, Okamoto T, Sasaki M, Miyamoto S, et al
    Safety enhancement of a genetically modified live rabies vaccine strain by introducing an attenuating Leu residue at position 333 in the glycoprotein.
    Vaccine. 2021 Jun 3. pii: S0264-410X(21)00553.
    PubMed     Abstract available

  452. CHANDRA D, Vipin B
    On the vaccine supply chain coordination under subsidy contract.
    Vaccine. 2021 Jun 3. pii: S0264-410X(21)00676.
    PubMed     Abstract available

  453. STUURMAN AL, Biccler J, Carmona A, Descamps A, et al
    Brand-specific influenza vaccine effectiveness estimates during 2019/20 season in Europe - Results from the DRIVE EU study platform.
    Vaccine. 2021 Jun 3. pii: S0264-410X(21)00654.
    PubMed     Abstract available

  454. UWINS C, Cyriac S, Bhandoria G
    HPV vaccine: Expanding indications and global disparity.
    Vaccine. 2021 Jun 3. pii: S0264-410X(21)00677.

  455. GATES A, Rahman S, Sim S, Pillay J, et al
    Health inequities related to vaccination: An evidence map of potentially influential factors and systematic review of interventions.
    Vaccine. 2021 Jun 3. pii: S0264-410X(21)00640.
    PubMed     Abstract available

  456. FERDINANDS JM, Thompson MG, Blanton L, Spencer S, et al
    Does influenza vaccination attenuate the severity of breakthrough infections? A narrative review and recommendations for further research.
    Vaccine. 2021 Jun 2. pii: S0264-410X(21)00562.
    PubMed     Abstract available

  457. LASKY T, McMahon AW, Hua W, Forshee R, et al
    Methodologic approaches in studies using real-world data (RWD) to measure pediatric safety and effectiveness of vaccines administered to pregnant women: A scoping review.
    Vaccine. 2021 Jun 2. pii: S0264-410X(21)00666.
    PubMed     Abstract available

  458. SHINGAI M, Nomura N, Sekiya T, Ohno M, et al
    Potent priming by inactivated whole influenza virus particle vaccines is linked to viral RNA uptake into antigen presenting cells.
    Vaccine. 2021 Jun 2. pii: S0264-410X(21)00660.
    PubMed     Abstract available

  459. YANG T, Liu B, Yue L, Xie T, et al
    Preclinical safety assessment of a combined vaccine against Hepatitis a virus and enterovirus 71.
    Vaccine. 2021 Jun 1. pii: S0264-410X(21)00653.
    PubMed     Abstract available

  460. JOHM P, Nkoum N, Ceesay A, Mbaye EH, et al
    Factors influencing acceptance of vaccination during pregnancy in The Gambia and Senegal.
    Vaccine. 2021 Jun 1. pii: S0264-410X(21)00663.
    PubMed     Abstract available

  461. SHI M, Chen X, Sun Y, Kim HK, et al
    A protein A based Staphylococcus aureus vaccine with improved safety.
    Vaccine. 2021 Jun 1. pii: S0264-410X(21)00667.
    PubMed     Abstract available

  462. CHYDERIOTIS S, Sicsic J, Raude J, Bonmarin I, et al
    Optimising HPV vaccination communication to adolescents: A discrete choice experiment.
    Vaccine. 2021 Jun 1. pii: S0264-410X(21)00656.
    PubMed     Abstract available

  463. WANG Y, Zhang Y, Wu H, Huang L, et al
    Safety and immunogenicity of a quadrivalent inactivated subunit non-adjuvanted influenza vaccine: A randomized, double-blind, active-controlled phase 1 clinical trial.
    Vaccine. 2021 Jun 1. pii: S0264-410X(21)00665.
    PubMed     Abstract available

  464. DEY A, Chozhavel Rajanathan TM, Chandra H, Pericherla HPR, et al
    Immunogenic potential of DNA vaccine candidate, ZyCoV-D against SARS-CoV-2 in animal models.
    Vaccine. 2021 Jun 1. pii: S0264-410X(21)00706.
    PubMed     Abstract available

  465. PATEL MK, Bergeri I, Bresee JS, Cowling BJ, et al
    Evaluation of post-introduction COVID-19 vaccine effectiveness: Summary of interim guidance of the World Health Organization.
    Vaccine. 2021 Jun 1. pii: S0264-410X(21)00707.
    PubMed     Abstract available

    May 2021
  466. BREWER NT, Mitchell CG, Alton Dailey S, Hora L, et al
    HPV vaccine communication training in healthcare systems: Evaluating a train-the-trainer model.
    Vaccine. 2021 May 30. pii: S0264-410X(21)00610.
    PubMed     Abstract available

  467. ZIPFEL CM, Colizza V, Bansal S
    The missing season: The impacts of the COVID-19 pandemic on influenza.
    Vaccine. 2021 May 30. pii: S0264-410X(21)00635.
    PubMed     Abstract available

  468. LEWIS NS, Banyard AC, Essen S, Whittard E, et al
    Antigenic evolution of contemporary clade HPAI H5 influenza A viruses and impact on vaccine use for mitigation and control.
    Vaccine. 2021 May 29. pii: S0264-410X(21)00655.
    PubMed     Abstract available

  469. GREWAL R, Deeks SL, Hart TA, Cox J, et al
    Human papillomavirus (HPV) vaccine uptake among a community-recruited sample of gay, bisexual, and other men who have sex with men in the three largest cities in Canada from 2017 to 2019.
    Vaccine. 2021 May 29. pii: S0264-410X(21)00603.
    PubMed     Abstract available

  470. MCGUINNESS D, Kaufhold RM, McHugh PM, Winters MA, et al
    Immunogenicity of PCV24, an expanded pneumococcal conjugate vaccine, in adult monkeys and protection in mice.
    Vaccine. 2021 May 29. pii: S0264-410X(21)00549.
    PubMed     Abstract available

  471. BARDENHEIER BH, Gravenstein S, Blackman C, Gutman R, et al
    Adverse events following mRNA SARS-CoV-2 vaccination among U.S. nursing home residents.
    Vaccine. 2021 May 28. pii: S0264-410X(21)00683.
    PubMed     Abstract available

  472. ABU MOUCH S, Roguin A, Hellou E, Ishai A, et al
    Myocarditis following COVID-19 mRNA vaccination.
    Vaccine. 2021 May 28. pii: S0264-410X(21)00682.
    PubMed     Abstract available

  473. WAGNER NM, Dempsey AF, Narwaney KJ, Gleason KS, et al
    Addressing logistical barriers to childhood vaccination using an automated reminder system and online resource intervention: A randomized controlled trial.
    Vaccine. 2021 May 28. pii: S0264-410X(21)00639.
    PubMed     Abstract available

  474. SULLIVAN E, Lecollinet S, Kerviel A, Hue E, et al
    Entry-competent-replication-abortive African horse sickness virus strains elicit robust immunity in ponies against all serotypes.
    Vaccine. 2021;39:3161-3168.
    PubMed     Abstract available

  475. BRANDILEONE MC, Almeida SCG, Bokermann S, Minamisava R, et al
    Dynamics of antimicrobial resistance of Streptococcus pneumoniae following PCV10 introduction in Brazil: Nationwide surveillance from 2007 to 2019.
    Vaccine. 2021;39:3207-3215.
    PubMed     Abstract available

  476. GURWITZ D
    COVID-19 vaccine hesitancy: Lessons from Israel.
    Vaccine. 2021 May 27. pii: S0264-410X(21)00680.

  477. CHU H, Ko LK, Ibrahim A, Bille Mohamed F, et al
    The impact of an educational forum intervention on East African mothers' HPV vaccine-related knowledge, attitudes, and intentions to vaccinate their adolescent children.
    Vaccine. 2021 May 27. pii: S0264-410X(21)00593.
    PubMed     Abstract available

  478. VUJOVICH-DUNN C, Kaufman J, King C, Skinner SR, et al
    A systematic review and meta-analysis of effectiveness of decision aids for vaccination decision-making.
    Vaccine. 2021 May 26. pii: S0264-410X(21)00583.
    PubMed     Abstract available

  479. KESSELS R, Luyten J, Tubeuf S
    Willingness to get vaccinated against Covid-19 and attitudes toward vaccination in general.
    Vaccine. 2021 May 26. pii: S0264-410X(21)00664.
    PubMed     Abstract available

  480. SATTLER C, Hoffmann P, Herzberg PY, Weber D, et al
    Primary vaccination in adult patients after allogeneic hematopoietic stem cell transplantation - A single center retrospective efficacy analysis.
    Vaccine. 2021 May 25. pii: S0264-410X(21)00511.
    PubMed     Abstract available

  481. WATESKA AR, Nowalk MP, Jalal H, Lin CJ, et al
    Is further research on adult pneumococcal vaccine uptake improvement programs worthwhile? Alpha value of information analysis.
    Vaccine. 2021 May 24. pii: S0264-410X(21)00609.
    PubMed     Abstract available

  482. COX SN, Wedlock PT, Pallas SW, Mitgang EA, et al
    A systems map of the economic considerations for vaccination: Application to hard-to-reach populations.
    Vaccine. 2021 May 24. pii: S0264-410X(21)00605.
    PubMed     Abstract available

  483. VANHEMS P
    A breath of humanity in the era of Covid-19 vaccine.
    Vaccine. 2021 May 24. pii: S0264-410X(21)00638.

  484. EARLE KA, Ambrosino DM, Fiore-Gartland A, Goldblatt D, et al
    Evidence for antibody as a protective correlate for COVID-19 vaccines.
    Vaccine. 2021 May 24. pii: S0264-410X(21)00658.
    PubMed     Abstract available

  485. GIDENGIL C, Goetz MB, Newberry S, Maglione M, et al
    Safety of vaccines used for routine immunization in the United States: An updated systematic review and meta-analysis.
    Vaccine. 2021 May 23. pii: S0264-410X(21)00385.
    PubMed     Abstract available

  486. NADARZYNSKI T, Frost M, Miller D, Wheldon CW, et al
    Vaccine acceptability, uptake and completion amongst men who have sex with men: A systematic review, meta-analysis and theoretical framework.
    Vaccine. 2021 May 22. pii: S0264-410X(21)00564.
    PubMed     Abstract available

  487. HIRST A, Hyer RN, Janssen RS
    Comparative cost-effectiveness of a 2-dose versus 3-dose vaccine for hepatitis B prevention in selected adult populations.
    Vaccine. 2021 May 21. pii: S0264-410X(21)00582.
    PubMed     Abstract available

  488. TUFAIL S, Shah MA, Zafar M, Asif TA, et al
    Identification of potent epitopes on hexon capsid protein and their evaluation as vaccine candidates against infections caused by members of Adenoviridae family.
    Vaccine. 2021 May 21. pii: S0264-410X(21)00585.
    PubMed     Abstract available

  489. ARDURA-GARCIA C, Kreis C, Rakic M, Jaboyedoff M, et al
    Rotavirus disease and health care utilisation among children under 5 years of age in highly developed countries: A systematic review and meta-analysis.
    Vaccine. 2021;39:2917-2928.
    PubMed     Abstract available

  490. BIANCHI FP, Larocca AMV, Bozzi A, Spinelli G, et al
    Long-term persistence of poliovirus neutralizing antibodies in the era of polio elimination: An Italian retrospective cohort study.
    Vaccine. 2021;39:2989-2994.
    PubMed     Abstract available

  491. VOGEL TP, Top KA, Karatzios C, Hilmers DC, et al
    Multisystem inflammatory syndrome in children and adults (MIS-C/A): Case definition & guidelines for data collection, analysis, and presentation of immunization safety data.
    Vaccine. 2021;39:3037-3049.
    PubMed     Abstract available

  492. SERAZIN NA, Edem B, Williams SR, Ortiz JR, et al
    Acute respiratory distress syndrome (ARDS) as an adverse event following immunization: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data.
    Vaccine. 2021;39:3028-3036.
    PubMed     Abstract available

  493. AIZAWA Y, Katsuta T, Sakiyama H, Tanaka-Taya K, et al
    Changes in childhood vaccination during the coronavirus disease 2019 pandemic in Japan.
    Vaccine. 2021 May 21. pii: S0264-410X(21)00636.
    PubMed     Abstract available

  494. OKORONKWO C, Taiwo LA, Asolo JA, Baptiste AEJ, et al
    Leveraging on the 2017/2018 measles vaccination campaign to improve health workers knowledge and practice on injection safety: A case study of north-central states, Nigeria.
    Vaccine. 2021 May 20. pii: S0264-410X(21)00565.
    PubMed     Abstract available

  495. SON HJ, Lee E, Park SY, Lee S, et al
    Promotion of healthcare personnel vaccinations among newly employed doctors and nurses: Evidence-guided strategy.
    Vaccine. 2021 May 20. pii: S0264-410X(21)00589.
    PubMed     Abstract available

  496. BLANCHARD-ROHNER G, Enriquez N, Lemaitre B, Cadau G, et al
    Pneumococcal immunity and PCV13 vaccine response in SOT-candidates and recipients.
    Vaccine. 2021 May 20. pii: S0264-410X(21)00594.
    PubMed     Abstract available

  497. NICHOLLS LAB, Gallant AJ, Cogan N, Rasmussen S, et al
    Older adults' vaccine hesitancy: Psychosocial factors associated with influenza, pneumococcal, and shingles vaccine uptake.
    Vaccine. 2021 May 19. pii: S0264-410X(21)00544.
    PubMed     Abstract available

  498. DANG JHT, Stewart SL, Blumberg DA, Rodriguez HP, et al
    Patient and clinician factors associated with uptake of the human papillomavirus (HPV) vaccine among adolescent patients of a primary care network.
    Vaccine. 2021 May 19. pii: S0264-410X(21)00525.
    PubMed     Abstract available

  499. KIM S, Williams TC, Viboud C, Campbell H, et al
    RSV genomic diversity and the development of a globally effective RSV intervention.
    Vaccine. 2021;39:2811-2820.
    PubMed     Abstract available

  500. NAG K, Chandra Baray J, Rahman Khan M, Mahmud A, et al
    An mRNA-based vaccine candidate against SARS-CoV-2 elicits stable immuno-response with single dose.
    Vaccine. 2021 May 18. pii: S0264-410X(21)00607.
    PubMed     Abstract available

  501. LUK TT, Zhao S, Wu Y, Wong JY, et al
    Prevalence and determinants of SARS-CoV-2 vaccine hesitancy in Hong Kong: A population-based survey.
    Vaccine. 2021 May 18. pii: S0264-410X(21)00608.
    PubMed     Abstract available

  502. MENKIR TF, Jbaily A, Verguet S
    Incorporating equity in infectious disease modeling: Case study of a distributional impact framework for measles transmission.
    Vaccine. 2021;39:2894-2900.
    PubMed     Abstract available

  503. GULLA K, Cibelli N, Cooper JW, Fuller HC, et al
    A non-affinity purification process for GMP production of prefusion-closed HIV-1 envelope trimers from clades A and C for clinical evaluation.
    Vaccine. 2021 May 18. pii: S0264-410X(21)00545.
    PubMed     Abstract available

  504. FUKUDA M, Nakamura J, Ito S, Kawazoe K, et al
    Vaccination inhibits the human adenoviral transduction in a mouse keratoconjunctivitis model.
    Vaccine. 2021 May 17. pii: S0264-410X(21)00561.
    PubMed     Abstract available

  505. NAKAHASHI-OUCHIDA R, Uchida Y, Yuki Y, Katakai Y, et al
    A nanogel-based trivalent PspA nasal vaccine protects macaques from intratracheal challenge with pneumococci.
    Vaccine. 2021 May 17. pii: S0264-410X(21)00552.
    PubMed     Abstract available

  506. CHAN YW, Wong ML, Kwok FY, Au AK, et al
    The effect of seasonal influenza vaccine on medically-attended influenza and non-influenza respiratory viruses infections at primary care level, Hong Kong SAR, 2017/18 to 2019/20.
    Vaccine. 2021 May 17. pii: S0264-410X(21)00541.
    PubMed     Abstract available

  507. MCGIRR A, Bourgoin T, Wortzman M, Millson B, et al
    An early look at the second dose completion of the recombinant zoster vaccine in Canadian adults: A retrospective database study.
    Vaccine. 2021 May 14. pii: S0264-410X(21)00523.
    PubMed     Abstract available

  508. AWAD AM, Ntoso A, Connaire JJ, Hernandez GT, et al
    An open-label, single-arm study evaluating the immunogenicity and safety of the hepatitis B vaccine HepB-CpG (HEPLISAV-B(R)) in adults receiving hemodialysis.
    Vaccine. 2021 May 14. pii: S0264-410X(21)00554.
    PubMed     Abstract available

  509. WOOD RM, Murch BJ, Moss SJ, Tyler JMB, et al
    Operational research for the safe and effective design of COVID-19 mass vaccination centres.
    Vaccine. 2021 May 14. pii: S0264-410X(21)00588.

  510. GUBERNOT D, Jazwa A, Niu M, Baumblatt J, et al
    U.S. Population-Based background incidence rates of medical conditions for use in safety assessment of COVID-19 vaccines.
    Vaccine. 2021 May 14. pii: S0264-410X(21)00578.
    PubMed     Abstract available

  511. CHUNG JR, Flannery B, Kim SS, Gaglani M, et al
    Sample size considerations for mid-season estimates from a large influenza vaccine effectiveness network in the United States.
    Vaccine. 2021 May 13. pii: S0264-410X(21)00555.
    PubMed     Abstract available

  512. WANG J, Jiang L, Zhang C, He W, et al
    The changes in the epidemiology of hand, foot, and mouth disease after the introduction of the EV-A71 vaccine.
    Vaccine. 2021 May 13. pii: S0264-410X(21)00560.
    PubMed     Abstract available

  513. LIU Y, Xiong Y, Liang Y, Deng X, et al
    Waning immunity and potential asymptomatic infection in 3-7 years old children who received one dose of measles-mumps-rubella vaccine: A 4-year prospective study.
    Vaccine. 2021 May 13. pii: S0264-410X(21)00559.
    PubMed     Abstract available

  514. KALKOWSKA DA, Pallansch MA, Wassilak SGF, Cochi SL, et al
    Serotype 2 oral poliovirus vaccine (OPV2) choices and the consequences of delaying outbreak response.
    Vaccine. 2021 May 13. pii: S0264-410X(21)00543.
    PubMed     Abstract available

  515. BANNISTER S, Sudbury E, Villanueva P, Perrett K, et al
    The safety of BCG revaccination: A systematic review.
    Vaccine. 2021;39:2736-2745.
    PubMed     Abstract available

  516. LONGCHAMPS C, Ducarroz S, Crouzet L, Vignier N, et al
    COVID-19 vaccine hesitancy among persons living in homeless shelters in France.
    Vaccine. 2021 May 12. pii: S0264-410X(21)00563.
    PubMed     Abstract available

  517. GROENEWEG L, Loeffen YGT, Versluys AB, Wolfs TFW, et al
    Safety and efficacy of early vaccination with live attenuated measles vaccine for hematopoietic stem cell transplant recipients and solid organ transplant recipients.
    Vaccine. 2021 May 12. pii: S0264-410X(21)00508.
    PubMed     Abstract available

  518. HAN B, Liu W, Du J, Liu H, et al
    Immunogenicity and safety of hepatitis B vaccination in patients with type 2 diabetes in China: An open-label randomized controlled trial.
    Vaccine. 2021 May 12. pii: S0264-410X(21)00540.
    PubMed     Abstract available

  519. KIM TH, Choi JH, Park SH, Yoo JH, et al
    Safety and immunogenicity of a seasonal quadrivalent influenza vaccine (GC3110A) in healthy participants aged >/= 65 years.
    Vaccine. 2021 May 12. pii: S0264-410X(21)00551.
    PubMed     Abstract available

  520. UWABOR E, Chau V, Romanin C, Loh LC, et al
    Digital tools for vaccine reporting: A perspective from the province of Ontario.
    Vaccine. 2021 May 12. pii: S0264-410X(21)00558.

  521. ARREDONDO JL, Villagomez Martinez SM, Concepcion Morales M, Meyer S, et al
    Immunogenicity and safety of a tetravalent dengue vaccine and a bivalent HPV vaccine given concomitantly or sequentially in girls aged 9 to 14 years in Mexico.
    Vaccine. 2021 May 12. pii: S0264-410X(21)00546.
    PubMed     Abstract available

  522. KRAIGSLEY AM, Moore KA, Bolster A, Peters M, et al
    Barriers and activities to implementing or expanding influenza vaccination programs in low- and middle-income countries: A global survey.
    Vaccine. 2021 May 12. pii: S0264-410X(21)00502.
    PubMed     Abstract available

  523. CHILENGI R, Mwila-Kazimbaya K, Chirwa M, Sukwa N, et al
    Immunogenicity and safety of two monovalent rotavirus vaccine, ROTAVAC(R) and ROTAVAC 5D(R) in Zambian infants.
    Vaccine. 2021 May 12. pii: S0264-410X(21)00542.
    PubMed     Abstract available

  524. GLENN BA, Nonzee NJ, Tieu L, Pedone B, et al
    Human papillomavirus (HPV) vaccination in the transition between adolescence and adulthood.
    Vaccine. 2021 May 12. pii: S0264-410X(21)00454.
    PubMed     Abstract available

  525. AFIFI TO, Salmon S, Taillieu T, Stewart-Tufescu A, et al
    Older adolescents and young adults willingness to receive the COVID-19 vaccine: Implications for informing public health strategies.
    Vaccine. 2021 May 12. pii: S0264-410X(21)00590.
    PubMed     Abstract available

  526. LEUNG VKY, Fox A, Carolan LA, Aban M, et al
    Impact of prior vaccination on antibody response and influenza-like illness among Australian healthcare workers after influenza vaccination in 2016.
    Vaccine. 2021 May 10. pii: S0264-410X(21)00483.
    PubMed     Abstract available

  527. POWELL H, Liu H, Pekosz A
    Changes in sialic acid binding associated with egg adaptation decrease live attenuated influenza virus replication in human nasal epithelial cell cultures.
    Vaccine. 2021 May 10. pii: S0264-410X(21)00535.
    PubMed     Abstract available

  528. DU QQ, Zeng HL, Yuan L, Tang P, et al
    One cross-sectional investigation revealed that non-vaccine serotypes of Streptococcus pneumoniae could be identified more frequently in elderly Chinese people.
    Vaccine. 2021 May 9. pii: S0264-410X(21)00233.
    PubMed     Abstract available

  529. PASTORINO R, Villani L, La Milia DI, Ieraci R, et al
    Influenza and pneumococcal vaccinations are not associated to COVID-19 outcomes among patients admitted to a university hospital.
    Vaccine. 2021 May 9. pii: S0264-410X(21)00566.
    PubMed     Abstract available

  530. HUANG JM, Wang SY, Lai MR, Tseng YK, et al
    Development of a respiratory syncytial virus vaccine using human hepatitis B core-based virus-like particles to induce mucosal immunity.
    Vaccine. 2021 May 7. pii: S0264-410X(21)00485.
    PubMed     Abstract available

  531. STABEL JR, Bannantine JP
    Reduced tissue colonization of Mycobacterium avium subsp. paratuberculosis in neonatal calves vaccinated with a cocktail of recombinant proteins.
    Vaccine. 2021 May 6. pii: S0264-410X(21)00510.
    PubMed     Abstract available

  532. TANG XY, Yan XX, Wei X, Qin QL, et al
    Timeliness, completeness, and timeliness-and-completeness of serial routine vaccinations among rural children in Southwest China: A multi-stage stratified cluster sampling survey.
    Vaccine. 2021 May 6. pii: S0264-410X(21)00507.
    PubMed     Abstract available

  533. KHALIL I, Walker R, Porter CK, Muhib F, et al
    Enterotoxigenic Escherichia coli (ETEC) vaccines: Priority activities to enable product development, licensure, and global access.
    Vaccine. 2021 May 6. pii: S0264-410X(21)00453.
    PubMed     Abstract available

  534. SOMIYA M, Mine S, Yasukawa K, Ikeda S, et al
    Sex differences in the incidence of anaphylaxis to LNP-mRNA COVID-19 vaccines.
    Vaccine. 2021 May 6. pii: S0264-410X(21)00548.

  535. SATOH C, Toizumi M, Nguyen HAT, Hara M, et al
    Prevalence and characteristics of children with otitis media with effusion in Vietnam.
    Vaccine. 2021;39:2613-2619.
    PubMed     Abstract available

  536. MANCA TA, Graham JE, MacDonald NE, Top KA, et al
    Healthcare providers' interpretations of product labelling information developed through a consensus stakeholder approach.
    Vaccine. 2021;39:2652-2659.
    PubMed     Abstract available

  537. CORREIA R, Meneses L, Richheimer C, Alves PM, et al
    Improved storage of influenza HA-VLPs using a trehalose-glycerol natural deep eutectic solvent system.
    Vaccine. 2021 May 6. pii: S0264-410X(21)00480.
    PubMed     Abstract available

  538. FAIRMAN J, Agarwal P, Barbanel S, Behrens C, et al
    Non-clinical immunological comparison of a Next-Generation 24-valent pneumococcal conjugate vaccine (VAX-24) using site-specific carrier protein conjugation to the current standard of care (PCV13 and PPV23).
    Vaccine. 2021 May 5. pii: S0264-410X(21)00374.
    PubMed     Abstract available

  539. JO CL, Burchett H, Bastias M, Campbell P, et al
    Using existing systematic reviews for developing vaccination recommendations: Results of an international expert workshop.
    Vaccine. 2021 May 5. pii: S0264-410X(21)00504.
    PubMed     Abstract available

  540. WANG J, Bai S, Zhou S, Zhao W, et al
    Immunogenicity and safety of 7-valent pneumococcal conjugate vaccine (PCV7) in children aged 2-5 years in China.
    Vaccine. 2021 May 5. pii: S0264-410X(21)00484.
    PubMed     Abstract available

  541. BITENCOURT J, Sarno A, Oliveira C, Souza RA, et al
    Comparing cytokine production and clinical response following vaccination with BCG Moreau and BCG Russia strains in a Brazilian infant population.
    Vaccine. 2021 May 5. pii: S0264-410X(21)00475.
    PubMed     Abstract available

  542. MILLAR EV, Bennett JW, Barin B, Carey PM, et al
    Safety, immunogenicity, and efficacy of NDV-3A against Staphylococcus aureus colonization: A phase 2 vaccine trial among US Army Infantry trainees.
    Vaccine. 2021 May 4. pii: S0264-410X(21)00478.
    PubMed     Abstract available

  543. HALL GC, Douglas I, Heath PT, Prabhakar P, et al
    Post-licensure observational safety study after meningococcal B vaccine 4CMenB (Bexsero) vaccination within the routine UK immunisation program.
    Vaccine. 2021 May 4. pii: S0264-410X(21)00256.
    PubMed     Abstract available

  544. MPHURU A, Li AJ, Kyesi F, Mwengee W, et al
    National introduction of human papillomavirus (HPV) vaccine in Tanzania: Programmatic decision-making and implementation.
    Vaccine. 2021 May 4. pii: S0264-410X(21)00472.
    PubMed     Abstract available

  545. OTERI AJ, Adamu U, Dieng B, Bawa S, et al
    Nigeria experience on the use of polio assets for the 2017/18 measles vaccination campaign follow-up.
    Vaccine. 2021 May 4. pii: S0264-410X(21)00497.
    PubMed     Abstract available

  546. LAURENZ M, von Eiff C, Borchert K, Jacob C, et al
    Vaccination rates and adherence in pneumococcal conjugate vaccination in mature born infants before and after vaccination schedule change - A claims database analysis.
    Vaccine. 2021 May 4. pii: S0264-410X(21)00476.
    PubMed     Abstract available

  547. TAMANDJOU TCHUEM CR, Andersson MI, Wiysonge CS, Mufenda J, et al
    Prevention of hepatitis B mother-to-child transmission in Namibia: A cost-effectiveness analysis.
    Vaccine. 2021 May 4. pii: S0264-410X(21)00498.
    PubMed     Abstract available

  548. MANDOMANDO I, Mumba M, Nsiari-Muzeyi Biey J, Kipese Paluku G, et al
    Implementation of the World Health Organization recommendation on the use of rotavirus vaccine without age restriction by African countries.
    Vaccine. 2021 May 3. pii: S0264-410X(21)00289.
    PubMed     Abstract available

  549. YOSHIMURA M, Shinmura Y, Shishido T, Takagi S, et al
    Persistence of neutralizing antibody and its protective efficacy induced by a live attenuated tetravalent dengue vaccine, KD-382, in cynomolgus monkeys.
    Vaccine. 2021 May 1. pii: S0264-410X(21)00477.
    PubMed     Abstract available

    April 2021
  550. WELSH KJ, Baumblatt J, Chege W, Goud R, et al
    Thrombocytopenia including immune thrombocytopenia after receipt of mRNA COVID-19 vaccines reported to the Vaccine Adverse Event Reporting System (VAERS).
    Vaccine. 2021 Apr 30. pii: S0264-410X(21)00524.
    PubMed     Abstract available

  551. EYAL N, Gerhard T, Strom BL
    Strengthening and accelerating SARS-CoV-2 vaccine safety surveillance through registered pre-approval rollout after challenge tests.
    Vaccine. 2021 Apr 30. pii: S0264-410X(21)00526.

  552. ITO S, Nakamura J, Fukuta M, Ura T, et al
    Prophylactic and therapeutic vaccine against Pseudomonas aeruginosa keratitis using bacterial membrane vesicles.
    Vaccine. 2021 Apr 29. pii: S0264-410X(21)00482.
    PubMed     Abstract available

  553. WILKINSON K, Righolt CH, Elliott LJ, Fanella S, et al
    Pertussis vaccine effectiveness and duration of protection - A systematic review and meta-analysis.
    Vaccine. 2021 Apr 29. pii: S0264-410X(21)00479.
    PubMed     Abstract available

  554. POLKOWSKA A, Rinta-Kokko H, Toropainen M, Palmu AA, et al
    Long-term population effects of infant 10-valent pneumococcal conjugate vaccination on pneumococcal meningitis in Finland.
    Vaccine. 2021 Apr 29. pii: S0264-410X(21)00186.
    PubMed     Abstract available

  555. KINI A, Morgan R, Kuo H, Shea P, et al
    Differences and disparities in seasonal influenza vaccine, acceptance, adverse reactions, and coverage by age, sex, gender, and race.
    Vaccine. 2021 Apr 28. pii: S0264-410X(21)00448.
    PubMed     Abstract available

  556. DIAS HF, Kuhtreiber WM, Nelson KJ, Ng NC, et al
    Epigenetic changes related to glucose metabolism in type 1 diabetes after BCG vaccinations: A vital role for KDM2B.
    Vaccine. 2021 Apr 28. pii: S0264-410X(21)00446.
    PubMed     Abstract available

  557. VEKEMANS J, Schellenberg D, Benns S, O'Brien K, et al
    Meeting report: WHO consultation on malaria vaccine development, Geneva, 15-16 July 2019.
    Vaccine. 2021 Apr 27. pii: S0264-410X(21)00409.
    PubMed     Abstract available

  558. SAITOH A, Okabe N
    Changes and remaining challenges for the Japanese immunization program: Closing the vaccine gap.
    Vaccine. 2021 Apr 27. pii: S0264-410X(21)00460.
    PubMed     Abstract available

  559. XU J, Doyon-Plourde P, Tunis M, Quach C, et al
    Effect of early measles vaccination on long-term protection: A systematic review.
    Vaccine. 2021 Apr 26. pii: S0264-410X(21)00447.
    PubMed     Abstract available

  560. KWON JH, Criado MF, Killmaster L, Ali MZ, et al
    Efficacy of two vaccines against recent emergent antigenic variants of clade highly pathogenic avian influenza viruses in Bangladesh.
    Vaccine. 2021 Apr 25. pii: S0264-410X(21)00459.
    PubMed     Abstract available

  561. MACINTYRE CR, Costantino V, Trent M
    Modelling of COVID-19 vaccination strategies and herd immunity, in scenarios of limited and full vaccine supply in NSW, Australia.
    Vaccine. 2021 Apr 24. pii: S0264-410X(21)00501.
    PubMed     Abstract available

  562. KREPS SE, Kriner DL
    Factors influencing Covid-19 vaccine acceptance across subgroups in the United States: Evidence from a conjoint experiment.
    Vaccine. 2021 Apr 24. pii: S0264-410X(21)00503.
    PubMed     Abstract available

  563. PARK MA, Jenkins SM, Smith CY, Pyle RC, et al
    Pneumococcal serotype-specific cut-offs based on antibody responses to pneumococcal polysaccharide vaccination in healthy adults.
    Vaccine. 2021 Apr 22. pii: S0264-410X(21)00450.
    PubMed     Abstract available

  564. XIRIDOU M, Visser M, Urbanus A, Matser A, et al
    Ending risk-group HBV vaccination for MSM after the introduction of universal infant HBV vaccination: A mathematical modelling study.
    Vaccine. 2021 Apr 22. pii: S0264-410X(21)00433.
    PubMed     Abstract available

  565. OLATUNJI EA, Ogunsola AS, Khodakarami N, Callaghan T, et al
    Who receives influenza vaccinations at the Pharmacy? An analysis of the Texas Behavioral Risk Factor Surveillance System.
    Vaccine. 2021 Apr 22. pii: S0264-410X(21)00451.
    PubMed     Abstract available

  566. SOLANS L, Debrie AS, Coutte L, Locht C, et al
    Construction and evaluation of a pertactin-deficient live attenuated pertussis vaccine candidate BPZE1 derivative.
    Vaccine. 2021 Apr 22. pii: S0264-410X(21)00449.
    PubMed     Abstract available

  567. ROY CHOUDHURY A, Polachek SW
    The impact of paid family leave on the timely vaccination of infants.
    Vaccine. 2021 Apr 22. pii: S0264-410X(21)00403.
    PubMed     Abstract available

  568. KAWAMURA Y, Hattori F, Higashimoto Y, Kozawa K, et al
    Evaluation of varicella vaccine effectiveness during outbreaks in schools or nurseries by cross-sectional study.
    Vaccine. 2021 Apr 21. pii: S0264-410X(21)00434.
    PubMed     Abstract available

  569. STEVENS NE, van Wolfswinkel M, Bao W, Ryan FJ, et al
    Immunisation with the BCG and DTPw vaccines induces different programs of trained immunity in mice.
    Vaccine. 2021 Apr 21. pii: S0264-410X(21)00400.
    PubMed     Abstract available

  570. HAMISU M, Dieng B, Taiwo L, Jean Baptiste AE, et al
    Microplanning verification and 2017/2018 measles vaccination campaign in Nigeria: Lessons learnt.
    Vaccine. 2021 Apr 20. pii: S0264-410X(21)00432.
    PubMed     Abstract available

  571. PIERSON BC, Cardile AP, Okwesili AC, Downs IL, et al
    Safety and immunogenicity of an inactivated eastern equine encephalitis virus vaccine.
    Vaccine. 2021 Apr 19. pii: S0264-410X(21)00309.
    PubMed     Abstract available

  572. JEAN BAPTISTE AE, Masresha B, Wagai J, Luce R, et al
    Trends in measles incidence and measles vaccination coverage in Nigeria, 2008-2018.
    Vaccine. 2021 Apr 17. pii: S0264-410X(21)00424.
    PubMed     Abstract available

  573. SAVAGE RD, Bell CA, Righolt CH, Wilkinson K, et al
    A multisite study of pertussis vaccine effectiveness by time since last vaccine dose from three Canadian provinces: A Canadian Immunization Research Network study.
    Vaccine. 2021 Apr 16. pii: S0264-410X(21)00310.
    PubMed     Abstract available

  574. OSTOLIN TLVDP, Gusmao MR, Mathias FAS, Cardoso JMO, et al
    A chimeric vaccine combined with adjuvant system induces immunogenicity and protection against visceral leishmaniasis in BALB/c mice.
    Vaccine. 2021 Apr 16. pii: S0264-410X(21)00429.
    PubMed     Abstract available

  575. MARTIN JC, Petrecz ML, Stek JE, Simon JK, et al
    Using the power law model to predict the long-term persistence and duration of detectable hepatitis A antibody after receipt of hepatitis A vaccine (VAQTA).
    Vaccine. 2021 Apr 15. pii: S0264-410X(21)00345.
    PubMed     Abstract available

  576. GUZMAN-HOLST A, Luna-Casas G, Cervantes-Apolinar MY, Huerta-Garcia GC, et al
    Pertussis infant morbidity and mortality trends after universal maternal immunisation in Mexico: An ecological database study with time-series analysis.
    Vaccine. 2021;39:2311-2318.
    PubMed     Abstract available

  577. YAMADA M, Li M, Iino T
    Pneumococcal vaccine coverage in Japan among patients with a history of splenectomy: Results of a retrospective administrative database study.
    Vaccine. 2021 Apr 14. pii: S0264-410X(21)00338.
    PubMed     Abstract available

  578. DANIEL M, Liang B, Luo M
    Assessment of the population coverage of an HIV-1 vaccine targeting sequences surrounding the viral protease cleavage sites in Gag, Pol, or all 12 protease cleavage sites.
    Vaccine. 2021 Apr 13. pii: S0264-410X(21)00372.
    PubMed     Abstract available

  579. BROOK B, Schaltz-Buchholzer F, Ben-Othman R, Kollmann T, et al
    A place for neutrophils in the beneficial pathogen-agnostic effects of the BCG vaccine.
    Vaccine. 2021 Apr 13. pii: S0264-410X(21)00408.
    PubMed     Abstract available

  580. LEVIN Y, Balakirski NM, Caraco Y, Ben-Ami E, et al
    Ethics and execution of developing a 2nd wave COVID vaccine - Our interim phase I/II VSV-SARS-CoV2 vaccine experience.
    Vaccine. 2021 Apr 13. pii: S0264-410X(21)00452.

  581. WANG C, Han B, Zhao T, Liu H, et al
    Vaccination willingness, vaccine hesitancy, and estimated coverage at the first round of COVID-19 vaccination in China: A national cross-sectional study.
    Vaccine. 2021 Apr 13. pii: S0264-410X(21)00455.
    PubMed     Abstract available

  582. YU Q, Li X, Fan M, Qiu H, et al
    The impact of childhood pneumococcal conjugate vaccine immunisation on all-cause pneumonia admissions in Hong Kong: A 14-year population-based interrupted time series analysis.
    Vaccine. 2021 Apr 12. pii: S0264-410X(21)00406.
    PubMed     Abstract available

  583. PRYMULA R, Povey M, Brzostek J, Cabrnochova H, et al
    Ten-year follow-up on efficacy, immunogenicity and safety of two doses of a combined measles-mumps-rubella-varicella vaccine or one dose of monovalent varicella vaccine: Results from five East European countries.
    Vaccine. 2021 Apr 12. pii: S0264-410X(21)00401.
    PubMed     Abstract available

  584. CHOI SK, Baik YO, Kim CW, Kim SK, et al
    An open-label, comparative, single dose, clinical Phase study to assess the safety and immunogenicity of typhoid conjugate vaccine (Vi-CRM197) in healthy Filipino adults.
    Vaccine. 2021 Apr 10. pii: S0264-410X(21)00405.
    PubMed     Abstract available

  585. LA EM, Garbinsky D, Hunter S, Poston S, et al
    Meningococcal B vaccination coverage among older adolescents in the United States.
    Vaccine. 2021 Apr 10. pii: S0264-410X(21)00375.
    PubMed     Abstract available

  586. HAMILTON RA, Krockow EM, Vekria P
    Attitudes towards influenza and uptake of the flu vaccine: A survey of pharmacy staff working in English hospitals.
    Vaccine. 2021 Apr 9. pii: S0264-410X(21)00407.
    PubMed     Abstract available

  587. JENSEN KJ, Tolstrup LK, Knobel DL, Aaby P, et al
    Non-specific effects of maternal and offspring rabies vaccination on mortality and antibiotic use in a Danish pig herd: A randomized trial.
    Vaccine. 2021 Apr 9. pii: S0264-410X(21)00399.
    PubMed     Abstract available

  588. PU J, Yu Q, Yin Z, Zhang Y, et al
    The safety and immunogenicity of an inactivated SARS-CoV-2 vaccine in Chinese adults aged 18-59 years: A phase I randomized, double-blinded, controlled trial.
    Vaccine. 2021 Apr 9. pii: S0264-410X(21)00431.
    PubMed     Abstract available

  589. DE SL, May S, Shah K, Slawinski M, et al
    Variable immunogenicity of a vivax malaria blood-stage vaccine candidate.
    Vaccine. 2021 Apr 8. pii: S0264-410X(21)00376.
    PubMed     Abstract available

  590. HOGAN AB, Winskill P, Watson OJ, Walker PGT, et al
    Within-country age-based prioritisation, global allocation, and public health impact of a vaccine against SARS-CoV-2: A mathematical modelling analysis.
    Vaccine. 2021 Apr 8. pii: S0264-410X(21)00427.
    PubMed     Abstract available

  591. CEYHAN M, Karadag-Oncel E, Hascelik G, Ustundag G, et al
    Nasopharyngeal carriage of Streptococcus pneumoniae in healthy children aged less than five years.
    Vaccine. 2021;39:2041-2047.
    PubMed     Abstract available

  592. PAGLIUSI S, Hayman B, Jarrett S
    Vaccines for a healthy future: 21st DCVMN Annual General Meeting 2020 report.
    Vaccine. 2021 Apr 7. pii: S0264-410X(21)00293.
    PubMed     Abstract available

  593. GRAMACHO WG, Turgeon M
    When politics collides with public health: COVID-19 vaccine country of origin and vaccination acceptance in Brazil.
    Vaccine. 2021 Apr 6. pii: S0264-410X(21)00396.
    PubMed     Abstract available

  594. HATZIANTONIOU S, Maltezou HC, Tsakris A, Poland GA, et al
    Anaphylactic reactions to mRNA COVID-19 vaccines: A call for further study.
    Vaccine. 2021 Apr 6. pii: S0264-410X(21)00377.

  595. DANIELS V, Saxena K, Roberts C, Kothari S, et al
    Impact of reduced human papillomavirus vaccination coverage rates due to COVID-19 in the United States: A model based analysis.
    Vaccine. 2021 Apr 6. pii: S0264-410X(21)00428.
    PubMed     Abstract available

  596. SMITH TG, Fooks AR, Moore SM, Freuling CM, et al
    Negligible risk of rabies importation in dogs thirty days after demonstration of adequate serum antibody titer.
    Vaccine. 2021 Apr 4. pii: S0264-410X(21)00368.

  597. DION SB, Major M, Gabriela Grajales A, Nepal RM, et al
    Invasive pneumococcal disease in Canada 2010-2017: The role of current and next-generation higher-valent pneumococcal conjugate vaccines.
    Vaccine. 2021 Apr 3. pii: S0264-410X(21)00260.
    PubMed     Abstract available

  598. DONG TQ, Wakefield J
    Modeling and presentation of vaccination coverage estimates using data from household surveys.
    Vaccine. 2021 Apr 3. pii: S0264-410X(21)00275.
    PubMed     Abstract available

  599. STALPERS CAL, Retmana IA, Pennings JLA, Vandebriel RJ, et al
    Variability of in vivo potency tests of Diphtheria, Tetanus and acellular Pertussis (DTaP) vaccines.
    Vaccine. 2021 Apr 3. pii: S0264-410X(21)00384.
    PubMed     Abstract available

  600. YAO T, Shao Z, Wu L, Dong S, et al
    Long-term persistent immunogenicity after successful standard and triple-dosed hepatitis B vaccine in hemodialysis patients: A 3-year follow-up study in China.
    Vaccine. 2021 Apr 2. pii: S0264-410X(21)00378.
    PubMed     Abstract available

  601. BEZERRA FSB, Silva MTO, Rezende AFS, Lopes AS, et al
    Saponin-adjuvanted recombinant vaccines containing rCP00660, rCP09720 or rCP01850 proteins against Corynebacterium pseudotuberculosis infection in mice.
    Vaccine. 2021 Apr 1. pii: S0264-410X(21)00366.
    PubMed     Abstract available

  602. DE MIRANDA LOPES KA, Baptista PN, de Medeiros Nascimento R, Pimentel A, et al
    Clinical repercussions in pertussis infants post-Tdpa vaccination of pregnant woman: An immunization success?
    Vaccine. 2021 Apr 1. pii: S0264-410X(21)00373.
    PubMed     Abstract available

  603. SUH J, Lee T, Choi JK, Lee J, et al
    The impact of two-dose varicella vaccination on varicella and herpes zoster incidence in South Korea using a mathematical model with changing population demographics.
    Vaccine. 2021 Apr 1. pii: S0264-410X(21)00349.
    PubMed     Abstract available

  604. CARR DJJ, Berube AN, Filiberti A, Gmyrek GB, et al
    Lack of neonatal Fc receptor does not diminish the efficacy of the HSV-1 0DeltaNLS vaccine against ocular HSV-1 challenge.
    Vaccine. 2021 Apr 1. pii: S0264-410X(21)00379.
    PubMed     Abstract available

  605. HOFFMAN BL, Colditz JB, Shensa A, Wolynn R, et al
    #DoctorsSpeakUp: Lessons learned from a pro-vaccine Twitter event.
    Vaccine. 2021 Apr 1. pii: S0264-410X(21)00365.
    PubMed     Abstract available

  606. CROWCROFT NS, Bolotin S, Li Y, Campbell H, et al
    Infant pertussis and maternal immunity: The curious case of Canada.
    Vaccine. 2021;39:1977-1981.
    PubMed     Abstract available

  607. AMIN-CHOWDHURY Z, Groves N, Sheppard CL, Litt D, et al
    Invasive pneumococcal disease due to 22F and 33F in England: A tail of two serotypes.
    Vaccine. 2021;39:1997-2004.
    PubMed     Abstract available

  608. QUAN DH, Counoupas C, Nagalingam G, Pinto R, et al
    Advax adjuvant formulations promote protective immunity against aerosol Mycobacterium tuberculosis in the absence of deleterious inflammation and reactogenicity.
    Vaccine. 2021;39:1990-1996.
    PubMed     Abstract available

    March 2021
  609. ERIKSSON M, Kayhty H, Lahdenkari M, Makisalo H, et al
    A randomized, controlled trial comparing the immunogenicity and safety of a 23-valent pneumococcal polysaccharide vaccination to a repeated dose 13-valent pneumococcal conjugate vaccination in adult liver transplant recipients.
    Vaccine. 2021 Mar 31. pii: S0264-410X(21)00367.
    PubMed     Abstract available

  610. KLOUWENS MJ, Salverda MLM, Trentelman JJ, Ersoz JI, et al
    Vaccination with meningococcal outer membrane vesicles carrying Borrelia OspA protects against experimental Lyme borreliosis.
    Vaccine. 2021 Mar 31. pii: S0264-410X(21)00363.
    PubMed     Abstract available

  611. AZZI L, Focosi D, Dentali F, Baj A, et al
    Anti-SARS-CoV-2 RBD IgG responses in convalescent versus naive BNT162b2 vaccine recipients.
    Vaccine. 2021 Mar 30. pii: S0264-410X(21)00402.

  612. CHEN H, Gao Z, Bai S, Liu X, et al
    Immunogenicity and safety of sabin-strain based inactivated poliovirus vaccine replacing salk-strain based inactivated poliovirus vaccine: An innovative application of different strain-IPVs replacement.
    Vaccine. 2021 Mar 30. pii: S0264-410X(21)00264.
    PubMed     Abstract available

  613. PELTON SI, Divino V, Postma MJ, Shah D, et al
    A retrospective cohort study assessing relative effectiveness of adjuvanted versus high-dose trivalent influenza vaccines among older adults in the United States during the 2018-19 influenza season.
    Vaccine. 2021 Mar 30. pii: S0264-410X(21)00347.
    PubMed     Abstract available

  614. GUR-ARIE R, Katz MA, Hirsch A, Greenberg D, et al
    "You Have to Die Not to Come to Work": A Mixed Methods Study of Attitudes and Behaviors regarding Presenteeism, Absenteeism and Influenza Vaccination among Healthcare Personnel with Respiratory Illness in Israel, 2016-2019.
    Vaccine. 2021 Mar 29. pii: S0264-410X(21)00361.
    PubMed     Abstract available

  615. YAMAWAKI RA, Rubio MDS, Alves LBR, de Almeida AM, et al
    Evaluation of transfer of maternal immunity to the offspring of broiler breeders vaccinated with a candidate recombinant vaccine against Salmonella Enteritidis.
    Vaccine. 2021 Mar 26. pii: S0264-410X(21)00343.
    PubMed     Abstract available

  616. BAVANANTHASIVAM J, Alizadeh M, Astill J, Alqazlan N, et al
    Effects of administration of probiotic lactobacilli on immunity conferred by the herpesvirus of turkeys vaccine against challenge with a very virulent Marek's disease virus in chickens.
    Vaccine. 2021 Mar 26. pii: S0264-410X(21)00339.
    PubMed     Abstract available

  617. WIJAYANTI KE, Schutze H, MacPhail C, Braunack-Mayer A, et al
    Parents' knowledge, beliefs, acceptance and uptake of the HPV vaccine in members of The Association of Southeast Asian Nations (ASEAN): A systematic review of quantitative and qualitative studies.
    Vaccine. 2021 Mar 26. pii: S0264-410X(21)00342.
    PubMed     Abstract available

  618. KUTER BJ, Offit PA, Poland GA
    The development of COVID-19 vaccines in the United States: Why and how so fast?
    Vaccine. 2021 Mar 26. pii: S0264-410X(21)00383.

  619. RUSSO AG, Decarli A, Valsecchi MG
    Strategy to identify priority groups for COVID-19 vaccination: A population based cohort study.
    Vaccine. 2021 Mar 26. pii: S0264-410X(21)00382.
    PubMed     Abstract available

  620. LAMPONEN T, Hetemaki I, Niemi HJ, Jarva H, et al
    Heterologous boosting of nonrelated toxoid immunity during acute Puumala hantavirus infection.
    Vaccine. 2021;39:1818-1825.
    PubMed     Abstract available

  621. VREMAN S, Rebel JMJ, McCaffrey J, Ledl K, et al
    Early immune responses in skin and lymph node after skin delivery of Toll-like receptor agonists in neonatal and adult pigs.
    Vaccine. 2021;39:1857-1869.
    PubMed     Abstract available

  622. WAN C, Gao C, Xie Q, Wang Y, et al
    Flagella hook protein FlgE is a novel vaccine candidate of Pseudomonas aeruginosa identified by a genomic approach.
    Vaccine. 2021 Mar 25. pii: S0264-410X(21)00344.
    PubMed     Abstract available

  623. NGUYEN KH, Santibanez TA, Stokley S, Lindley MC, et al
    Parental vaccine hesitancy and its association with adolescent HPV vaccination.
    Vaccine. 2021 Mar 25. pii: S0264-410X(21)00341.

  624. GKENTZI D, Aggelopoulos K, Karatza A, Sinopidis X, et al
    Influenza vaccination among caregivers and household contacts of children with asthma.
    Vaccine. 2021 Mar 25. pii: S0264-410X(21)00325.
    PubMed     Abstract available

  625. MPHAHLELE MJ, Groome MJ, Page NA, Bhagwandin N, et al
    A decade of rotavirus vaccination in Africa - Saving lives and changing the face of diarrhoeal diseases: Report of the 12(th) African Rotavirus Symposium.
    Vaccine. 2021 Mar 25. pii: S0264-410X(21)00282.
    PubMed     Abstract available

  626. SALMON DA, Dudley MZ, Brewer J, Kan L, et al
    COVID-19 vaccination attitudes, values and intentions among United States adults prior to emergency use authorization.
    Vaccine. 2021 Mar 24. pii: S0264-410X(21)00315.
    PubMed     Abstract available

  627. MURRAY SM, McKay PF
    Chlamydia trachomatis: Cell biology, immunology and vaccination.
    Vaccine. 2021 Mar 24. pii: S0264-410X(21)00326.
    PubMed     Abstract available

  628. BEISSBARTH J, Wilson N, Arrowsmith B, Binks MJ, et al
    Nasopharyngeal carriage of otitis media pathogens in infants receiving 10-valent non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10), 13-valent pneumococcal conjugate vaccine (PCV13) or a mixed primary schedule of both vaccines
    Vaccine. 2021 Mar 23. pii: S0264-410X(21)00311.
    PubMed     Abstract available

  629. ROSA SS, Prazeres DMF, Azevedo AM, Marques MPC, et al
    mRNA vaccines manufacturing: Challenges and bottlenecks.
    Vaccine. 2021 Mar 23. pii: S0264-410X(21)00319.
    PubMed     Abstract available

  630. HAEDER SF
    Joining the herd? U.S. public opinion and vaccination requirements across educational settings during the COVID-19 pandemic.
    Vaccine. 2021 Mar 23. pii: S0264-410X(21)00348.
    PubMed     Abstract available

  631. ANGELIS A, Darrow J
    Safeguarding evidence-based decision making in the FDA for COVID-19 vaccines.
    Vaccine. 2021 Mar 22. pii: S0264-410X(21)00346.

  632. KOCHHAR S, Dube E, Graham J, Jee Y, et al
    COVID-19 vaccine safety questions and answers for healthcare providers (CONSIDER).
    Vaccine. 2021 Mar 22. pii: S0264-410X(21)00364.

  633. ZHANG Y, Li D, Zhao H, Wang L, et al
    The role of multiple SARS-CoV-2 viral antigens in a vaccine-induced integrated immune response.
    Vaccine. 2021 Mar 22. pii: S0264-410X(21)00371.

  634. ANTONELLI INCALZI R, Trevisan C, Del Signore S, Volpato S, et al
    Are vaccines against COVID-19 tailored to the most vulnerable people?
    Vaccine. 2021 Mar 22. pii: S0264-410X(21)00370.

  635. KENDAL A
    Safety monitoring of COVID-19 vaccines - Lessons learned from the 1976 national influenza immunization program about detecting rare vaccine-related severe adverse events in emergency mass-vaccination programs.
    Vaccine. 2021 Mar 20. pii: S0264-410X(21)00283.

  636. CHEN D, Ye Z, Pi Z, Mizukami S, et al
    Cost-effectiveness of dual influenza and pneumococcal vaccination among the elderly in Shenzhen, China.
    Vaccine. 2021 Mar 20. pii: S0264-410X(21)00324.
    PubMed     Abstract available

  637. VILCHES TN, Zhang K, Van Exan R, Langley JM, et al
    Projecting the impact of a two-dose COVID-19 vaccination campaign in Ontario, Canada.
    Vaccine. 2021 Mar 20. pii: S0264-410X(21)00362.
    PubMed     Abstract available

    A half-century of meningococcal vaccines.
    Vaccine. 2021 Mar 19. pii: S0264-410X(21)00292.
    PubMed     Abstract available

  639. EL BARA A, Pivert A, Veillon P, Ng Wing Sang C, et al
    From national HBV and HDV screenings to vaccination and treatment in healthcare workers: The Mauritanian pilot study.
    Vaccine. 2021 Mar 19. pii: S0264-410X(21)00279.
    PubMed     Abstract available

  640. ZHANG Z, Pan J, Chen M, Zhang T, et al
    Seroepidemiology of pertussis in China: A population-based, cross-sectional study.
    Vaccine. 2021;39:1687-1692.
    PubMed     Abstract available

  641. RANE MS, Page LC, McVeigh E, Miller K, et al
    Improving adolescent human papillomavirus (HPV) immunization uptake in school-based health centers through awareness campaigns.
    Vaccine. 2021;39:1765-1772.
    PubMed     Abstract available

  642. KHANNA M, Rady H, Dai G, Ramsay AJ, et al
    Intranasal boosting with MVA encoding secreted mycobacterial proteins Ag85A and ESAT-6 generates strong pulmonary immune responses and protection against M. tuberculosis in mice given BCG as neonates.
    Vaccine. 2021;39:1780-1787.
    PubMed     Abstract available

  643. TEMPLE B, Nation ML, Dai VTT, Beissbarth J, et al
    Effect of a 2+1 schedule of ten-valent versus 13-valent pneumococcal conjugate vaccine on pneumococcal carriage: Results from a randomised controlled trial in Vietnam.
    Vaccine. 2021 Mar 18. pii: S0264-410X(21)00223.
    PubMed     Abstract available

  644. NWOGU IB, Jones M, Langley T
    Economic evaluation of meningococcal serogroup B (MenB) vaccines: A systematic review.
    Vaccine. 2021 Mar 18. pii: S0264-410X(21)00229.
    PubMed     Abstract available

  645. BROWN DR, Joura EA, Yen GP, Kothari S, et al
    Systematic literature review of cross-protective effect of HPV vaccines based on data from randomized clinical trials and real-world evidence.
    Vaccine. 2021 Mar 17. pii: S0264-410X(20)31564.
    PubMed     Abstract available

  646. PHUA LC, Choi HCW, Wu J, Jit M, et al
    Cost-effectiveness analysis of the nonavalent human papillomavirus vaccine for the prevention of cervical cancer in Singapore.
    Vaccine. 2021 Mar 17. pii: S0264-410X(21)00321.
    PubMed     Abstract available

  647. AGOCS M, Ismail A, Kamande K, Tabu C, et al
    Reasons why children miss vaccinations in Western Kenya; A step in a five-point plan to improve routine immunization.
    Vaccine. 2021 Mar 17. pii: S0264-410X(21)00262.
    PubMed     Abstract available

  648. CAMBOU MC, Copeland TP, Nielsen-Saines K, Macinko J, et al
    Insurance status predicts self-reported influenza vaccine coverage among pregnant women in the United States: A cross-sectional analysis of the National Health Interview Study Data from 2012 to 2018.
    Vaccine. 2021 Mar 17. pii: S0264-410X(21)00294.
    PubMed     Abstract available

  649. HAMIDI A, Hoeksema F, Velthof P, Lemckert A, et al
    Developing a manufacturing process to deliver a cost effective and stable liquid human rotavirus vaccine.
    Vaccine. 2021 Mar 17. pii: S0264-410X(21)00312.
    PubMed     Abstract available

  650. UEKI S, Matsunaka E, Takao K, Kitao M, et al
    The effectiveness of vibratory stimulation in reducing pain in children receiving vaccine injection: A randomized controlled trial.
    Vaccine. 2021 Mar 17. pii: S0264-410X(21)00281.
    PubMed     Abstract available

  651. SZIGETI R, Kellermayer R
    Natural unblinding of BCG vaccination trials.
    Vaccine. 2021 Mar 17. pii: S0264-410X(21)00320.
    PubMed     Abstract available

  652. GRAUPENSPERGER S PHD, Abdallah DA, Lee CM
    Social norms and vaccine uptake: College students' COVID vaccination intentions, attitudes, and estimated peer norms and comparisons with influenza vaccine.
    Vaccine. 2021 Mar 17. pii: S0264-410X(21)00286.
    PubMed     Abstract available

  653. STEIMLE LN, Havumaki J, Eisenberg MC, Eisenberg JNS, et al
    Cost-effectiveness of pediatric norovirus vaccination in daycare settings.
    Vaccine. 2021 Mar 16. pii: S0264-410X(21)00257.
    PubMed     Abstract available

  654. SUSARLA SK, Palkar S, Sv PS, Diwan A, et al
    Safety and immunogenicity of inactivated hepatitis-A vaccine developed by Human Biologicals Institute in two age groups of healthy subjects: A phase I open label study.
    Vaccine. 2021 Mar 16. pii: S0264-410X(21)00280.
    PubMed     Abstract available

  655. DEERIN JF, Clifton R, Elmi A, Lewis PE, et al
    Hepatitis B birth dose vaccination patterns in the military health System, 2014-2018.
    Vaccine. 2021 Mar 16. pii: S0264-410X(21)00278.
    PubMed     Abstract available

  656. ALLINGTON D, McAndrew S, Moxham-Hall VL, Duffy B, et al
    Media usage predicts intention to be vaccinated against SARS-CoV-2 in the US and the UK.
    Vaccine. 2021 Mar 16. pii: S0264-410X(21)00234.
    PubMed     Abstract available

  657. CHOI UY, Kim KH, Lee KY, Kim JH, et al
    Active-controlled phase III study of an egg-cultivated quadrivalent inactivated split-virion influenza vaccine (GC3110A) in healthy Korean children aged 6-35 months.
    Vaccine. 2021 Mar 15. pii: S0264-410X(21)00273.
    PubMed     Abstract available

  658. HARRISON GBL, Heath DD, Robinson CM, Lawrence SB, et al
    Combined use of two separate but protective vaccine antigens provides protection against Taenia ovis infection in lambs in the presence of protective maternal antibody.
    Vaccine. 2021 Mar 15. pii: S0264-410X(21)00308.
    PubMed     Abstract available

  659. MOLODECKY NA, Usman A, Javaid A, Wahdan A, et al
    Quantifying movement patterns and vaccination status of high risk mobile populations in Pakistan and Afghanistan to inform poliovirus risk and vaccination strategy.
    Vaccine. 2021 Mar 15. pii: S0264-410X(21)00269.
    PubMed     Abstract available

  660. HABIB MA, Prymula R, Carryn S, Esposito S, et al
    Correlation of protection against varicella in a randomized Phase III varicella-containing vaccine efficacy trial in healthy infants.
    Vaccine. 2021 Mar 15. pii: S0264-410X(21)00265.
    PubMed     Abstract available

  661. NET P, Colrat F, Nascimento Costa M, Bianic F, et al
    Estimating public health and economic benefits along 10 years of Fluzone(R) High Dose in the United States.
    Vaccine. 2021;39 Suppl 1:A56-A69.
    PubMed     Abstract available

  662. FERREIRA MN, Netto EM, Nascimento-Carvalho CM
    The impact of 10-valent pneumococcal conjugate vaccine upon hospitalization rate of children with pneumonia in different Brazilian administrative regions.
    Vaccine. 2021 Mar 14. pii: S0264-410X(21)00231.
    PubMed     Abstract available

  663. WILLIAMSON JD, Gould KG, Brown K
    Richard Pfeiffer's typhoid vaccine and Almroth Wright's claim to priority.
    Vaccine. 2021 Mar 13. pii: S0264-410X(21)00285.
    PubMed     Abstract available

  664. RIGHOLT CH, Pabla G, Donelle J, Brna P, et al
    Vaccine coverage among children with epilepsy in two Canadian provinces: A Canadian immunization research network study.
    Vaccine. 2021 Mar 13. pii: S0264-410X(21)00277.
    PubMed     Abstract available

    Developing standard safety outcomes for COVID-19 vaccines.
    Vaccine. 2021 Mar 12. pii: S0264-410X(21)00272.

  666. THANAWASTIEN A, Joyce KE, Cartee RT, Haines LA, et al
    Preclinical in vitro and in vivo profile of a highly-attenuated, broadly efficacious pneumolysin genetic toxoid.
    Vaccine. 2021;39:1652-1660.
    PubMed     Abstract available

  667. LEE J, Li Y, Li Y, Cino-Ozuna AG, et al
    Bat influenza vectored NS1-truncated live vaccine protects pigs against heterologous virus challenge.
    Vaccine. 2021 Mar 11. pii: S0264-410X(21)00268.
    PubMed     Abstract available

  668. BERTRAN K, Kassa A, Criado MF, Nunez IA, et al
    Efficacy of recombinant Marek's disease virus vectored vaccines with computationally optimized broadly reactive antigen (COBRA) hemagglutinin insert against genetically diverse H5 high pathogenicity avian influenza viruses.
    Vaccine. 2021 Mar 11. pii: S0264-410X(21)00266.
    PubMed     Abstract available

  669. EBAMA MS, Chu SY, Azziz-Baumgartner E, Lafond KE, et al
    Ancillary benefits of seasonal influenza vaccination in middle-income countries.
    Vaccine. 2021 Mar 10. pii: S0264-410X(21)00228.
    PubMed     Abstract available

  670. GBENEWEI E, Nomhwange T, Taiwo L, Ayodeji I, et al
    Adverse events following immunization: Findings from 2017/2018 measles vaccination campaign, Nigeria AEFI reporting in 2017/2018 measles vaccination campaign.
    Vaccine. 2021 Mar 10. pii: S0264-410X(21)00258.
    PubMed     Abstract available

  671. MOMOH J, Oteri AJ, Mogekwu F, Onwu N, et al
    Ensuring accountability in implementation of supplementary immunisation activities: A case study of the 2017/2018 measles vaccination campaign in Nigeria.
    Vaccine. 2021 Mar 10. pii: S0264-410X(21)00259.
    PubMed     Abstract available

  672. REPERANT LA, Osterhaus ADME
    COVID-19 vaccination and critical care capacity: Perilous months ahead.
    Vaccine. 2021 Mar 10. pii: S0264-410X(21)00316.

  673. WENTZELL E, Racila AM
    The social experience of participation in a COVID-19 vaccine trial: Subjects' motivations, others' concerns, and insights for vaccine promotion.
    Vaccine. 2021 Mar 10. pii: S0264-410X(21)00317.
    PubMed     Abstract available

  674. LATKIN C, Dayton LA, Yi G, Konstantopoulos A, et al
    COVID-19 vaccine intentions in the United States, a social-ecological framework.
    Vaccine. 2021 Mar 10. pii: S0264-410X(21)00238.
    PubMed     Abstract available

  675. KWAK BO, Kwon YS, Hong YJ, Shin SH, et al
    Immunogenicity and safety of the third booster dose of the inactivated Japanese encephalitis vaccine in Korean children: A prospective multicenter study.
    Vaccine. 2021 Mar 9. pii: S0264-410X(21)00267.
    PubMed     Abstract available

  676. STEFFEN CA, Henaff L, Durupt A, Omeiri NE, et al
    Evidence-informed vaccination decision-making in countries: Progress, challenges and opportunities.
    Vaccine. 2021 Mar 9. pii: S0264-410X(21)00235.
    PubMed     Abstract available

  677. GATWOOD J, Chiu CY, Shuvo S, Ramachandran S, et al
    Role of social determinants of health in pneumococcal vaccination among high-risk adults.
    Vaccine. 2021 Mar 9. pii: S0264-410X(21)00241.
    PubMed     Abstract available

  678. GUIDRY JPD, Perrin PB, Laestadius LI, Vraga EK, et al
    U.S. public support for COVID-19 vaccine donation to low- and middle-income countries during the COVID-19 pandemic.
    Vaccine. 2021 Mar 9. pii: S0264-410X(21)00306.
    PubMed     Abstract available

  679. MINTA AA, Silva MWT, Shrestha A, de Quiroz-Castro M, et al
    Hepatitis B surface antigen seroprevalence among children in the Philippines, 2018.
    Vaccine. 2021 Mar 9. pii: S0264-410X(21)00222.
    PubMed     Abstract available

  680. SADARANGANI M, Abu Raya B, Conway JM, Iyaniwura SA, et al
    Importance of COVID-19 vaccine efficacy in older age groups.
    Vaccine. 2021 Mar 8. pii: S0264-410X(21)00288.
    PubMed     Abstract available

  681. KISZEWSKI AE, Cleary EG, Jackson MJ, Ledley FD, et al
    NIH funding for vaccine readiness before the COVID-19 pandemic.
    Vaccine. 2021 Mar 8. pii: S0264-410X(21)00290.
    PubMed     Abstract available

  682. PULLAN S, Dey M
    Vaccine hesitancy and anti-vaccination in the time of COVID-19: A Google Trends analysis.
    Vaccine. 2021 Mar 6. pii: S0264-410X(21)00287.
    PubMed     Abstract available

  683. DONADEL M, Panero MS, Ametewee L, Shefer AM, et al
    National decision-making for the introduction of new vaccines: A systematic review, 2010-2020.
    Vaccine. 2021 Mar 6. pii: S0264-410X(21)00239.
    PubMed     Abstract available

  684. WILLIAMSON SL, Gadd E, Pillay T, Toldi G, et al
    Non-specific effects of BCG vaccination on neutrophil and lymphocyte counts of healthy neonates from a developed country.
    Vaccine. 2021 Mar 6. pii: S0264-410X(21)00255.
    PubMed     Abstract available

  685. HASNAN S, Tan NC
    Multi-domain narrative review of vaccine hesitancy in childhood.
    Vaccine. 2021 Mar 6. pii: S0264-410X(21)00237.
    PubMed     Abstract available

  686. BLACK SB, Law B, Chen RT, Dekker CL, et al
    The critical role of background rates of possible adverse events in the assessment of COVID-19 vaccine safety.
    Vaccine. 2021 Mar 6. pii: S0264-410X(21)00284.
    PubMed     Abstract available

  687. PIRAS-DOUCE F, Raynal F, Raquin A, Girerd-Chambaz Y, et al
    Next generation live-attenuated yellow fever vaccine candidate: Safety and immuno-efficacy in small animal models.
    Vaccine. 2021 Mar 5. pii: S0264-410X(21)00200.
    PubMed     Abstract available

  688. YOKOMICHI H, Kojima R, Horiuchi S, Ooka T, et al
    Effectiveness of influenza vaccination in infants and toddlers with and without prior infection history: The Japan Environment and Children's Study.
    Vaccine. 2021 Mar 5. pii: S0264-410X(21)00224.
    PubMed     Abstract available

  689. DU Y, Xu Y, Feng J, Hu L, et al
    Intranasal administration of a recombinant RBD vaccine induced protective immunity against SARS-CoV-2 in mouse.
    Vaccine. 2021 Mar 5. pii: S0264-410X(21)00274.
    PubMed     Abstract available

  690. KUO H, Shapiro JR, Dhakal S, Morgan R, et al
    Sex-specific effects of age and body mass index on antibody responses to seasonal influenza vaccines in healthcare workers.
    Vaccine. 2021 Mar 4. pii: S0264-410X(21)00227.
    PubMed     Abstract available

  691. WOO EJ, Moro PL
    Postmarketing safety surveillance of quadrivalent recombinant influenza vaccine: Reports to the vaccine adverse event reporting system.
    Vaccine. 2021 Mar 4. pii: S0264-410X(21)00232.
    PubMed     Abstract available

  692. STURM L, Kasting ML, Head KJ, Hartsock JA, et al
    Influenza vaccination in the time of COVID-19: A national U.S. survey of adults.
    Vaccine. 2021 Mar 4. pii: S0264-410X(21)00271.
    PubMed     Abstract available

  693. HELMKAMP LJ, Szilagyi PG, Zimet G, Saville AW, et al
    A validated modification of the vaccine hesitancy scale for childhood, influenza and HPV vaccines.
    Vaccine. 2021 Mar 3. pii: S0264-410X(21)00206.
    PubMed     Abstract available

  694. JOURA EA, Ulied A, Vandermeulen C, Rua Figueroa M, et al
    Immunogenicity and safety of a nine-valent human papillomavirus vaccine in women 27-45years of age compared to women 16-26years of age: An open-label phase 3 study.
    Vaccine. 2021 Mar 3. pii: S0264-410X(21)00128.
    PubMed     Abstract available

  695. WENDLAND EM, Kops NL, Bessel M, Comerlato J, et al
    Effectiveness of a universal vaccination program with an HPV quadrivalent vaccine in young Brazilian women.
    Vaccine. 2021 Mar 2. pii: S0264-410X(21)00207.
    PubMed     Abstract available

  696. FELL DB, Dimitris MC, Hutcheon JA, Ortiz JR, et al
    Guidance for design and analysis of observational studies of fetal and newborn outcomes following COVID-19 vaccination during pregnancy.
    Vaccine. 2021 Mar 2. pii: S0264-410X(21)00261.
    PubMed     Abstract available

  697. CUTTS FT, Danovaro-Holliday MC, Rhoda DA
    Challenges in measuring supplemental immunization activity coverage among measles zero-dose children.
    Vaccine. 2021;39:1359-1363.

  698. WANG Y, Huang C, Tang J, Liu G, et al
    Salmonella Pullorum spiC mutant is a desirable LASV candidate with proper virulence, high immune protection and easy-to-use oral administration.
    Vaccine. 2021;39:1383-1391.
    PubMed     Abstract available

    February 2021
  699. STANLEY M, Joura E, Yen GP, Kothari S, et al
    Systematic literature review of neutralizing antibody immune responses to non-vaccine targeted high-risk HPV types induced by the bivalent and the quadrivalent vaccines.
    Vaccine. 2021 Feb 28. pii: S0264-410X(21)00099.
    PubMed     Abstract available

  700. WANG J, Lyu Y, Zhang H, Jing R, et al
    Willingness to pay and financing preferences for COVID-19 vaccination in China.
    Vaccine. 2021 Feb 27. pii: S0264-410X(21)00240.
    PubMed     Abstract available

  701. SHEN M, Zu J, Fairley CK, Pagan JA, et al
    Projected COVID-19 epidemic in the United States in the context of the effectiveness of a potential vaccine and implications for social distancing and face mask use.
    Vaccine. 2021 Feb 27. pii: S0264-410X(21)00236.
    PubMed     Abstract available

  702. BERNSTEIN DN, Alokozai A, Humbyrd CJ
    Vaccinating America's children: A job for orthopaedic surgeons & other non-primary care specialists?
    Vaccine. 2021 Feb 26. pii: S0264-410X(21)00175.

  703. AYASSE M, Ahmed A, McCullum C, Espinosa ML, et al
    Vaccines do not cause atopic dermatitis: A systematic review and meta-analysis.
    Vaccine. 2021 Feb 26. pii: S0264-410X(21)00203.
    PubMed     Abstract available

  704. WON H, Kim AR, Yoo JS, Chung GT, et al
    Cross-neutralization between vaccine and circulating wild-type mumps viruses in Korea.
    Vaccine. 2021 Feb 25. pii: S0264-410X(21)00055.
    PubMed     Abstract available

  705. ANDERSEN AR, Kolmos SK, Flanagan KL, Benn CS, et al
    Systematic review and meta-analysis of the effect of pertussis vaccine in pregnancy on the risk of chorioamnionitis, non-pertussis infectious diseases and other adverse pregnancy outcomes.
    Vaccine. 2021 Feb 25. pii: S0264-410X(21)00166.
    PubMed     Abstract available

  706. SPENCER JA, Penfound T, Salehi S, Aranha MP, et al
    Cross-reactive immunogenicity of group A streptococcal vaccines designed using a recurrent neural network to identify conserved M protein linear epitopes.
    Vaccine. 2021 Feb 25. pii: S0264-410X(21)00129.
    PubMed     Abstract available

  707. SANDBRINK JB, Koblentz GD
    Biosecurity risks associated with vaccine platform technologies.
    Vaccine. 2021 Feb 25. pii: S0264-410X(21)00171.
    PubMed     Abstract available

  708. LEE MHP, Tan CW, Tee HK, Ong KC, et al
    Vaccine candidates generated by codon and codon pair deoptimization of enterovirus A71 protect against lethal challenge in mice.
    Vaccine. 2021 Feb 24. pii: S0264-410X(21)00172.
    PubMed     Abstract available

  709. SELL TK, Gastfriend D, Watson M, Watson C, et al
    Building the global vaccine manufacturing capacity needed to respond to pandemics.
    Vaccine. 2021 Feb 24. pii: S0264-410X(21)00165.

  710. MUNOZ FM, Cramer JP, Dekker CL, Dudley MZ, et al
    Vaccine-associated enhanced disease: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data.
    Vaccine. 2021 Feb 23. pii: S0264-410X(21)00094.
    PubMed     Abstract available

  711. ALDAKAK L, Huber VM, Ruhli F, Bender N, et al
    Sex difference in the immunogenicity of the quadrivalent Human Papilloma Virus vaccine: Systematic review and meta-analysis.
    Vaccine. 2021 Feb 23. pii: S0264-410X(21)00170.
    PubMed     Abstract available

  712. BONANNI P, Villani A, Scotti S, Biasci P, et al
    The recommended lifetime immunization schedule from the board of vaccination calendar for life in Italy: A continuing example of impact on public health policies.
    Vaccine. 2021;39:1183-1186.
    PubMed     Abstract available

  713. VERELST F, Beutels P, Hens N, Willem L, et al
    Workplace influenza vaccination to reduce employee absenteeism: An economic analysis from the employers' perspective.
    Vaccine. 2021 Feb 22. pii: S0264-410X(21)00168.
    PubMed     Abstract available

  714. SU QD, Zou YN, Yi Y, Shen LP, et al
    Recombinant SARS-CoV-2 RBD with a built in T helper epitope induces strong neutralization antibody response.
    Vaccine. 2021;39:1241-1247.
    PubMed     Abstract available

  715. BLUNCK BN, Aideyan L, Ye X, Avadhanula V, et al
    A prospective surveillance study on the kinetics of the humoral immune response to the respiratory syncytial virus fusion protein in adults in Houston, Texas.
    Vaccine. 2021;39:1248-1256.
    PubMed     Abstract available

  716. CHOI UY, Kim KH, Lee J, Eun BW, et al
    Immunogenicity and safety profiles of a new MAV/06 strain varicella vaccine in healthy children: A multinational, multicenter, randomized, double-blinded, active-controlled phase III study.
    Vaccine. 2021 Feb 21. pii: S0264-410X(21)00161.
    PubMed     Abstract available

  717. REN S, Attia J, Li SC, Newby D, et al
    Pneumococcal polysaccharide vaccine is a cost saving strategy for prevention of acute coronary syndrome.
    Vaccine. 2021 Feb 21. pii: S0264-410X(21)00167.
    PubMed     Abstract available

  718. MCPHERSON AS, Whittington RJ, Hall E, Cook EJ, et al
    A comparison of multivalent and bivalent vaccination strategies for the control of virulent ovine footrot.
    Vaccine. 2021 Feb 20. pii: S0264-410X(21)00159.
    PubMed     Abstract available

  719. KABIR A, Newall AT, Randall D, Menzies R, et al
    Estimating pneumococcal vaccine coverage among Australian Indigenous children and children with medically at-risk conditions using record linkage.
    Vaccine. 2021 Feb 20. pii: S0264-410X(21)00163.
    PubMed     Abstract available

  720. DAS SC, Price JD, Gosling K, MacLennan N, et al
    Liposome engraftment and antigen combination potentiate the immune response towards conserved epitopes of the malaria vaccine candidate MSP2.
    Vaccine. 2021 Feb 20. pii: S0264-410X(21)00158.
    PubMed     Abstract available

  721. SAUER M, Vasudevan P, Meghani A, Luthra K, et al
    Situational assessment of adult vaccine preventable disease and the potential for immunization advocacy and policy in low- and middle-income countries.
    Vaccine. 2021 Feb 19. pii: S0264-410X(21)00107.
    PubMed     Abstract available

  722. CHOI J, Jo HJ, Jung SS, Choi J, et al
    Evaluation of swine protection with foot-and-mouth disease O1/Campos and O/Primorsky/2014 vaccines against the O Mya-98 lineage virus from East Asia.
    Vaccine. 2021 Feb 19. pii: S0264-410X(21)00173.
    PubMed     Abstract available

  723. ORTIZ JR, Robertson J, Hsu JS, Yu SL, et al
    The potential effects of deploying SARS-Cov-2 vaccines on cold storage capacity and immunization workload in countries of the WHO African Region.
    Vaccine. 2021 Feb 19. pii: S0264-410X(21)00204.
    PubMed     Abstract available

  724. DENG L, Danchin M, Lewis G, Cheung A, et al
    Revaccination outcomes of children with vaccine proximate seizures.
    Vaccine. 2021 Feb 18. pii: S0264-410X(21)00164.
    PubMed     Abstract available

  725. MARTINON-TORRES F, Halperin SA, Nolan T, Tapiero B, et al
    Impact of maternal diphtheria-tetanus-acellular pertussis vaccination on pertussis booster immune responses in toddlers: Follow-up of a randomized trial.
    Vaccine. 2021 Feb 18. pii: S0264-410X(21)00130.
    PubMed     Abstract available

  726. CHANG LJ, Anderson EJ, Jeanfreau R, He Y, et al
    Safety and immunogenicity of high doses of quadrivalent influenza vaccine in children 6months through<18years of age: A randomized controlled phase II dose-finding trial.
    Vaccine. 2021 Feb 18. pii: S0264-410X(21)00162.
    PubMed     Abstract available

  727. CONSTANTINOU CA, Ziogas DC, Venetsanopoulou A, Gamaletsou MN, et al
    A clinical audit of pneumococcal vaccination among patients with autoimmune rheumatic diseases living in Greece: The power of awareness.
    Vaccine. 2021 Feb 17. pii: S0264-410X(21)00157.
    PubMed     Abstract available

  728. PALMU AA, De Wals P, Toropainen M, Ladhani SN, et al
    Similar impact and replacement disease after pneumococcal conjugate vaccine introduction in hospitalised children with invasive pneumococcal disease in Europe and North America.
    Vaccine. 2021 Feb 17. pii: S0264-410X(21)00111.
    PubMed     Abstract available

  729. KUTER BJ, Browne S, Momplaisir FM, Feemster KA, et al
    Perspectives on the receipt of a COVID-19 vaccine: A survey of employees in two large hospitals in Philadelphia.
    Vaccine. 2021 Feb 16. pii: S0264-410X(21)00185.
    PubMed     Abstract available

  730. JUSTE RA, Geijo MV, Elguezabal N, Sevilla IA, et al
    Paratuberculosis vaccination specific and non-specific effects on cattle lifespan.
    Vaccine. 2021 Feb 15. pii: S0264-410X(21)00097.
    PubMed     Abstract available

  731. WU MJ, Chung JR, Kim SS, Jackson ML, et al
    Influenza vaccination coverage among persons seeking outpatient medical care for acute respiratory illness in five states in the United States, 2011-2012 through 2018-2019.
    Vaccine. 2021 Feb 15. pii: S0264-410X(21)00106.
    PubMed     Abstract available

  732. TZANAKAKI G, Xirogianni A, Tsitsika A, Clark SA, et al
    Estimated strain coverage of serogroup B meningococcal vaccines: A retrospective study for disease and carrier strains in Greece (2010-2017).
    Vaccine. 2021 Feb 14. pii: S0264-410X(21)00127.
    PubMed     Abstract available

  733. RID A, Shah SK, Miller FG, Danis M, et al
    Ethical trade-offs in vaccine development and distribution-Response to Gurwitz.
    Vaccine. 2021;39:1028-1029.

  734. GURWITZ D
    Ethical tradeoffs in SARS-CoV-2 vaccine development: Assuring fair availability for low-income countries.
    Vaccine. 2021;39:1027.

  735. MCALISTER SM, van den Biggelaar AHJ, Woodman TL, Hutton H, et al
    An observational study of antibody responses to a primary or subsequent pertussis booster vaccination in Australian healthcare workers.
    Vaccine. 2021 Feb 12. pii: S0264-410X(21)00068.
    PubMed     Abstract available

  736. NICACIO AAMF, Peracchi OAB, Yamada J, Fraga MM, et al
    Tdap booster to adolescents with juvenile idiopathic arthritis on and off anti-TNF agents is safe and immunogenic.
    Vaccine. 2021;39:1165-1172.
    PubMed     Abstract available

  737. HAI NM, Dung ND, Pho DC, Son VT, et al
    Immunogenicity, safety and reactogenicity of ROTAVAC(R) in healthy infants aged 6-8 weeks in Vietnam.
    Vaccine. 2021;39:1140-1147.
    PubMed     Abstract available

  738. DOCKRELL HM, Butkeviciute E
    Can what have we learnt about BCG vaccination in the last 20 years help us to design a better tuberculosis vaccine?
    Vaccine. 2021 Feb 11. pii: S0264-410X(21)00109.
    PubMed     Abstract available

  739. KHETSURIANI N, Zaika O, Chitadze N, Slobodianyk L, et al
    Seroprevalence of hepatitis B virus infection markers among children in Ukraine, 2017.
    Vaccine. 2021 Feb 11. pii: S0264-410X(21)00133.
    PubMed     Abstract available

  740. LIN J, Dobbins T, Wood JG, Bernardo C, et al
    Effectiveness of the live-attenuated herpes zoster vaccine 2 years after its introduction in Australia.
    Vaccine. 2021 Feb 10. pii: S0264-410X(21)00108.
    PubMed     Abstract available

  741. WARD BJ, Seguin A, Couillard J, Trepanier S, et al
    Phase III: Randomized observer-blind trial to evaluate lot-to-lot consistency of a new plant-derived quadrivalent virus like particle influenza vaccine in adults 18-49 years of age.
    Vaccine. 2021 Feb 10. pii: S0264-410X(21)00004.
    PubMed     Abstract available

  742. POLAND CM, Matthews AKS, Poland GA
    Improving COVID-19 vaccine acceptance: Including insights from human decision-making under conditions of uncertainty and human-centered design.
    Vaccine. 2021 Feb 10. pii: S0264-410X(21)00154.

  743. BRUCE-STASKAL PJ, Woods RM, Borisov OV, Massare MJ, et al
    Corrigendum to "Hemagglutinin from multiple divergent influenza A and B viruses bind to a distinct branched, sialylated poly-LacNAc glycan by surface plasmon resonance" [Vaccine 38(43) (2020) 6757-6765].
    Vaccine. 2021 Feb 9. pii: S0264-410X(21)00105.

  744. CHU L, McPhee R, Huang W, Bennett H, et al
    A preliminary report of a randomized controlled phase 2 trial of the safety and immunogenicity of mRNA-1273 SARS-CoV-2 vaccine.
    Vaccine. 2021 Feb 9. pii: S0264-410X(21)00153.
    PubMed     Abstract available

  745. VULPE SN, Rughinis C
    Social amplification of risk and "probable vaccine damage": A typology of vaccination beliefs in 28 European countries.
    Vaccine. 2021 Feb 8. pii: S0264-410X(21)00102.
    PubMed     Abstract available

  746. SINGH A
    Why not the 'marker' or DIVA vaccines for the control of emerging infectious diseases of humans?
    Vaccine. 2021 Feb 8. pii: S0264-410X(21)00110.

  747. ROBINSON E, Jones A, Lesser I, Daly M, et al
    International estimates of intended uptake and refusal of COVID-19 vaccines: A rapid systematic review and meta-analysis of large nationally representative samples.
    Vaccine. 2021 Feb 6. pii: S0264-410X(21)00140.
    PubMed     Abstract available

  748. BAUER BU, Knittler MR, Prufer TL, Wolf A, et al
    Humoral immune response to Q fever vaccination of three sheep flocks naturally pre-infected with Coxiella burnetii.
    Vaccine. 2021 Feb 5. pii: S0264-410X(21)00101.
    PubMed     Abstract available

  749. DUDLEY MZ, Taitel MS, Smith-Ray R, Singh T, et al
    Effect of educational and financial incentive-based interventions on immunization attitudes, beliefs, intentions and receipt among close contacts of pregnant women.
    Vaccine. 2021;39:961-967.
    PubMed     Abstract available

  750. HODGKINSON B, Wang T, Byrnes J, Scuffham P, et al
    Modelling a cost-effective vaccination strategy for the prevention of varicella and herpes zoster infection: A systematic review.
    Vaccine. 2021 Feb 4. pii: S0264-410X(21)00100.
    PubMed     Abstract available

  751. SPANOS KE, Kraschnewski JL, Moss JL, Wong A, et al
    Parent support for social media standards combatting vaccine misinformation.
    Vaccine. 2021 Feb 4. pii: S0264-410X(21)00005.
    PubMed     Abstract available

  752. PINPATHOMRAT N, Bull N, Pasricha J, Harrington-Kandt R, et al
    Using an effective TB vaccination regimen to identify immune responses associated with protection in the murine model.
    Vaccine. 2021 Feb 3. pii: S0264-410X(21)00050.
    PubMed     Abstract available

  753. DIACO M, Chang LJ, Seet B, Robertson CA, et al
    Introductory paper: High dose influenza vaccine.
    Vaccine. 2021 Feb 3. pii: S0264-410X(20)31147.
    PubMed     Abstract available

  754. BABAKURA B, Nomhwange T, Jean Baptiste AE, Dede O, et al
    The challenges of insecurity on implementing vaccination campaign and its effect on measles elimination and control efforts: A case study of 2017/18 measles campaign in Borno state, Nigeria.
    Vaccine. 2021 Feb 2. pii: S0264-410X(21)00040.
    PubMed     Abstract available

  755. SATO R, Thompson A, Sani I, Metiboba L, et al
    Effect of Vaccine Direct Delivery (VDD) on vaccine stockouts and number of vaccinations: Case study from Bauchi State, Nigeria.
    Vaccine. 2021 Feb 1. pii: S0264-410X(21)00053.
    PubMed     Abstract available

  756. GAO J, Tang F, Wang Z, Yu J, et al
    Post-marketing safety surveillance for inactivated Enterovirus 71 vaccines in Jiangsu, China from 2017 to 2019.
    Vaccine. 2021 Feb 1. pii: S0264-410X(21)00075.
    PubMed     Abstract available

  757. WILCK MB, Jin Xu Z, Stek JE, Goveia MG, et al
    Protective immune responses against Haemophilus influenza type B elicited by a fully-liquid DTaP-IPV-Hib-HepB vaccine (VAXELIS).
    Vaccine. 2021 Feb 1. pii: S0264-410X(21)00073.
    PubMed     Abstract available

    January 2021
  758. AXELSEN PH, Poland GA
    Vaccines, masks, distancing and credibility: An urgent warning for pandemic management.
    Vaccine. 2021 Jan 31. pii: S0264-410X(21)00079.

  759. LIU Y, Li W, Dong Q, Chen M, et al
    Non-linear relationships between children age and pneumococcal vaccine coverage: Important implications for vaccine prevention strategies.
    Vaccine. 2021 Jan 30. pii: S0264-410X(21)00095.
    PubMed     Abstract available

  760. LUANGASANATIP N, Mahikul W, Poovorawan K, Cooper BS, et al
    Cost-effectiveness and budget impact analyses for the prioritisation of the four available rotavirus vaccines in the national immunisation programme in Thailand.
    Vaccine. 2021 Jan 30. pii: S0264-410X(21)00078.
    PubMed     Abstract available

  761. D'ARCO C, McCormick AA, Arnaboldi PM
    Single-dose intranasal subunit vaccine rapidly clears secondary sepsis in a high-dose pneumonic plague infection.
    Vaccine. 2021 Jan 30. pii: S0264-410X(21)00067.
    PubMed     Abstract available

  762. ANDANI A, van Damme P, Bunge EM, Salgado F, et al
    One or two doses of hepatitis A vaccine in universal vaccination programs in children in 2020: A systematic review.
    Vaccine. 2021 Jan 29. pii: S0264-410X(21)00054.
    PubMed     Abstract available

  763. XU W, Yang M
    Genetic variation and evolution of foot-and-mouth disease virus serotype A in relation to vaccine matching.
    Vaccine. 2021 Jan 29. pii: S0264-410X(21)00069.
    PubMed     Abstract available

  764. COLRAT F, Thommes E, Largeron N, Alvarez FP, et al
    Economic evaluation of high-dose inactivated influenza vaccine in adults aged >/=65 years: A systematic literature review.
    Vaccine. 2021 Jan 29. pii: S0264-410X(20)31603.
    PubMed     Abstract available

  765. HAMPTON LM, Aggarwal R, Evans SJW, Law B, et al
    General determination of causation between Covid-19 vaccines and possible adverse events.
    Vaccine. 2021 Jan 29. pii: S0264-410X(21)00096.

  766. KROLIK M, Csepregi L, Hartmann F, Engetschwiler C, et al
    Recombinant lymphocytic choriomeningitis virus-based vaccine vector protects type I interferon receptor deficient mice from viral challenge.
    Vaccine. 2021 Jan 28. pii: S0264-410X(21)00074.
    PubMed     Abstract available

  767. SORUP S, Englund H, Laake I, Nieminen H, et al
    Revaccination with measles-mumps-rubella vaccine and hospitalization for infection in Denmark and Sweden - An interrupted time-series analysis.
    Vaccine. 2021 Jan 28. pii: S0264-410X(21)00044.
    PubMed     Abstract available

  768. SEREMBA E, Ocama P, Ssekitoleko R, Mayanja-Kizza H, et al
    Immune response to the hepatitis B vaccine among HIV-infected adults in Uganda.
    Vaccine. 2021 Jan 27. pii: S0264-410X(21)00070.
    PubMed     Abstract available

  769. LI AJ, Kyesi F, Mwengee W, Mphuru A, et al
    Impact of the human papillomavirus (HPV) vaccine supply shortage on Tanzania's national HPV vaccine introduction.
    Vaccine. 2021 Jan 25. pii: S0264-410X(21)00052.

  770. LY TDA, Castaneda S, Hoang VT, Dao TL, et al
    Vaccine-preventable diseases other than tuberculosis, and homelessness: A scoping review of the published literature, 1980 to 2020.
    Vaccine. 2021 Jan 25. pii: S0264-410X(21)00051.
    PubMed     Abstract available

  771. JONSSON G, Hansson C, Mellhammar L, Gullstrand B, et al
    Increased serum bactericidal activity of autologous serum in C2 deficiency after vaccination against Haemophilus influenzae type b, and further support for an MBL-dependent C2 bypass mechanism.
    Vaccine. 2021 Jan 25. pii: S0264-410X(21)00007.
    PubMed     Abstract available

  772. BELCHER T, Kammoun H, Coutte L, Debrie AS, et al
    Live attenuated Bordetella pertussis vaccine candidate BPZE1 transiently protects against lethal pneumococcal disease in mice.
    Vaccine. 2021 Jan 25. pii: S0264-410X(21)00041.
    PubMed     Abstract available

  773. KIM SH, Paldurai A, Xiao S, Collins PL, et al
    Retraction notice to "Modified Newcastle disease virus vectors expressing the H5 hemagglutinin induce enhanced protection against highly pathogenic H5N1 avian influenza virus in chickens" [Vaccine 32(35) (2014) 4428-4435].
    Vaccine. 2021;39:775.

  774. KNOBEL DL, Arega SM, Conan A
    Sex-differential non-specific effects of rabies vaccine in dogs: An extended analysis of a randomized controlled trial in a high-mortality population.
    Vaccine. 2021 Jan 22. pii: S0264-410X(21)00045.
    PubMed     Abstract available

  775. AMANI A, Tatang CA, Bayiha CN, Woung M, et al
    A reactive vaccination campaign with single dose oral cholera vaccine (OCV) during a cholera outbreak in Cameroon.
    Vaccine. 2021 Jan 22. pii: S0264-410X(21)00021.
    PubMed     Abstract available

  776. HUTTON DW, McCullough JS, Prosser L, Ye W, et al
    Costs implications of pneumococcal vaccination of adults aged 30-60 with a recent diagnosis of diabetes.
    Vaccine. 2021 Jan 22. pii: S0264-410X(20)31535.
    PubMed     Abstract available

  777. OKOLI GN, Racovitan F, Abdulwahid T, Righolt CH, et al
    Variable seasonal influenza vaccine effectiveness across geographical regions, age groups and levels of vaccine antigenic similarity with circulating virus strains: A systematic review and meta-analysis of the evidence from test-negative design studie
    Vaccine. 2021 Jan 22. pii: S0264-410X(21)00048.
    PubMed     Abstract available

  778. FRIEDMAN-KLABANOFF DJ, Berry AA, Travassos MA, Cox C, et al
    Low dose recombinant full-length circumsporozoite protein-based Plasmodium falciparum vaccine is well-tolerated and highly immunogenic in phase 1 first-in-human clinical testing.
    Vaccine. 2021 Jan 22. pii: S0264-410X(20)31590.
    PubMed     Abstract available

  779. JAMROZIK E, Littler K, Bull S, Emerson C, et al
    Key criteria for the ethical acceptability of COVID-19 human challenge studies: Report of a WHO Working Group.
    Vaccine. 2021;39:633-640.
    PubMed     Abstract available

  780. MENZIES R, Stein AN, Booy R, Van Buynder PG, et al
    The impact of the changing pneumococcal national immunisation program among older Australians.
    Vaccine. 2021;39:720-728.
    PubMed     Abstract available

  781. COX AD, Kuo Lee R, Ulanova M, Bruce MG, et al
    Proceedings of a workshop to discuss the epidemiology of invasive Haemophilus influenzae disease with emphasis on serotype a and b in the Americas, 2019.
    Vaccine. 2021;39:627-632.
    PubMed     Abstract available

  782. JIANG R, Liu X, Sun X, Wang J, et al
    Immunogenicity and safety of the inactivated poliomyelitis vaccine made from Sabin strains in a phase IV clinical trial for the vaccination of a large population.
    Vaccine. 2021 Jan 21. pii: S0264-410X(21)00043.
    PubMed     Abstract available

  783. KLASSEN AC, Milliron BJ, Reynolds L, Bakhtibekova Z, et al
    Formative research to address vaccine hesitancy in Tajikistan.
    Vaccine. 2021 Jan 21. pii: S0264-410X(21)00049.
    PubMed     Abstract available

  784. ALDRICH C, Leroux-Roels I, Huang KB, Bica MA, et al
    Proof-of-concept of a low-dose unmodified mRNA-based rabies vaccine formulated with lipid nanoparticles in human volunteers: A phase 1 trial.
    Vaccine. 2021 Jan 21. pii: S0264-410X(20)31667.
    PubMed     Abstract available

  785. NIYIBITEGEKA F, Riewpaiboon A, Youngkong S, Thavorncharoensap M, et al
    Economic analysis for national immunization program planning: A case of rotavirus vaccines in Burundi.
    Vaccine. 2021 Jan 21. pii: S0264-410X(21)00047.
    PubMed     Abstract available

  786. HAYMAN B, Bowles A, Evans B, Eyermann E, et al
    Advancing innovation for vaccine manufacturers from developing countries: Prioritization, barriers, opportunities.
    Vaccine. 2021 Jan 21. pii: S0264-410X(21)00009.
    PubMed     Abstract available

  787. POLAND EG, McGuire DK, Ratishvili T, Poland GA, et al
    The economics of global COVID vaccine administration during a pandemic - Why continue skin alcohol preparation as a costly but ineffective practice?
    Vaccine. 2021 Jan 20. pii: S0264-410X(20)31694.

  788. WINOKUR P, El Sahly HM, Mulligan MJ, Frey SE, et al
    Immunogenicity and safety of different dose schedules and antigen doses of an MF59-adjuvanted H7N9 vaccine in healthy adults aged 65 years and older.
    Vaccine. 2021 Jan 20. pii: S0264-410X(20)31504.
    PubMed     Abstract available

  789. JAS D, Frances-Duvert V, Brunet S, Oberli F, et al
    Evaluation of safety and immunogenicity of feline vaccines with reduced volume.
    Vaccine. 2021 Jan 20. pii: S0264-410X(21)00042.
    PubMed     Abstract available

  790. MUGO N, Eckert LO, Odero L, Gakuo S, et al
    Antibody responses to prophylactic quadrivalent human papillomavirus vaccine at 48 months among HIV-infected girls and boys ages 9-14 in Kenya, Africa.
    Vaccine. 2021 Jan 20. pii: S0264-410X(20)31587.
    PubMed     Abstract available

  791. BALASUBRAMANI GK, Zimmerman RK, Eng H, Lyons J, et al
    Comparison of local influenza vaccine effectiveness using two methods.
    Vaccine. 2021 Jan 20. pii: S0264-410X(21)00017.
    PubMed     Abstract available

  792. DAL-RE R
    US FDA erratic approach to placebo-controlled trials after issuing an emergency use authorization for a COVID-19 vaccine.
    Vaccine. 2021 Jan 20. pii: S0264-410X(21)00077.

  793. LOIACONO MM, Pool V, van Aalst R
    DTaP combination vaccine use and adherence: A retrospective cohort study.
    Vaccine. 2021 Jan 19. pii: S0264-410X(21)00013.
    PubMed     Abstract available

  794. CAO L, Lou J, Zhao S, Chan RWY, et al
    In silico prediction of influenza vaccine effectiveness by sequence analysis.
    Vaccine. 2021 Jan 19. pii: S0264-410X(21)00006.
    PubMed     Abstract available

  795. EINARSDOTTIR S, Nicklasson M, Veje M, Bergstrom T, et al
    Vaccination against tick-borne encephalitis (TBE) after autologous and allogeneic stem cell transplantation.
    Vaccine. 2021 Jan 19. pii: S0264-410X(20)31670.
    PubMed     Abstract available

  796. BROCATO RL, Kwilas SA, Josleyn MD, Long S, et al
    Small animal jet injection technique results in enhanced immunogenicity of hantavirus DNA vaccines.
    Vaccine. 2021 Jan 19. pii: S0264-410X(21)00002.
    PubMed     Abstract available

  797. REEMERS S, Verstegen I, Basten S, Hubers W, et al
    A broad spectrum HVT-H5 avian influenza vector vaccine which induces a rapid onset of immunity.
    Vaccine. 2021 Jan 19. pii: S0264-410X(21)00022.
    PubMed     Abstract available

  798. FATOBA AJ, Maharaj L, Adeleke VT, Okpeku M, et al
    Immunoinformatics prediction of overlapping CD8(+) T-cell, IFN-gamma and IL-4 inducer CD4(+) T-cell and linear B-cell epitopes based vaccines against COVID-19 (SARS-CoV-2).
    Vaccine. 2021 Jan 18. pii: S0264-410X(21)00003.
    PubMed     Abstract available

  799. SCOTT EM, Stein R, Brown MF, Hershberger J, et al
    Vaccination patterns of the northeast Ohio Amish revisited.
    Vaccine. 2021 Jan 18. pii: S0264-410X(21)00026.
    PubMed     Abstract available

  800. OTERI J, Idi Hussaini M, Bawa S, Ibizugbe S, et al
    Application of the Geographic Information System (GIS) in immunisation service delivery; its use in the 2017/2018 measles vaccination campaign in Nigeria.
    Vaccine. 2021 Jan 18. pii: S0264-410X(21)00025.
    PubMed     Abstract available

  801. SOHN S, Hong K, Hwang H, Chun BC, et al
    Paradoxical health care utilization patterns among children in Korea who did not receive mandatory pneumococcal vaccination.
    Vaccine. 2021 Jan 18. pii: S0264-410X(21)00016.
    PubMed     Abstract available

  802. XU C, Lau CL, Clark J, Rafferty AC, et al
    Immunogenicity after pre- and post-exposure rabies vaccination: A systematic review and dose-response meta-analysis.
    Vaccine. 2021 Jan 18. pii: S0264-410X(21)00039.
    PubMed     Abstract available

  803. WHITAKER JA, Parikh SA, Shanafelt TD, Kay NE, et al
    The humoral immune response to high-dose influenza vaccine in persons with monoclonal B-cell lymphocytosis (MBL) and chronic lymphocytic leukemia (CLL).
    Vaccine. 2021 Jan 15. pii: S0264-410X(21)00001.
    PubMed     Abstract available

  804. MOGEKWU FI, Oteri JA, Nsubuga P, Ezebilo O, et al
    Using data to improve outcomes of supplemental immunisation activities: 2017/2018 Nigeria measles vaccination campaign.
    Vaccine. 2021 Jan 15. pii: S0264-410X(20)31659.
    PubMed     Abstract available

  805. ZHAO X, Zeng X, Dai Q, Hou Y, et al
    Immunogenicity and protection efficacy of a Salmonella enterica serovar Typhimurium fnr, arcA and fliC mutant.
    Vaccine. 2021;39:588-595.
    PubMed     Abstract available

  806. VAN DEN BOOGAARD J, de Gier B, de Oliveira Bressane Lima P, Desai S, et al
    Immunogenicity, duration of protection, effectiveness and safety of rubella containing vaccines: A systematic literature review and meta-analysis.
    Vaccine. 2021 Jan 13. pii: S0264-410X(20)31691.
    PubMed     Abstract available

  807. WHITWORTH HS, Schiller J, Markowitz LE, Jit M, et al
    Continued HPV vaccination in the face of unexpected challenges: A commentary on the rationale for an extended interval two-dose schedule.
    Vaccine. 2021 Jan 13. pii: S0264-410X(20)31598.

  808. OTERI J, Bawa S, Christopher E, Nsubuga P, et al
    Potential for improving routine immunisation waste management using measles vaccination campaign 2017 in Kebbi State, Nigeria.
    Vaccine. 2021 Jan 12. pii: S0264-410X(20)31654.
    PubMed     Abstract available

  809. ATSMON J, Machluf N, Yagon-Gur V, Sabbah C, et al
    Rapid and high seroprotection rates achieved with a tri-antigenic Hepatitis B vaccine in healthy young adults: Results from a Phase IV study.
    Vaccine. 2021 Jan 12. pii: S0264-410X(20)31630.
    PubMed     Abstract available

  810. YANG R, Liu Q, Pang W, Gao F, et al
    Two immunogenic recombinant protein vaccine candidates showed disparate protective efficacy against Zika virus infection in rhesus macaques.
    Vaccine. 2021 Jan 12. pii: S0264-410X(20)31674.
    PubMed     Abstract available

  811. ARCON N, Picchio MS, Fenoy IM, Moretta RE, et al
    Synergistic effect of GRA7 and profilin proteins in vaccination against chronic Toxoplasma gondii infection.
    Vaccine. 2021 Jan 12. pii: S0264-410X(20)31669.
    PubMed     Abstract available

  812. GUALANO MR, Corradi A, Voglino G, Catozzi D, et al
    Healthcare Workers' (HCWs) attitudes towards mandatory influenza vaccination: A systematic review and meta-analysis.
    Vaccine. 2021 Jan 12. pii: S0264-410X(20)31655.
    PubMed     Abstract available

  813. AKMATOV MK, Holstiege J, Steffen A, Batzing J, et al
    Utilization of influenza vaccination among chronically ill individuals in Germany: A nationwide claims-based analysis.
    Vaccine. 2021 Jan 12. pii: S0264-410X(20)31693.
    PubMed     Abstract available

  814. FENTON ATHR, Orefice C, Eun TJ, Biancarelli D, et al
    Effect of provider recommendation style on the length of adolescent vaccine discussions.
    Vaccine. 2021 Jan 11. pii: S0264-410X(20)31441.
    PubMed     Abstract available

  815. KORNUTA CA, Langellotti CA, Bidart JE, Soria I, et al
    A plasmid encoding the extracellular domain of CD40 ligand and Montanide GEL01 as adjuvants enhance the immunogenicity and the protection induced by a DNA vaccine against BoHV-1.
    Vaccine. 2021 Jan 11. pii: S0264-410X(20)31553.
    PubMed     Abstract available

  816. SANTANA CP, Luhm KR, Shimakura SE
    Impact of Tdap vaccine during pregnancy on the incidence of pertussis in children under one year in Brazil - A time series analysis.
    Vaccine. 2021 Jan 11. pii: S0264-410X(20)31636.
    PubMed     Abstract available

  817. ACKERSON B, Qian L, Sy LS, Bruxvoort K, et al
    Completion of the two-dose recombinant zoster vaccine series in adults 50 years and older.
    Vaccine. 2021 Jan 11. pii: S0264-410X(20)31673.
    PubMed     Abstract available

  818. BURGER AE, Reither EN, Mamelund SE, Lim S, et al
    Black-white disparities in 2009 H1N1 vaccination among adults in the United States: A cautionary tale for the COVID-19 pandemic.
    Vaccine. 2021 Jan 11. pii: S0264-410X(20)31666.
    PubMed     Abstract available

  819. SINGH J, Malik D, Raina A
    Immuno-informatics approach for B-cell and T-cell epitope based peptide vaccine design against novel COVID-19 virus.
    Vaccine. 2021 Jan 9. pii: S0264-410X(21)00015.
    PubMed     Abstract available

  820. RUIZ JB, Bell RA
    Predictors of intention to vaccinate against COVID-19: Results of a nationwide survey.
    Vaccine. 2021 Jan 9. pii: S0264-410X(21)00014.
    PubMed     Abstract available

  821. WIEMKEN TL, Rutschman AS
    Development of vaccines for influenza disease: Opportunity costs of the COVID-19 pandemic.
    Vaccine. 2021 Jan 9. pii: S0264-410X(21)00018.

  822. BEIGI RH, Krubiner C, Jamieson DJ, Lyerly AD, et al
    The need for inclusion of pregnant women in COVID-19 vaccine trials.
    Vaccine. 2021 Jan 8. pii: S0264-410X(20)31671.

  823. CHAUDHURY S, MacGill RS, Early AM, Bolton JS, et al
    Breadth of humoral immune responses to the C-terminus of the circumsporozoite protein is associated with protective efficacy induced by the RTS,S malaria vaccine.
    Vaccine. 2021 Jan 8. pii: S0264-410X(20)31635.
    PubMed     Abstract available

  824. ABDI I, Gidding H, Leong RN, Moore HC, et al
    Vaccine coverage in children born to migrant mothers in Australia: A population-based cohort study.
    Vaccine. 2021 Jan 8. pii: S0264-410X(20)31638.
    PubMed     Abstract available

  825. DESMET S, Wouters I, Heirstraeten LV, Beutels P, et al
    In-depth analysis of pneumococcal serotypes in Belgian children (2015-2018): Diversity, invasive disease potential, and antimicrobial susceptibility in carriage and disease.
    Vaccine. 2021;39:372-379.
    PubMed     Abstract available

  826. MAITI S, Howlader DR, Halder P, Bhaumik U, et al
    Bivalent non-typhoidal Salmonella outer membrane vesicles immunized mice sera confer passive protection against gastroenteritis in a suckling mice model.
    Vaccine. 2021;39:380-393.
    PubMed     Abstract available

  827. WILLIAMS J, Degeling C, McVernon J, Dawson A, et al
    How should we conduct pandemic vaccination?
    Vaccine. 2021 Jan 7. pii: S0264-410X(20)31639.
    PubMed     Abstract available

  828. SHARMA H, Anil K, Parekh S, Pujari P, et al
    A phase-I, open label clinical trial to assess the safety of Tdap vaccine manufactured by Serum Institute of India Pvt. Ltd. in adults.
    Vaccine. 2021 Jan 7. pii: S0264-410X(20)31656.
    PubMed     Abstract available

  829. CALDERA F, Mercer M, Samson SI, Pitt JM, et al
    Influenza vaccination in immunocompromised populations: Strategies to improve immunogenicity.
    Vaccine. 2021 Jan 7. pii: S0264-410X(20)31490.
    PubMed     Abstract available

  830. KELSO JM
    Anaphylactic reactions to novel mRNA SARS-CoV-2/COVID-19 vaccines.
    Vaccine. 2021 Jan 6. pii: S0264-410X(20)31696.

  831. SU JR, McNeil MM, Welsh KJ, Marquez PL, et al
    Myopericarditis after vaccination, Vaccine Adverse Event Reporting System (VAERS), 1990-2018.
    Vaccine. 2021 Jan 6. pii: S0264-410X(20)31614.
    PubMed     Abstract available

  832. NISAR MI, Ahmed S, Jehan F, Shahid S, et al
    Direct and indirect effect of 10 valent pneumococcal vaccine on nasopharyngeal carriage in children under 2 years of age in Matiari, Pakistan.
    Vaccine. 2021 Jan 6. pii: S0264-410X(20)31662.
    PubMed     Abstract available

  833. SCHEPPLER L, De Clercq N, McGoldrick M, Dias J, et al
    Regulatory Harmonization and Streamlining of Clinical Trial Applications globally should lead to faster clinical development and earlier access to life-saving vaccines.
    Vaccine. 2021 Jan 6. pii: S0264-410X(20)31569.
    PubMed     Abstract available

  834. KOHLI M, Maschio M, Becker D, Weinstein MC, et al
    The potential public health and economic value of a hypothetical COVID-19 vaccine in the United States: Use of cost-effectiveness modeling to inform vaccination prioritization.
    Vaccine. 2021 Jan 6. pii: S0264-410X(20)31690.
    PubMed     Abstract available

  835. MIDDELDORP M, van Lier A, van der Maas N, Veldhuijzen I, et al
    Short term impact of the COVID-19 pandemic on incidence of vaccine preventable diseases and participation in routine infant vaccinations in the Netherlands in the period March-September 2020.
    Vaccine. 2021 Jan 6. pii: S0264-410X(20)31692.
    PubMed     Abstract available

  836. WONG MCS, Wong ELY, Huang J, Cheung AWL, et al
    Acceptance of the COVID-19 vaccine based on the health belief model: A population-based survey in Hong Kong.
    Vaccine. 2021 Jan 6. pii: S0264-410X(20)31695.
    PubMed     Abstract available

  837. GODINOT LD, Sicsic J, Lachatre M, Bouvet E, et al
    Quantifying preferences around vaccination against frequent, mild disease with risk for vulnerable persons: A discrete choice experiment among French hospital health care workers.
    Vaccine. 2021 Jan 5. pii: S0264-410X(20)31637.
    PubMed     Abstract available

  838. SCHLEY K, Malerczyk C, Beier D, Schiffner-Rohe J, et al
    Vaccination rate and adherence of tick-borne encephalitis vaccination in Germany.
    Vaccine. 2021 Jan 4. pii: S0264-410X(20)31615.
    PubMed     Abstract available

  839. FIELDING J, Sullivan SG, Beard F, Macartney K, et al
    Constructing an ethical framework for priority allocation of pandemic vaccines.
    Vaccine. 2021 Jan 3. pii: S0264-410X(20)31633.
    PubMed     Abstract available

  840. RUSSELL LB, Kim SY, Toscano C, Cosgriff B, et al
    Comparison of static and dynamic models of maternal immunization to prevent infant pertussis in Brazil.
    Vaccine. 2021;39:158-166.
    PubMed     Abstract available

  841. BAGATTINI AM, Policena G, Minamisava R, Andrade ALS, et al
    The data used to build the models: Pertussis morbidity and mortality burden considering various Brazilian data sources.
    Vaccine. 2021;39:137-146.
    PubMed     Abstract available

  842. RUSSELL LB, Sobanjo-Ter Meulen A, Toscano CM
    Evaluating the cost-effectiveness of maternal pertussis immunization in low- and middle-income countries: A review of lessons learnt.
    Vaccine. 2021;39:121-124.
    PubMed     Abstract available

  843. MITCHELL T, Dalal W, Klosovsky A, Yen C, et al
    An immunization program for US-bound refugees: Development, challenges, and opportunities 2012-present.
    Vaccine. 2021;39:68-77.
    PubMed     Abstract available

    December 2020
  844. JIANG X, Shang X, Lin J, Zhao Y, et al
    Impacts of free vaccination policy and associated factors on influenza vaccination behavior of the elderly in China: A quasi-experimental study.
    Vaccine. 2020 Dec 31. pii: S0264-410X(20)31608.
    PubMed     Abstract available

  845. GROVES PJ, Williamson SL, Ahaduzzaman M, Diamond M, et al
    Can a combination of vaccination, probiotic and organic acid treatment in layer hens protect against early life exposure to Salmonella Typhimurium and challenge at sexual maturity?
    Vaccine. 2020 Dec 31. pii: S0264-410X(20)31612.
    PubMed     Abstract available

  846. DAMJANOVSKA S, Smith C, Sayin I, Burant CJ, et al
    Adjuvant effect of type I interferon induced by many but not all commercial influenza vaccines.
    Vaccine. 2020 Dec 31. pii: S0264-410X(20)31631.
    PubMed     Abstract available

  847. SRINIVASA REDDY Y, Narendra Babu K, Uday Kumar P, Harishankar N, et al
    Nonclinical safety evaluation of oral recombinant anti-human papilloma virus vaccine (RHPV 16 & 18): Regulatory toxicology studies in mice, rats and rabbits - An innovative approach.
    Vaccine. 2020 Dec 30. pii: S0264-410X(20)31463.
    PubMed     Abstract available

  848. PRETO C, Maron de Mello A, Cesario Pereira Maluf EM, Teixeira Krainski E, et al
    Vaccination coverage and adherence to a dengue vaccination program in the state of Parana, Brazil.
    Vaccine. 2020 Dec 29. pii: S0264-410X(20)31597.
    PubMed     Abstract available

  849. GUPTA S, Tiku VR, Gauhar M, Khatoon K, et al
    Genetic diversity of G9 rotavirus strains circulating among diarrheic children in North India: A comparison with 116E rotavirus vaccine strain.
    Vaccine. 2020 Dec 29. pii: S0264-410X(20)31604.
    PubMed     Abstract available

  850. TOMLJENOVIC M, Petrovic G, Antoljak N, Hansen L, et al
    Vaccination attitudes, beliefs and behaviours among primary health care workers in northern Croatia.
    Vaccine. 2020 Dec 29. pii: S0264-410X(20)31502.
    PubMed     Abstract available

  851. ZHONG Y, Clapham HE, Aishworiya R, Chua YX, et al
    Childhood vaccinations: Hidden impact of COVID-19 on children in Singapore.
    Vaccine. 2020 Dec 26. pii: S0264-410X(20)31634.
    PubMed     Abstract available

  852. PITTET LF, Tebruegge M, Dutta B, Donath S, et al
    Mycobacterium ulcerans-specific immune response after immunisation with bacillus Calmette-Guerin (BCG) vaccine.
    Vaccine. 2020 Dec 25. pii: S0264-410X(20)31498.
    PubMed     Abstract available

  853. SUAU R, Vidal M, Aguilar R, Ruiz-Olalla G, et al
    RTS,S/AS01E malaria vaccine induces IgA responses against CSP and vaccine-unrelated antigens in African children in the phase 3 trial.
    Vaccine. 2020 Dec 24. pii: S0264-410X(20)31606.
    PubMed     Abstract available

  854. MORO PL, Marquez P
    Reports of cell-based influenza vaccine administered during pregnancy in the Vaccine Adverse Event Reporting System (VAERS), 2013-2020.
    Vaccine. 2020 Dec 24. pii: S0264-410X(20)31613.
    PubMed     Abstract available

  855. ULANOVA M, Huska B, Desbiens A, Gaultier GN, et al
    Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine in 23-valent pneumococcal polysaccharide vaccine-naive and previously immunized adult patients with severe chronic kidney disease.
    Vaccine. 2020 Dec 24. pii: S0264-410X(20)31602.
    PubMed     Abstract available

  856. THANGARAJAH D, Malo JA, Field E, Andrews R, et al
    Effectiveness of quadrivalent influenza vaccination in the first year of a funded childhood program in Queensland, Australia, 2018.
    Vaccine. 2020 Dec 23. pii: S0264-410X(20)31579.
    PubMed     Abstract available

  857. KOSKAN A, Klasko-Foster L, Stecher C, Rodriguez S, et al
    Human papillomavirus vaccine guideline adherence among Arizona's Medicaid beneficiaries.
    Vaccine. 2020 Dec 23. pii: S0264-410X(20)31609.
    PubMed     Abstract available

  858. CUI YA, Folaranmi T, Buchwald UK
    The Japanese 23-valent pneumococcal polysaccharide vaccine randomized clinical trial: Further reflections on the design and results.
    Vaccine. 2020 Dec 22. pii: S0264-410X(20)31600.
    PubMed     Abstract available

  859. APARECIDO NUNES A, De Jesus Lopes De Abreu A, Cintra O, A C T Cintra M, et al
    Meningococcal disease epidemiology in Brazil (2005-2018) and impact of MenC vaccination.
    Vaccine. 2020 Dec 22. pii: S0264-410X(20)31542.
    PubMed     Abstract available

  860. GINI R, Dodd CN, Bollaerts K, Bartolini C, et al
    Quantifying outcome misclassification in multi-database studies: The case study of pertussis in the ADVANCE project.
    Vaccine. 2020;38 Suppl 2:B56-B64.
    PubMed     Abstract available

  861. ITTEFAQ M, Baines A, Abwao M, Shah SFA, et al
    "Does Pakistan still have polio cases?": Exploring discussions on polio and polio vaccine in online news comments in Pakistan.
    Vaccine. 2020 Dec 21. pii: S0264-410X(20)31607.
    PubMed     Abstract available

  862. MCFADDEN K, Seale H
    A review of hospital-based interventions to improve inpatient influenza vaccination uptake for high-risk adults.
    Vaccine. 2020 Dec 21. pii: S0264-410X(20)31610.
    PubMed     Abstract available

  863. RAMAKRISHNAN A, Joseph SS, Reynolds ND, Poncet D, et al
    Evaluation of the immunogenicity and protective efficacy of a recombinant CS6-based ETEC vaccine in an Aotus nancymaae CS6 + ETEC challenge model.
    Vaccine. 2020 Dec 20. pii: S0264-410X(20)31601.
    PubMed     Abstract available

  864. MARCHAL C, Belhassen M, Guiso N, Jacoud F, et al
    Vaccination coverage rates for Diphtheria, Tetanus, Poliomyelitis and Pertussis booster vaccination in France between 2013 and 2017: Learnings from an analysis of National Health System Real-World Data.
    Vaccine. 2020 Dec 20. pii: S0264-410X(20)31588.
    PubMed     Abstract available

  865. DOUGLASS N, van Diepen MT, Chapman R, Galant S, et al
    Modifications to the HIV-1 SAAVI MVA-C vaccine improve in vitro expression and in vivo immunogenicity.
    Vaccine. 2020 Dec 17. pii: S0264-410X(20)31591.
    PubMed     Abstract available

  866. FAN S, Liao Y, Jiang G, Wang L, et al
    Efficacy of an inactivated bivalent vaccine for enterovirus 71 and coxsackievirus A16 in mice immunized intradermally.
    Vaccine. 2020 Dec 17. pii: S0264-410X(20)31552.
    PubMed     Abstract available

  867. GRETER H, Ivol S, Oriol Mathieu V, Erismann S, et al
    Heterologous vaccine regimen: Stakeholder acceptance and implementation considerations.
    Vaccine. 2020 Dec 17. pii: S0264-410X(20)31566.
    PubMed     Abstract available

  868. BETLACH AM, Fano E, VanderWaal K, Pieters M, et al
    Effect of multiple vaccinations on transmission and degree of Mycoplasma hyopneumoniae infection in gilts.
    Vaccine. 2020 Dec 17. pii: S0264-410X(20)31443.
    PubMed     Abstract available

  869. KIM K, Hahn TW
    Evaluation of novel recombinant porcine circovirus type 2d (PCV2d) vaccine in pigs naturally infected with PCV2d.
    Vaccine. 2020 Dec 17. pii: S0264-410X(20)31580.
    PubMed     Abstract available

  870. SPARROW E, Wood JG, Chadwick C, Newall AT, et al
    Global production capacity of seasonal and pandemic influenza vaccines in 2019.
    Vaccine. 2020 Dec 16. pii: S0264-410X(20)31585.
    PubMed     Abstract available

  871. FULVINI AA, Tuteja A, Le J, Pokorny BA, et al
    HA1 (Hemagglutinin) quantitation for influenza A H1N1 and H3N2 high yield reassortant vaccine candidate seed viruses by RP-UPLC.
    Vaccine. 2020 Dec 16. pii: S0264-410X(20)31563.
    PubMed     Abstract available

  872. BORRIELLO A, Master D, Pellegrini A, Rose JM, et al
    Preferences for a COVID-19 vaccine in Australia.
    Vaccine. 2020 Dec 16. pii: S0264-410X(20)31599.
    PubMed     Abstract available

  873. BOKEMPER SE, Huber GA, Gerber AS, James EK, et al
    Timing of COVID-19 vaccine approval and endorsement by public figures.
    Vaccine. 2020 Dec 16. pii: S0264-410X(20)31616.
    PubMed     Abstract available

  874. MONTGOMERY VA, Lindsey CY, Smith LA, Webb RP, et al
    Development of an o-pthalaldehyde (OPA) assay to measure protein content in Ricin Vaccine E. coli (RVEc).
    Vaccine. 2020 Dec 15. pii: S0264-410X(20)31573.
    PubMed     Abstract available

  875. SANFTENBERG L, Kuehne F, Anraad C, Jung-Sievers C, et al
    Assessing the impact of shared decision making processes on influenza vaccination rates in adult patients in outpatient care: A systematic review and meta-analysis.
    Vaccine. 2020 Dec 14. pii: S0264-410X(20)31581.
    PubMed     Abstract available

  876. BROOCKMAN D, Kalla J, Guerrero A, Budolfson M, et al
    Broad cross-national public support for accelerated COVID-19 vaccine trial designs.
    Vaccine. 2020 Dec 14. pii: S0264-410X(20)31555.
    PubMed     Abstract available

  877. FLORES-VALDEZ MA, Segura-Cerda CA
    Preclinical evaluation of tuberculosis vaccine candidates: Is it time to harmonize study design and readouts for prioritizing their development?
    Vaccine. 2020 Dec 14. pii: S0264-410X(20)31556.

  878. STEVENS VW, Russo EM, Young-Xu Y, Leecaster M, et al
    Identification of patients at risk of Clostridioides difficile infection for enrollment in vaccine clinical trials.
    Vaccine. 2020 Dec 14. pii: S0264-410X(20)31583.
    PubMed     Abstract available

  879. BRAVO-GRANDE JL, Asuncion Blanco-Gonzalez M, de la Torre-Robles JM, Asmat-Inostrosa MP, et al
    Vaccination adjuvated against hepatitis B in Spanish National Healthcare System (SNS) workers typed as non-responders to conventional vaccines.
    Vaccine. 2020 Dec 14. pii: S0264-410X(20)31571.
    PubMed     Abstract available

  880. CASTANO-ZUBIETA MR, Rossetti CA, Garcia-Gonzalez DG, Maurizio E, et al
    Evaluation of the safety profile of the vaccine candidate Brucella melitensis 16MDeltavjbR strain in goats.
    Vaccine. 2020 Dec 13. pii: S0264-410X(20)31473.
    PubMed     Abstract available

  881. BOUCHEZ M, Ward JK, Bocquier A, Benamouzig D, et al
    Physicians' decision processes about the HPV vaccine: A qualitative study.
    Vaccine. 2020 Dec 13. pii: S0264-410X(20)31586.
    PubMed     Abstract available

  882. SARINHO E, Goudouris E, Sole D
    BCG vaccine: Worrying proposal for COVID-19.
    Vaccine. 2020 Dec 13. pii: S0264-410X(20)31593.
    PubMed     Abstract available

  883. DEGELING C, Williams J, Carter SM, Moss R, et al
    Priority allocation of pandemic influenza vaccines in Australia - Recommendations of 3 community juries.
    Vaccine. 2020 Dec 11. pii: S0264-410X(20)31577.
    PubMed     Abstract available

  884. ZACHARIA A, Harberts E, Valencia SM, Myers B, et al
    Optimization of RG1-VLP vaccine performance in mice with novel TLR4 agonists.
    Vaccine. 2020 Dec 10. pii: S0264-410X(20)31541.
    PubMed     Abstract available

  885. DE OLIVEIRA EMERICK S, Vieira de Carvalho T, Meirelles Miranda B, Carneiro da Silva A, et al
    Lipophosphoglycan-3 protein from Leishmania infantum chagasi plus saponin adjuvant: A new promising vaccine against visceral leishmaniasis.
    Vaccine. 2020 Dec 10. pii: S0264-410X(20)31539.
    PubMed     Abstract available

  886. LIU C, Huang P, Zhao D, Xia M, et al
    Effects of rotavirus NSP4 protein on the immune response and protection of the SR69A-VP8* nanoparticle rotavirus vaccine.
    Vaccine. 2020 Dec 10. pii: S0264-410X(20)31568.
    PubMed     Abstract available

  887. HOLM MR, Poland GA
    Critical aspects of packaging, storage, preparation, and administration of mRNA and adenovirus-vectored COVID-19 vaccines for optimal efficacy.
    Vaccine. 2020 Dec 9. pii: S0264-410X(20)31584.

  888. CARIAS C, Pawaskar M, Nyaku M, Conway JH, et al
    Potential impact of COVID-19 pandemic on vaccination coverage in children: A case study of measles-containing vaccine administration in the United States (US).
    Vaccine. 2020 Dec 9. pii: S0264-410X(20)31557.
    PubMed     Abstract available

  889. DULIN N, Spanier A, Merino K, Hutter JN, et al
    Systematic review of Marburg virus vaccine nonhuman primate studies and human clinical trials.
    Vaccine. 2020 Dec 9. pii: S0264-410X(20)31495.
    PubMed     Abstract available

  890. GHASWALLA PK, Bengtson LGS, Marshall GS, Buikema AR, et al
    Meningococcal vaccination in patients with newly diagnosed asplenia in the United States.
    Vaccine. 2020 Dec 9. pii: S0264-410X(20)31550.
    PubMed     Abstract available

  891. RASTEGAR M, Tavana M, Meraj A, Mina H, et al
    An inventory-location optimization model for equitable influenza vaccine distribution in developing countries during the COVID-19 pandemic.
    Vaccine. 2020 Dec 9. pii: S0264-410X(20)31589.
    PubMed     Abstract available

  892. WILLIAMS JTB, Robinson K, Abbott E, Rojop N, et al
    Adapting and piloting a vaccine hesitancy questionnaire in rural Guatemala.
    Vaccine. 2020 Dec 8. pii: S0264-410X(20)31551.
    PubMed     Abstract available

  893. LUISI MLR
    From bad to worse II: Risk amplification of the HPV vaccine on Facebook.
    Vaccine. 2020 Dec 7. pii: S0264-410X(20)31540.
    PubMed     Abstract available

  894. GHIGA I, Richardson S, Alvarez AMR, Kato M, et al
    PIPDeploy: Development and implementation of a gamified table top simulation exercise to strengthen national pandemic vaccine preparedness and readiness.
    Vaccine. 2020 Dec 5. pii: S0264-410X(20)31500.
    PubMed     Abstract available

  895. DHAKAL S, Deshpande S, McMahon M, Strohmeier S, et al
    Female-biased effects of aging on a chimeric hemagglutinin stalk-based universal influenza virus vaccine in mice.
    Vaccine. 2020 Dec 5. pii: S0264-410X(20)31510.
    PubMed     Abstract available

  896. LENG A, Maitland E, Wang S, Nicholas S, et al
    Individual preferences for COVID-19 vaccination in China.
    Vaccine. 2020 Dec 5. pii: S0264-410X(20)31576.
    PubMed     Abstract available

  897. LLAU AF, Williams ML, Tejada CE
    National vaccine coverage trends and funding in Latin America and the Caribbean.
    Vaccine. 2020 Dec 4. pii: S0264-410X(20)31534.
    PubMed     Abstract available

  898. DOLL MK, Weitzen SD, Morrison KT
    Trends in the uptake of pediatric measles-containing vaccine in the United States: A Disneyland effect?
    Vaccine. 2020 Dec 4. pii: S0264-410X(20)31501.
    PubMed     Abstract available

  899. WENZEL NS, Atkins KE, van Leeuwen E, Halloran ME, et al
    Cost-effectiveness of live-attenuated influenza vaccination among school-age children.
    Vaccine. 2020 Dec 4. pii: S0264-410X(20)31282.
    PubMed     Abstract available

  900. MAYKIN MM, Heuser C, Feltovich H
    Pregnant people deserve the protection offered by SARS-CoV-2 vaccines.
    Vaccine. 2020 Dec 4. pii: S0264-410X(20)31572.

  901. DIMOPOULOU D, Koutsaki M, Giorgi M, Spanou M, et al
    Effects of measles-containing vaccination in children with severe underlying neurologic disease.
    Vaccine. 2020 Dec 3. pii: S0264-410X(20)31536.
    PubMed     Abstract available

  902. LEADER AE, Burke-Garcia A, Massey PM, Roark JB, et al
    Understanding the messages and motivation of vaccine hesitant or refusing social media influencers.
    Vaccine. 2020 Dec 3. pii: S0264-410X(20)31533.
    PubMed     Abstract available

  903. MOHAMMED H, Roberts CT, Grzeskowiak LE, Giles LC, et al
    Safety of maternal pertussis vaccination on pregnancy and birth outcomes: A prospective cohort study.
    Vaccine. 2020 Dec 3. pii: S0264-410X(20)31505.
    PubMed     Abstract available

  904. OCRAN-APPIAH J, Boutry C, Herve C, Soni J, et al
    Safety of the adjuvanted recombinant zoster vaccine in adults aged 50 years or older. A phase IIIB, non-randomized, multinational, open-label study in previous ZOE-50 and ZOE-70 placebo recipients.
    Vaccine. 2020 Dec 1. pii: S0264-410X(20)31323.
    PubMed     Abstract available

    November 2020
  905. EDOKA I, Kohli-Lynch C, Fraser H, Hofman K, et al
    A cost-effectiveness analysis of South Africa's seasonal influenza vaccination programme.
    Vaccine. 2020 Nov 30. pii: S0264-410X(20)31468.
    PubMed     Abstract available

  906. FOCOSI D, Maggi F, Pistello M
    Corrigendum to "Getting the most from the Ebola vaccine success" [Vaccine 33 (2015) 7141].
    Vaccine. 2020 Nov 30. pii: S0264-410X(20)31537.

  907. HABER P, Tate J, Marquez PL, Moro PL, et al
    Safety profile of rotavirus vaccines among individuals aged>/=8months of age, United States, vaccine adverse event reporting system (VAERS), 2006-2019.
    Vaccine. 2020 Nov 29. pii: S0264-410X(20)31466.
    PubMed     Abstract available

  908. MAJED L, Bresse X, El Mouaddin N, Schmidt A, et al
    Public health impact and cost-effectiveness of a nine-valent gender-neutral HPV vaccination program in France.
    Vaccine. 2020 Nov 28. pii: S0264-410X(20)31420.
    PubMed     Abstract available

  909. GATES A, Gates M, Rahman S, Guitard S, et al
    A systematic review of factors that influence the acceptability of vaccines among Canadians.
    Vaccine. 2020 Nov 27. pii: S0264-410X(20)31332.
    PubMed     Abstract available

  910. DE CASTRO JC, de Almeida LV, Cardoso MS, Oliveira FMS, et al
    Vaccination with chimeric protein induces protection in murine model against ascariasis.
    Vaccine. 2020 Nov 26. pii: S0264-410X(20)31499.
    PubMed     Abstract available

  911. HAVERI A, Ikonen N, Savolainen-Kopra C, Julkunen I, et al
    Long-lasting heterologous antibody responses after sequential vaccination with A/Indonesia/5/2005 and A/Vietnam/1203/2004 pre-pandemic influenza A(H5N1) virus vaccines.
    Vaccine. 2020 Nov 24. pii: S0264-410X(20)31494.
    PubMed     Abstract available

  912. VANDER STICHELE RH, Hay C, Fladvad M, Sturkenboom MCJM, et al
    How to ensure we can track and trace global use of COVID-19 vaccines?
    Vaccine. 2020 Nov 24. pii: S0264-410X(20)31508.

  913. KITANO T, Aoki H
    A model for the incremental burden of invasive Haemophilus influenzae type b due to a decline of childhood vaccination during the COVID-19 outbreak: A dynamic transmission model in Japan.
    Vaccine. 2020 Nov 24. pii: S0264-410X(20)31506.
    PubMed     Abstract available

  914. URA T, Yamashita A, Mizuki N, Okuda K, et al
    New vaccine production platforms used in developing SARS-CoV-2 vaccine candidates.
    Vaccine. 2020 Nov 24. pii: S0264-410X(20)31507.
    PubMed     Abstract available

  915. KITTIKRAISAK W, Phadungkiatwatana P, Ditsungnoen D, Kaoiean S, et al
    Comparison of influenza antibody titers among women who were vaccinated in the 2(nd) and the 3(rd) trimesters of pregnancy.
    Vaccine. 2020 Nov 23. pii: S0264-410X(20)31472.
    PubMed     Abstract available

  916. DRORI Y, Pando R, Sefty H, Rosenberg A, et al
    Influenza vaccine effectiveness against laboratory-confirmed influenza in a vaccine-mismatched influenza B-dominant season.
    Vaccine. 2020 Nov 23. pii: S0264-410X(20)31394.
    PubMed     Abstract available

  917. PECKEU L, van der Ende A, de Melker HE, Sanders EAM, et al
    Impact and effectiveness of the 10-valent pneumococcal conjugate vaccine on invasive pneumococcal disease among children under 5 years of age in the Netherlands.
    Vaccine. 2020 Nov 23. pii: S0264-410X(20)31456.
    PubMed     Abstract available

  918. HU S, Xu X, Zhang Y, Liu Y, et al
    A nationwide post-marketing survey of knowledge, attitude and practice toward human papillomavirus vaccine in general population: Implications for vaccine roll-out in mainland China.
    Vaccine. 2020 Nov 23. pii: S0264-410X(20)31469.
    PubMed     Abstract available

  919. HUANG Z, He J, Su J, Ou Z, et al
    Immunogenicity and safety of the quadrivalent human papillomavirus vaccine in Chinese females aged 9 to 26 years: A phase 3, open-label, immunobridging study.
    Vaccine. 2020 Nov 22. pii: S0264-410X(20)31434.
    PubMed     Abstract available

  920. CLOSSON K, Karim ME, Sadarangani M, Naus M, et al
    Association between human papillomavirus vaccine status and sexually transmitted infection outcomes among females aged 18-35 with a history of sexual activity in the United States: A population survey-based cross-sectional analysis.
    Vaccine. 2020 Nov 22. pii: S0264-410X(20)31327.
    PubMed     Abstract available

  921. JULIAO P, Abadia I, Welby S, Wery S, et al
    Hepatitis A antibody persistence 8 and 10 years after 1-dose and 2-dose vaccination in children from Panama.
    Vaccine. 2020 Nov 22. pii: S0264-410X(20)31470.
    PubMed     Abstract available

  922. LINDSEY NP, Perry L, Fischer M, Woolpert T, et al
    Duration of seropositivity following yellow fever vaccination in U.S. military service members.
    Vaccine. 2020 Nov 22. pii: S0264-410X(20)31462.
    PubMed     Abstract available

  923. FIX A, Kirkwood CD, Steele D, Flores J, et al
    Next-generation rotavirus vaccine developers meeting: Summary of a meeting sponsored by PATH and the bill & melinda gates foundation (19-20 June 2019, Geneva).
    Vaccine. 2020 Nov 21. pii: S0264-410X(20)31474.
    PubMed     Abstract available

  924. OHFUJI S, Okada K, Mouri Y, Mihara Y, et al
    Effectiveness of four doses of pertussis vaccine during infancy diminished in elementary school age: A test-negative case-control study in Japan.
    Vaccine. 2020 Nov 20. pii: S0264-410X(20)31475.
    PubMed     Abstract available

  925. ALLEN JC, Toapanta FR, Chen W, Tennant SM, et al
    Understanding immunosenescence and its impact on vaccination of older adults.
    Vaccine. 2020 Nov 20. pii: S0264-410X(20)31426.
    PubMed     Abstract available

  926. GANGULY M, Yeolekar L, Tyagi P, Sagar U, et al
    Evaluation of manufacturing feasibility and safety of an MDCK cell-based live attenuated influenza vaccine (LAIV) platform.
    Vaccine. 2020 Nov 20. pii: S0264-410X(20)31424.
    PubMed     Abstract available

  927. SUNDARAM ME, Wolfson J, Osterholm M, Sow S, et al
    Meningococcal vaccines and protein-energy undernutrition in children in the African meningitis belt.
    Vaccine. 2020 Nov 19. pii: S0264-410X(20)31438.
    PubMed     Abstract available

  928. HOA-TRAN TN, Dao ATH, Nguyen AT, Kataoka C, et al
    Coxsackieviruses A6 and A16 associated with hand, foot, and mouth disease in Vietnam, 2008-2017: Essential information for rational vaccine design.
    Vaccine. 2020 Nov 19. pii: S0264-410X(20)31471.
    PubMed     Abstract available

  929. ZHU S, Chang J, Hayat K, Li P, et al
    Parental preferences for HPV vaccination in junior middle school girls in China: A discrete choice experiment.
    Vaccine. 2020 Nov 19. pii: S0264-410X(20)31460.
    PubMed     Abstract available

  930. YEUNG KHT, Lin SL, Clark A, McGhee SM, et al
    Economic evaluation of the introduction of rotavirus vaccine in Hong Kong.
    Vaccine. 2020 Nov 18. pii: S0264-410X(20)31361.
    PubMed     Abstract available

  931. THANH THI LE X, Ishizumi A, Thi Thu Nguyen H, Thi Duong H, et al
    Social and behavioral determinants of attitudes towards and practices of hepatitis B vaccine birth dose in Vietnam.
    Vaccine. 2020 Nov 18. pii: S0264-410X(20)31435.
    PubMed     Abstract available

  932. KHERA A, Singh R, Shakila H, Rao V, et al
    Corrigendum to 'Elicitation of efficient, protective immune responses by using DNA vaccines against tuberculosis' [Vaccine 23 (2005) 5655-5665].
    Vaccine. 2020;38:7874-7875.

  933. GRAVAGNA K, Becker A, Valeris-Chacin R, Mohammed I, et al
    Global assessment of national mandatory vaccination policies and consequences of non-compliance.
    Vaccine. 2020;38:7865-7873.
    PubMed     Abstract available

  934. XU X, Wang C, Huang Y, Zhang S, et al
    Evaluation of the vaccine efficacy of three digestive protease antigens from Dermanyssus gallinae using an in vivo rearing system.
    Vaccine. 2020;38:7842-7849.
    PubMed     Abstract available

  935. BAROUTSOU V, Zens KD, Sinniger P, Fehr J, et al
    Analysis of Tick-borne Encephalitis vaccination coverage and compliance in adults in Switzerland, 2018.
    Vaccine. 2020;38:7825-7833.
    PubMed     Abstract available

  936. PHUGARE S, Kale S, Sharma P, Kumar Goel S, et al
    Quantitation of novel pentavalent meningococcal polysaccharide conjugate vaccine (Men A-TT, Men C-CRM, Men Y-CRM, Men W-CRM, Men X-TT) using sandwich ELISA.
    Vaccine. 2020;38:7815-7824.
    PubMed     Abstract available

  937. TUCKERMAN JL, Kaufman J, Danchin M, Marshall HS, et al
    Influenza vaccination: A qualitative study of practice level barriers from medical practitioners caring for children with special risk medical conditions.
    Vaccine. 2020;38:7806-7814.
    PubMed     Abstract available

  938. GUESS AM, Nyhan B, O'Keeffe Z, Reifler J, et al
    The sources and correlates of exposure to vaccine-related (mis)information online.
    Vaccine. 2020;38:7799-7805.
    PubMed     Abstract available

  939. PHILLIPS MT, Warren JL, Givon-Lavi N, Tothpal A, et al
    Evaluating post-vaccine expansion patterns of pneumococcal serotypes.
    Vaccine. 2020;38:7756-7763.
    PubMed     Abstract available

  940. HEO JY, Seo YB, Jeong HW, Choi MJ, et al
    Epidemiology of community-acquired pneumonia in the era of extended serotype-covering multivalent pneumococcal conjugate vaccines.
    Vaccine. 2020;38:7747-7755.
    PubMed     Abstract available

  941. MOHAMED N, Simba D, Mphuru A, Lyimo D, et al
    Lessons learned in the implementation of supplementary immunization activity (SIA) field guidelines for injectable vaccines - Experiences from Tanzania.
    Vaccine. 2020;38:7741-7746.
    PubMed     Abstract available

  942. TOLL M, Li A
    Vaccine sentiments and under-vaccination: Attitudes and behaviour around Measles, Mumps, and Rubella vaccine (MMR) in an Australian cohort.
    Vaccine. 2020 Nov 17. pii: S0264-410X(20)31461.
    PubMed     Abstract available

  943. XIAOJIN S, Rodewald LE, Guomin Z, Hui Z, et al
    Long-term seropositivity, safety, and impact of inactivated and live, attenuated hepatitis a vaccines in China - A cross-sectional study.
    Vaccine. 2020 Nov 16. pii: S0264-410X(20)31457.
    PubMed     Abstract available

  944. MAGWIRA CA, Kgosana LP, Esona MD, Seheri ML, et al
    Low fecal rotavirus vaccine virus shedding is significantly associated with non-secretor histo-blood group antigen phenotype among infants in northern Pretoria, South Africa.
    Vaccine. 2020 Nov 16. pii: S0264-410X(20)31465.
    PubMed     Abstract available

  945. ROBERTS JR, Dawley E, Garbe C, Cooper T, et al
    A survey of office practice: Parents, front office staff, nurses and clinicians hold disparate views on adolescent vaccines.
    Vaccine. 2020 Nov 15. pii: S0264-410X(20)31440.
    PubMed     Abstract available

  946. SHEARER JD, Henning L, Sanford DC, Li N, et al
    Efficacy of the AV7909 anthrax vaccine candidate in guinea pigs and nonhuman primates following two immunizations two weeks apart.
    Vaccine. 2020 Nov 13. pii: S0264-410X(20)31433.
    PubMed     Abstract available

  947. ZUO XX, Zhao YH, Zhou MX, Deng BH, et al
    Live vaccine preserved at room temperature: Preparation and characterization of a freeze-dried classical swine fever virus vaccine.
    Vaccine. 2020 Nov 13. pii: S0264-410X(20)31425.
    PubMed     Abstract available

  948. JARRETT S, Wilmansyah T, Bramanti Y, Alitamsar H, et al
    The role of manufacturers in the implementation of global traceability standards in the supply chain to combat vaccine counterfeiting and enhance safety monitoring.
    Vaccine. 2020 Nov 13. pii: S0264-410X(20)31437.
    PubMed     Abstract available

  949. VYSE A, Campling J, Czudek C, Ellsbury G, et al
    The proportion of contemporary invasive pneumococcal disease and pneumococcal pneumonia in UK adults reflected by serotypes included in the 13-valent pneumococcal conjugate vaccine and next generation higher valency pneumococcal conjugate vaccines in
    Vaccine. 2020 Nov 12. pii: S0264-410X(20)31421.

  950. CROOKE SN, Riggenbach MM, Ovsyannikova IG, Warner ND, et al
    Durability of humoral immune responses to rubella following MMR vaccination.
    Vaccine. 2020 Nov 12. pii: S0264-410X(20)31396.
    PubMed     Abstract available

  951. WANG Q, Zhang W, Cai H, Cao Y, et al
    Understanding the perceptions of Chinese women of the commercially available domestic and imported HPV vaccine: A semantic network analysis.
    Vaccine. 2020 Nov 12. pii: S0264-410X(20)31442.
    PubMed     Abstract available

  952. MASHININI DP, Fogarty KJ, Potter RC, Berles JD, et al
    Geographic hot spot analysis of vaccine exemption clustering patterns in Michigan from 2008 to 2017.
    Vaccine. 2020 Nov 12. pii: S0264-410X(20)31422.
    PubMed     Abstract available

  953. KWON WJ, Choi JC, Hong S, Kim YC, et al
    Development of a high-dose vaccine formulation for prevention of megalocytivirus infection in rock bream (Oplegnathus fasciatus).
    Vaccine. 2020 Nov 11. pii: S0264-410X(20)31423.
    PubMed     Abstract available

  954. HALL LM, Ediriweera Y, Banks J, Nambiar A, et al
    Cooling to reduce the pain associated with vaccination: A systematic review.
    Vaccine. 2020 Nov 11. pii: S0264-410X(20)31429.
    PubMed     Abstract available

  955. GARCIA LY, Cerda AA
    Acceptance of a COVID-19 vaccine: A multifactorial consideration.
    Vaccine. 2020;38:7587.

  956. GRAFFIGNA G, Palamenghi L, Barello S, Stefania B, et al
    "Cultivating" acceptance of a COVID-19 vaccination program: Lessons from Italy.
    Vaccine. 2020;38:7585-7586.

  957. COUDEVILLE L, Gomez GB, Jollivet O, Harris RC, et al
    Exploring uncertainty and risk in the accelerated response to a COVID-19 vaccine: Perspective from the pharmaceutical industry.
    Vaccine. 2020;38:7588-7595.

  958. DOUBOVETZKY M, Ataman-Onal Y, Chousterman B, Feroldi E, et al
    Safety biomarkers for development of vaccines and biologics: Report from the safety biomarkers symposium held on November 28-29, 2017, Marcy l'Etoile, France.
    Vaccine. 2020 Nov 10. pii: S0264-410X(20)31306.
    PubMed     Abstract available

  959. JUSTHY DP
    Vaccine as a Platform (VaaP): Why the future of disease eradication needs to be data driven.
    Vaccine. 2020 Nov 10. pii: S0264-410X(20)31403.

  960. NAVIN MC, Danchin M
    Vaccine mandates in the US and Australia: balancing benefits and burdens for children and physicians.
    Vaccine. 2020 Nov 9. pii: S0264-410X(20)31400.

  961. ZHANG W, Gao J, Chen L, Tian J, et al
    Estimated influenza illnesses and hospitalizations averted by influenza vaccination among children aged 6-59 months in Suzhou, China, 2011/12 to 2015/16 influenza seasons.
    Vaccine. 2020 Nov 8. pii: S0264-410X(20)31389.
    PubMed     Abstract available

  962. FORTUNA L, Chaithongwongwatthana S, Soonthornworasiri N, Spiegel J, et al
    Enhanced post-licensure safety surveillance of a new recombinant acellular pertussis vaccine licensed as a monovalent (aP, Pertagen(R)) and tetanus, reduced-dose diphtheria combination (TdaP, Boostagen(R)) vaccine for immunization of adolescents and a
    Vaccine. 2020 Nov 8. pii: S0264-410X(20)31390.
    PubMed     Abstract available

  963. MAUBRIGADES LR, Santos FDS, Goncalves VS, Rodrigues PRC, et al
    Association of Bacillus toyonensis spores with alum improves bovine herpesvirus 5 subunit vaccine immune response in mice.
    Vaccine. 2020 Nov 7. pii: S0264-410X(20)31386.
    PubMed     Abstract available

  964. MURALL CL, Reyne B, Selinger C, Bernat C, et al
    HPV cervical infections and serological status in vaccinated and unvaccinated women.
    Vaccine. 2020 Nov 6. pii: S0264-410X(20)31398.
    PubMed     Abstract available

  965. CHIU SS, Chua H, Kwan MYW, Chan ELY, et al
    Influenza vaccination effectiveness in preventing influenza hospitalization in children, Hong Kong, winter 2019/20.
    Vaccine. 2020 Nov 6. pii: S0264-410X(20)31401.
    PubMed     Abstract available

  966. GIRISH KUMAR CP, Giri S, Chawla-Sarkar M, Gopalkrishna V, et al
    Epidemiology of rotavirus diarrhea among children less than 5 years hospitalized with acute gastroenteritis prior to rotavirus vaccine introduction in India.
    Vaccine. 2020 Nov 6. pii: S0264-410X(20)31404.
    PubMed     Abstract available

  967. CHEN RT, Kochhar S, Condit R
    The Brighton Collaboration standardized templates for collection of key information for benefit-risk assessment of vaccines by technology (BRAVATO; formerly V3SWG).
    Vaccine. 2020 Nov 6. pii: S0264-410X(20)31392.

  968. SARASTY O, Carpio CE, Hudson D, Guerrero-Ochoa PA, et al
    The demand for a COVID-19 vaccine in Ecuador.
    Vaccine. 2020 Nov 6. pii: S0264-410X(20)31439.
    PubMed     Abstract available

  969. BULULA N, Mwiru DP, Swalehe O, Thomas Mori A, et al
    Vaccine storage and distribution between expanded program on immunization and medical store department in Tanzania: a cost-minimization analysis.
    Vaccine. 2020 Nov 5. pii: S0264-410X(20)31419.
    PubMed     Abstract available

  970. SIKORA AE, Gomez C, Le Van A, Baarda BI, et al
    A novel gonorrhea vaccine composed of MetQ lipoprotein formulated with CpG shortens experimental murine infection.
    Vaccine. 2020 Nov 5. pii: S0264-410X(20)31397.
    PubMed     Abstract available

  971. HITCHINGS MDT, Cummings DAT, Grais RF, Isanaka S, et al
    A mixture model to assess the the immunogenicity of an oral rotavirus vaccine among healthy infants in Niger.
    Vaccine. 2020 Nov 5. pii: S0264-410X(20)31399.
    PubMed     Abstract available

  972. KESKE S, Mutters NT, Tsioutis C, Ergonul O, et al
    Influenza vaccination among infection control teams: A EUCIC survey prior to COVID-19 pandemic.
    Vaccine. 2020 Nov 5. pii: S0264-410X(20)31427.
    PubMed     Abstract available

  973. ROSENTHAL EM, Hall EW, Rosenberg ES, Harris A, et al
    Assessing the cost-utility of preferentially administering Heplisav-B vaccine to certain populations.
    Vaccine. 2020 Nov 4. pii: S0264-410X(20)31387.
    PubMed     Abstract available

  974. SEITEL T, Cagol L, Prelog M, Frivolt K, et al
    Varicella-zoster-virus vaccination of immunosuppressed children with inflammatory bowel disease or autoimmune hepatitis: A prospective observational study.
    Vaccine. 2020 Nov 4. pii: S0264-410X(20)31322.
    PubMed     Abstract available

  975. GRIFFITH BC, Ulrich AK, Becker AB, Nederhoff D, et al
    Does education about local vaccination rates and the importance of herd immunity change US parents' concern about measles?
    Vaccine. 2020 Nov 3. pii: S0264-410X(20)31258.
    PubMed     Abstract available

  976. LOWELL JA, Dikici E, Joshi PM, Landgraf R, et al
    Vaccination against cocaine using a modifiable dendrimer nanoparticle platform.
    Vaccine. 2020 Nov 3. pii: S0264-410X(20)31335.
    PubMed     Abstract available

  977. CROOKE SN, Ovsyannikova IG, Kennedy RB, Warner ND, et al
    Associations between markers of cellular and humoral immunity to rubella virus following a third dose of measles-mumps-rubella vaccine.
    Vaccine. 2020 Nov 3. pii: S0264-410X(20)31391.
    PubMed     Abstract available

  978. CHEN WH, Tao X, Agrawal AS, Algaissi A, et al
    Yeast-expressed SARS-CoV recombinant receptor-binding domain (RBD219-N1) formulated with aluminum hydroxide induces protective immunity and reduces immune enhancement.
    Vaccine. 2020;38:7533-7541.
    PubMed     Abstract available

  979. PEUBEZ I, Margot S, Buffin S, Pion C, et al
    A novel lamprey antibody sequence to multimerize and increase the immunogenicity of recombinant viral and bacterial vaccine antigens.
    Vaccine. 2020 Nov 2. pii: S0264-410X(20)31393.
    PubMed     Abstract available

    October 2020
  980. UDDEN F, Filipe M, Slotved HC, Yamba-Yamba L, et al
    Pneumococcal carriage among children aged 4 - 12 years in Angola 4 years after the introduction of a pneumococcal conjugate vaccine.
    Vaccine. 2020 Oct 31. pii: S0264-410X(20)31369.
    PubMed     Abstract available

  981. MANGION M, Gelinas JF, Bakhshi Zadeh Gashti A, Azizi H, et al
    Evaluation of novel HIV vaccine candidates using recombinant vesicular stomatitis virus vector produced in serum-free Vero cell cultures.
    Vaccine. 2020 Oct 30. pii: S0264-410X(20)31367.
    PubMed     Abstract available

  982. SHARMA T, Joshi N, Kumar Mandyal A, Nordqvist SL, et al
    Development of Hillchol(R), a low-cost inactivated single strain Hikojima oral cholera vaccine.
    Vaccine. 2020 Oct 30. pii: S0264-410X(20)31337.
    PubMed     Abstract available

  983. VESIKARI T, Ramsey K, Pitisuttithum P, Capeding R, et al
    Repeated exposure to an MF-59 adjuvanted quadrivalent subunit influenza vaccine (aQIV) in children: Results of two revaccination studies.
    Vaccine. 2020 Oct 30. pii: S0264-410X(20)31330.
    PubMed     Abstract available

  984. LOLI S, Carcamo CP
    Rotavirus vaccination and stunting: Secondary Data Analysis from the Peruvian Demographic and Health Survey.
    Vaccine. 2020 Oct 30. pii: S0264-410X(20)31338.
    PubMed     Abstract available

  985. PALANIAPPAN PA, Mohamed Sukur S, Liow YL, Maniam S, et al
    Carriage of Haemophilus influenzae among children attending childcare centres in Kuala Lumpur, Malaysia in the post vaccination era: A cross-sectional study.
    Vaccine. 2020 Oct 30. pii: S0264-410X(20)31237.
    PubMed     Abstract available

  986. SAITOH A, Saitoh A, Katsuta T, Mine M, et al
    Effect of a vaccine information statement (VIS) on immunization status and parental knowledge, attitudes, and beliefs regarding infant immunization in Japan.
    Vaccine. 2020 Oct 30. pii: S0264-410X(20)31355.
    PubMed     Abstract available

  987. BONANNI P, Angelillo IF, Villani A, Biasci P, et al
    Maintain and increase vaccination coverage in children, adolescents, adults and elderly people: Let's avoid adding epidemics to the pandemic: Appeal from the Board of the Vaccination Calendar for Life in Italy: Maintain and increase coverage also by r
    Vaccine. 2020 Oct 30. pii: S0264-410X(20)31318.
    PubMed     Abstract available

  988. CARCELEN AC, Vilajeliu A, Malik F, Gilman RH, et al
    Perceptions and attitudes towards vaccination during pregnancy in a peri urban area of Lima, Peru.
    Vaccine. 2020 Oct 30. pii: S0264-410X(20)31325.
    PubMed     Abstract available

  989. GAO F, Jiang Y, Li G, Zhang Y, et al
    Immune duration of a recombinant PRRSV vaccine expressing E2 of CSFV.
    Vaccine. 2020 Oct 29. pii: S0264-410X(20)31366.
    PubMed     Abstract available

  990. SONG JY, Jeong HW, Yun JW, Lee J, et al
    Immunogenicity and safety of a modified three-dose priming and booster schedule for the Hantaan virus vaccine (Hantavax): A multi-center phase III clinical trial in healthy adults.
    Vaccine. 2020 Oct 29. pii: S0264-410X(20)31329.
    PubMed     Abstract available

  991. SCHNEIKART G, Tavarini S, Sammicheli C, Torricelli G, et al
    The respiratory syncytial virus fusion protein-specific B cell receptor repertoire reshaped by post-fusion subunit vaccination.
    Vaccine. 2020 Oct 29. pii: S0264-410X(20)31371.
    PubMed     Abstract available

  992. SCHOCH-SPANA M, Brunson EK, Long R, Ruth A, et al
    The public's role in COVID-19 vaccination: Human-centered recommendations to enhance pandemic vaccine awareness, access, and acceptance in the United States.
    Vaccine. 2020 Oct 29. pii: S0264-410X(20)31368.
    PubMed     Abstract available

  993. LIU B, Shi P, Wang T, Zhao Y, et al
    Recombinant H7 hemagglutinin expressed in glycoengineered Pichia pastoris forms nanoparticles that protect mice from challenge with H7N9 influenza virus.
    Vaccine. 2020 Oct 29. pii: S0264-410X(20)31370.
    PubMed     Abstract available

  994. WOLFE DN, Espeland EM, Gao Y, Lu D, et al
    Evaluation of BioThrax(R) and AV7909 anthrax vaccines in adults 66 years of age or older.
    Vaccine. 2020 Oct 28. pii: S0264-410X(20)31362.
    PubMed     Abstract available

  995. ANDERSON MG, Ballinger EA, Benjamin D, Frenkel LD, et al
    A clinical perspective of the U.S. anti-vaccination epidemic: Considering marginal costs and benefits, CDC best practices guidelines, free riders, and herd immunity.
    Vaccine. 2020 Oct 28. pii: S0264-410X(20)31388.

  996. LIU X, Drelich A, Li W, Chen C, et al
    Enhanced elicitation of potent neutralizing antibodies by the SARS-CoV-2 spike receptor binding domain Fc fusion protein in mice.
    Vaccine. 2020;38:7205-7212.
    PubMed     Abstract available

  997. CHESSON HW, Meites E, Ekwueme DU, Saraiya M, et al
    Cost-effectiveness of HPV vaccination for adults through age 45 years in the United States: Estimates from a simplified transmission model.
    Vaccine. 2020 Oct 26. pii: S0264-410X(20)31312.
    PubMed     Abstract available

  998. ORAMI T, Ford R, Kirkham LA, Thornton R, et al
    Pneumococcal conjugate vaccine primes mucosal immune responses to pneumococcal polysaccharide vaccine booster in Papua New Guinean children.
    Vaccine. 2020 Oct 26. pii: S0264-410X(20)31336.
    PubMed     Abstract available

  999. DAS R, Jobayer Chisti M, Ahshanul Haque M, Ashraful Alam M, et al
    Evaluating association of vaccine response to low serum zinc and vitamin D levels in children of a birth cohort study in Dhaka.
    Vaccine. 2020 Oct 26. pii: S0264-410X(20)31352.
    PubMed     Abstract available

  1000. SPINA CI, Brewer SE, Ellingson MK, Chamberlain AT, et al
    Adapting Center for Disease Control and Prevention's immunization quality improvement program to improve maternal vaccination uptake in obstetrics.
    Vaccine. 2020 Oct 26. pii: S0264-410X(20)31360.
    PubMed     Abstract available

  1001. VALENTE PINTO M, Davis K, Andrews N, Goldblatt D, et al
    Understanding the reactogenicity of 4CMenB vaccine: Comparison of a novel and conventional method of assessing post-immunisation fever and correlation with pre-release in vitro pyrogen testing.
    Vaccine. 2020 Oct 24. pii: S0264-410X(20)31316.
    PubMed     Abstract available

  1002. LATIF AA, Steyn HC, Josemans AI, Marumo RD, et al
    Safety and efficacy of an attenuated heartwater (Ehrlichia ruminantium) vaccine administered by the intramuscular route in cattle, sheep and Angora goats.
    Vaccine. 2020 Oct 24. pii: S0264-410X(20)31326.
    PubMed     Abstract available

  1003. GUEBRE-XABIER M, Patel N, Tian JH, Zhou B, et al
    NVX-CoV2373 vaccine protects cynomolgus macaque upper and lower airways against SARS-CoV-2 challenge.
    Vaccine. 2020 Oct 23. pii: S0264-410X(20)31373.
    PubMed     Abstract available

  1004. ALLEGRA JR, Baughman RH
    Vaccine time-temperature indicators for present and future viral threats.
    Vaccine. 2020;38:6967-6968.

  1005. CHANDIR S, Siddiqi DA, Mehmood M, Setayesh H, et al
    Impact of COVID-19 pandemic response on uptake of routine immunizations in Sindh, Pakistan: An analysis of provincial electronic immunization registry data.
    Vaccine. 2020;38:7146-7155.
    PubMed     Abstract available

  1006. RUSCIO BA, Hotez P
    Expanding global and national influenza vaccine systems to match the COVID-19 pandemic response.
    Vaccine. 2020 Oct 21. pii: S0264-410X(20)31364.

  1007. FREUDENBURG-DE GRAAF W, Knol MJ, van der Ende A
    Predicted coverage by 4CMenB vaccine against invasive meningococcal disease cases in the Netherlands.
    Vaccine. 2020 Oct 20. pii: S0264-410X(20)31283.
    PubMed     Abstract available

  1008. CHAKRABORTY C, Agoramoorthy G
    India's cost-effective COVID-19 vaccine development initiatives.
    Vaccine. 2020 Oct 20. pii: S0264-410X(20)31365.

  1009. BELL S, Clarke R, Mounier-Jack S, Walker JL, et al
    Parents' and guardians' views on the acceptability of a future COVID-19 vaccine: A multi-methods study in England.
    Vaccine. 2020 Oct 19. pii: S0264-410X(20)31321.
    PubMed     Abstract available

  1010. ROSS JC, Saidu Y, Nzuobontane D, Voukings MZ, et al
    Application of the remaining vaccine vial monitor life calculation to field temperature monitoring data to improve visibility into cold chain equipment performance.
    Vaccine. 2020 Oct 17. pii: S0264-410X(20)31260.
    PubMed     Abstract available

  1011. VOLKMANN A, Williamson AL, Weidenthaler H, Meyer TPH, et al
    The Brighton Collaboration standardized template for collection of key information for risk/benefit assessment of a Modified Vaccinia Ankara (MVA) vaccine platform.
    Vaccine. 2020 Oct 17. pii: S0264-410X(20)31091.
    PubMed     Abstract available

  1012. MALTEZOU HC, Theodora M, Lytras T, Fotiou A, et al
    Knowledge, attitudes and practices about vaccine-preventable diseases and vaccinations of children among pregnant women in Greece.
    Vaccine. 2020 Oct 16. pii: S0264-410X(20)31278.
    PubMed     Abstract available

  1013. ABU-ELYAZEED R, Klein NP, Moerman L, Povey M, et al
    Concomitant administration of a liquid formulation of human rotavirus vaccine (porcine circovirus-free) with routine childhood vaccines in infants in the United States: Results from a phase 3, randomized trial.
    Vaccine. 2020 Oct 16. pii: S0264-410X(20)31122.
    PubMed     Abstract available

  1014. KABORE L, Meda B, Medah I, Shendale S, et al
    Assessment of missed opportunities for vaccination (MOV) in Burkina Faso using the World Health Organization's revised MOV strategy: Findings and strategic considerations to improve routine childhood immunization coverage.
    Vaccine. 2020 Oct 16. pii: S0264-410X(20)31314.
    PubMed     Abstract available

  1015. ZHAI Y, Santibanez TA, Kahn KE, Srivastav A, et al
    Rural, urban, and suburban differences in influenza vaccination coverage among children.
    Vaccine. 2020 Oct 15. pii: S0264-410X(20)31324.
    PubMed     Abstract available

  1016. MO AXY, Pesce J, Augustine AD, Bodmer JL, et al
    Understanding vaccine-elicited protective immunity against pre-erythrocytic stage malaria in endemic regions.
    Vaccine. 2020 Oct 15. pii: S0264-410X(20)31253.
    PubMed     Abstract available

  1017. VERGKIZI S, Nikolakakis I
    Bacillus Calmette-Guerin (BCG) vaccine generates immunoregulatory cells in the cervical lymph nodes in guinea pigs injected intra dermally.
    Vaccine. 2020 Oct 15. pii: S0264-410X(20)31284.
    PubMed     Abstract available

  1018. GURWITH M, Condit RC, Excler JL, Robertson JS, et al
    Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG) standardized template for collection of key information for benefit-risk assessment of live-attenuated viral vaccines.
    Vaccine. 2020 Oct 15. pii: S0264-410X(20)31202.
    PubMed     Abstract available

  1019. GARCIA PJ, George PE, Romero C, Soto G, et al
    "The flu... is a little more complicated than a cold": Knowledge, beliefs, and practices related to influenza and influenza vaccination among at-risk populations and health professionals in Peru.
    Vaccine. 2020 Oct 15. pii: S0264-410X(20)31236.
    PubMed     Abstract available

  1020. BELL H, Kamal N, Wong U
    Blistering autoimmune skin reaction following SHINGRIX vaccination in an ulcerative colitis patient: Case report and literature review.
    Vaccine. 2020 Oct 13. pii: S0264-410X(20)31255.
    PubMed     Abstract available

  1021. SEO Y, Pacifici E
    Elements of Regulatory Dissonance: Examining FDA and EMA Product Labeling of New Vaccines (2006-2018).
    Vaccine. 2020 Oct 12. pii: S0264-410X(20)31249.
    PubMed     Abstract available

  1022. MALTEZOU HC, Theodoridou K, Tseroni M, Raftopoulos V, et al
    Influenza vaccination policies for health workers in low-income and middle-income countries: A cross-sectional survey, January-March 2020.
    Vaccine. 2020 Oct 12. pii: S0264-410X(20)31276.
    PubMed     Abstract available

  1023. MO Y, Zeng J, Xiao C, Zhang, et al
    Effectiveness and safety of pneumococcal vaccines used alone or combined with influenza vaccination in dialysis patients: A systematic review and meta-analysis.
    Vaccine. 2020 Oct 12. pii: S0264-410X(20)31262.
    PubMed     Abstract available

  1024. GOLDMAN RD, Yan TD, Seiler M, Parra Cotanda C, et al
    Caregiver willingness to vaccinate their children against COVID-19: Cross sectional survey.
    Vaccine. 2020 Oct 10. pii: S0264-410X(20)31317.
    PubMed     Abstract available

  1025. BEYER WEP, Osterhaus ADME
    Bivalent AS04-adjuvanted HPV vaccine provides optimal cancer prevention for HPV types not included in the vaccine.
    Vaccine. 2020 Oct 10. pii: S0264-410X(20)31157.
    PubMed     Abstract available

  1026. MCCLUNG N, Burnett J, Wejnert C, Markowitz LE, et al
    Human papillomavirus vaccination coverage among men who have sex with men-National HIV Behavioral Surveillance, United States, 2017.
    Vaccine. 2020 Oct 9. pii: S0264-410X(20)31081.
    PubMed     Abstract available

  1027. SAFAVI A, Kefayat A, Mahdevar E, Abiri A, et al
    Exploring the out of sight antigens of SARS-CoV-2 to design a candidate multi-epitope vaccine by utilizing immunoinformatics approaches.
    Vaccine. 2020 Oct 9. pii: S0264-410X(20)31307.
    PubMed     Abstract available

  1028. RONCATI L, Vadala M, Corazzari V, Palmieri B, et al
    COVID-19 vaccine and boosted immunity: Nothing ad interim to do?
    Vaccine. 2020 Oct 9. pii: S0264-410X(20)31303.
    PubMed     Abstract available

  1029. SINGH JA
    COVID-19 vaccine trials: Duty of care and standard of prevention considerations.
    Vaccine. 2020 Oct 9. pii: S0264-410X(20)31302.

  1030. LATOURETTE PC 2ND, Awasthi S, Desmond A, Pardi N, et al
    Protection against herpes simplex virus type 2 infection in a neonatal murine model using a trivalent nucleoside-modified mRNA in lipid nanoparticle vaccine.
    Vaccine. 2020 Oct 8. pii: S0264-410X(20)31261.
    PubMed     Abstract available

  1031. THOMPSON HA, Hogan AB, Walker PGT, White MT, et al
    Modelling the roles of antibody titre and avidity in protection from Plasmodium falciparum malaria infection following RTS,S/AS01 vaccination.
    Vaccine. 2020 Oct 8. pii: S0264-410X(20)31251.
    PubMed     Abstract available

  1032. AUDREY S, Farr M, Roderick M, Evans K, et al
    How acceptable is adolescent self-consent for the HPV vaccination: Findings from a qualitative study in south-west England.
    Vaccine. 2020 Oct 8. pii: S0264-410X(20)31256.
    PubMed     Abstract available

  1033. THIELMANN A, Puth MT, Weltermann B
    Improving knowledge on vaccine storage management in general practices: Learning effectiveness of an online-based program.
    Vaccine. 2020 Oct 8. pii: S0264-410X(20)31210.
    PubMed     Abstract available

  1034. ADEIKALAM S, de Champs Leger H, Vignier N, Grabar S, et al
    Utility of the Tetanos Quick Stick(R) in the vaccine catch-up of adult migrants without proof of prior vaccination.
    Vaccine. 2020 Oct 8. pii: S0264-410X(20)31231.
    PubMed     Abstract available

  1035. DU F, Chantler T, Francis MR, Sun FY, et al
    The determinants of vaccine hesitancy in China: A cross-sectional study following the Changchun Changsheng vaccine incident.
    Vaccine. 2020 Oct 8. pii: S0264-410X(20)31257.
    PubMed     Abstract available

  1036. YAO L, Wang JY, Bao LN, Fan MX, et al
    DNA adjuvant Amiloride conjunct long immunization interval promote higher antibody responses to HIV-1 gp41 and gp140 immunogens.
    Vaccine. 2020 Oct 8. pii: S0264-410X(20)31259.
    PubMed     Abstract available

  1037. MACIAS AE, McElhaney JE, Chaves SS, Nealon J, et al
    The disease burden of influenza beyond respiratory illness.
    Vaccine. 2020 Oct 8. pii: S0264-410X(20)31209.
    PubMed     Abstract available

  1038. CROOKE SN, Haralambieva IH, Grill DE, Ovsyannikova IG, et al
    Corrigendum to "Seroprevalence and durability of rubella virus antibodies in a highly immunized population". [Vaccine 37 (2019) 3876-3882].
    Vaccine. 2020;38:6858.

  1039. MILLER ER, McNeil MM, Moro PL, Duffy J, et al
    The reporting sensitivity of the Vaccine Adverse Event Reporting System (VAERS) for anaphylaxis and for Guillain-Barre syndrome.
    Vaccine. 2020 Oct 7. pii: S0264-410X(20)31254.
    PubMed     Abstract available

  1040. GUILFOYLE K, Major D, Skeldon S, James H, et al
    Protective efficacy of a polyvalent influenza A DNA vaccine against both homologous (H1N1pdm09) and heterologous (H5N1) challenge in the ferret model.
    Vaccine. 2020 Oct 6. pii: S0264-410X(20)31233.
    PubMed     Abstract available

  1041. BIOLCHI A, De Angelis G, Moschioni M, Tomei S, et al
    Multicomponent meningococcal serogroup B vaccination elicits cross-reactive immunity in infants against genetically diverse serogroup C, W and Y invasive disease isolates.
    Vaccine. 2020 Oct 6. pii: S0264-410X(20)31220.
    PubMed     Abstract available

  1042. LEE JKH, Lam GKL, Shin T, Samson SI, et al
    Efficacy and effectiveness of high-dose influenza vaccine in older adults by circulating strain and antigenic match: An updated systematic review and meta-analysis.
    Vaccine. 2020 Oct 6. pii: S0264-410X(20)31146.
    PubMed     Abstract available

  1043. WOLF J, Hansen R, Hassis K, Lapps W, et al
    The impact of export regulations on recombinant viral vaccine development for emerging infectious diseases.
    Vaccine. 2020 Oct 5. pii: S0264-410X(20)31228.

  1044. CHILENGI R, Simuyandi M, Chibuye M, Chirwa M, et al
    A pilot study on use of live attenuated rotavirus vaccine (Rotarix) as an infection challenge model.
    Vaccine. 2020 Oct 5. pii: S0264-410X(20)31177.
    PubMed     Abstract available

  1045. LACK A, Hiligsmann M, Bloem P, Tunnessen M, et al
    Parent, provider and vaccinee preferences for HPV vaccination: A systematic review of discrete choice experiments.
    Vaccine. 2020 Oct 3. pii: S0264-410X(20)31133.
    PubMed     Abstract available

  1046. CUSTERS J, Kim D, Leyssen M, Gurwith M, et al
    Vaccines based on replication incompetent Ad26 viral vectors: Standardized template with key considerations for a risk/benefit assessment.
    Vaccine. 2020 Oct 3. pii: S0264-410X(20)31160.
    PubMed     Abstract available

  1047. HOSHI SL, Shono A, Seposo X, Okubo I, et al
    Cost-effectiveness analysis of influenza vaccination during pregnancy in Japan.
    Vaccine. 2020 Oct 2. pii: S0264-410X(20)31180.
    PubMed     Abstract available

  1048. KATALANI C, Ahmadian G, Nematzadeh G, Amani J, et al
    Immunization with oral and parenteral subunit chimeric vaccine candidate confers protection against Necrotic Enteritis in chickens.
    Vaccine. 2020 Oct 2. pii: S0264-410X(20)31208.
    PubMed     Abstract available

  1049. CARRASQUILLA G, Porras A, Martinez S, DeAntonio R, et al
    Incidence and mortality of pertussis disease in infants <12 months of age following introduction of pertussis maternal universal mass vaccination in Bogota, Colombia.
    Vaccine. 2020 Oct 1. pii: S0264-410X(20)30977.
    PubMed     Abstract available

  1050. EZOE S, Palacpac NMQ, Tetsutani K, Yamamoto K, et al
    First-in-human randomised trial and follow-up study of Plasmodium falciparum blood-stage malaria vaccine BK-SE36 with CpG-ODN(K3).
    Vaccine. 2020 Oct 1. pii: S0264-410X(20)31227.
    PubMed     Abstract available

  1051. FAKHRI O, Devlin JM, Browning GF, Coppo MJC, et al
    Superinfection and recombination of infectious laryngotracheitis virus vaccines in the natural host.
    Vaccine. 2020 Oct 1. pii: S0264-410X(20)31235.
    PubMed     Abstract available

  1052. NIANG M, Deming ME, Goudiaby D, Diop OM, et al
    Immunogenicity of seasonal inactivated influenza and inactivated polio vaccines among children in Senegal: Results from a cluster-randomized trial.
    Vaccine. 2020 Oct 1. pii: S0264-410X(20)31230.
    PubMed     Abstract available

    September 2020
  1053. HAIMOWITZ R, Torres R, Caleb S, Thompson D, et al
    Serogroup B meningococcal vaccination practice patterns on college campuses.
    Vaccine. 2020 Sep 30. pii: S0264-410X(20)31195.
    PubMed     Abstract available

  1054. LAWTON B, Howe AS, Turner N, Filoche S, et al
    Retraction notice to "Association of prior HPV vaccination with reduced preterm birth: A population based study" [Vaccine 36 (2018) 134-140].
    Vaccine. 2020;38:6658.

  1055. HATTORI F, Kozawa K, Miura H, Kawamura Y, et al
    Trend in varicella patients 4 years after implementation of universal two-dose varicella vaccination in Japan.
    Vaccine. 2020 Sep 29. pii: S0264-410X(20)31198.
    PubMed     Abstract available

  1056. CHARANIA NA, Gaze N, Kung JY, Brooks S, et al
    Interventions to reduce the burden of vaccine-preventable diseases among migrants and refugees worldwide: A scoping review of published literature, 2006-2018.
    Vaccine. 2020 Sep 29. pii: S0264-410X(20)31225.
    PubMed     Abstract available

  1057. IMRAN KHAN M, Aijaz S, Syed FF, Kaljee L, et al
    An optimal typhoid conjugate vaccine coverage complemented with WASH is imperative for the control of antimicrobial resistance in Pakistan.
    Vaccine. 2020 Sep 29. pii: S0264-410X(20)31221.

  1058. MUNSERI P, Said J, Amour M, Magohe A, et al
    DAR-901 vaccine for the prevention of infection with Mycobacterium tuberculosis among BCG-immunized adolescents in Tanzania: A randomized controlled, double-blind phase 2b trial.
    Vaccine. 2020 Sep 28. pii: S0264-410X(20)31226.
    PubMed     Abstract available

  1059. FALKENBERG SM, Dassanayake RP, Palmer MV, Silveira S, et al
    Changes in circulating lymphocytes and lymphoid tissue associated with vaccination of colostrum deprived calves.
    Vaccine. 2020 Sep 25. pii: S0264-410X(20)31206.
    PubMed     Abstract available

  1060. VIDANAPATHIRANA G, Angulmaduwa S, Munasinghe T, Ekanayake A, et al
    Pneumococcal colonization among healthy and hospitalized vaccine-naive Sri Lankan children.
    Vaccine. 2020 Sep 24. pii: S0264-410X(20)31200.
    PubMed     Abstract available

  1061. JIMBO SOTOMAYOR R, Toscano CM, Sanchez Choez X, Vilema Ortiz M, et al
    Impact of pneumococcal conjugate vaccine on pneumonia hospitalization and mortality in children and elderly in Ecuador: Time series analyses.
    Vaccine. 2020 Sep 24. pii: S0264-410X(20)31192.
    PubMed     Abstract available

  1062. LEE CHJ, Sibley CG
    Ethnic disparities in vaccine safety attitudes and perceptions of family doctors/general practitioners.
    Vaccine. 2020 Sep 24. pii: S0264-410X(20)31190.
    PubMed     Abstract available

  1063. VAN DER GRAAF R, Macklin R, Rid A, Bhan A, et al
    Integrating public health programs and research after the malaria vaccine implementation program (MVIP): Recommendations for next steps.
    Vaccine. 2020 Sep 24. pii: S0264-410X(20)31132.
    PubMed     Abstract available

  1064. CHRISTIANSON B, Sharif-Mohamed F, Heath J, Roddy M, et al
    Parental attitudes and decisions regarding MMR vaccination during an outbreak of measles among an undervaccinated Somali community in Minnesota.
    Vaccine. 2020 Sep 24. pii: S0264-410X(20)31176.
    PubMed     Abstract available

  1065. SUN J, Han Z, Zhao R, Ai H, et al
    Protection of chicks from Newcastle disease by combined vaccination with a plasmid DNA and the pre-fusion protein of the virulent genotype VII of Newcastle disease virus.
    Vaccine. 2020 Sep 24. pii: S0264-410X(20)31199.
    PubMed     Abstract available

  1066. ASHKENAZI S, Livni G, Klein A, Kremer N, et al
    The relationship between parental source of information and knowledge about measles / measles vaccine and vaccine hesitancy.
    Vaccine. 2020 Sep 24. pii: S0264-410X(20)31204.
    PubMed     Abstract available

  1067. MACIAS SAINT-GERONS D, Sola Arnau I, De Mucio B, Arevalo-Rodriguez I, et al
    Adverse events associated with the use of recommended vaccines during pregnancy: An overview of systematic reviews.
    Vaccine. 2020 Sep 21. pii: S0264-410X(20)30979.
    PubMed     Abstract available

  1068. WILLIAMS JTB, Miller A, O'Leary ST
    Sacred or secular? Exploring religious Coloradans' questions about vaccines.
    Vaccine. 2020 Sep 21. pii: S0264-410X(20)31194.

  1069. Risk of intussusception after monovalent rotavirus vaccine (Rotavac) in Indian infants: A self-controlled case series analysis.
    Vaccine. 2020 Sep 21. pii: S0264-410X(20)31161.
    PubMed     Abstract available

  1070. FAUZIA MALIK A, Belizan M, Gutierrez M, Vilajeliu A, et al
    Pregnant women's perspectives about maternal immunization in Latin America Journal: Vaccine.
    Vaccine. 2020 Sep 21. pii: S0264-410X(20)31151.
    PubMed     Abstract available

  1071. FAIX DJ, Gordon DM, Perry LN, Raymond-Loher I, et al
    Prospective safety surveillance study of ACAM2000 smallpox vaccine in deploying military personnel.
    Vaccine. 2020 Sep 20. pii: S0264-410X(20)31197.
    PubMed     Abstract available

  1072. ISTRATE A, Azoicai D, Almas A, Radulescu A, et al
    Variable anti-HBs antibody titers in vaccinated birth cohorts - A cross-sectional population-based study.
    Vaccine. 2020 Sep 19. pii: S0264-410X(20)31184.
    PubMed     Abstract available

  1073. JENNINGS MC, Manchester C, Sauer M
    Navigating country decisions in response to a global rotavirus vaccine shortage.
    Vaccine. 2020 Sep 18. pii: S0264-410X(20)31131.

  1074. ANDREW MK, McNeil SA
    Influenza vaccination and the evolution of evidence-based recommendations for older adults: A Canadian perspective.
    Vaccine. 2020 Sep 18. pii: S0264-410X(20)31153.
    PubMed     Abstract available

  1075. LI Q, Ren J, Xian H, Yin C, et al
    rOmpF and OMVs as efficient subunit vaccines against Salmonella enterica serovar Enteritidis infections in poultry farms.
    Vaccine. 2020 Sep 17. pii: S0264-410X(20)31126.
    PubMed     Abstract available

  1076. ROMANUTTI C, Keller L, Zanetti FA
    Current status of virus-vectored vaccines against pathogens that affect poultry.
    Vaccine. 2020 Sep 17. pii: S0264-410X(20)31155.
    PubMed     Abstract available

  1077. LEE CHJ, Overall NC, Sibley CG
    Maternal and paternal confidence in vaccine safety: Whose attitudes are predictive of children's vaccination?
    Vaccine. 2020 Sep 17. pii: S0264-410X(20)31163.
    PubMed     Abstract available

  1078. DETOC M, Bruel S, Frappe P, Tardy B, et al
    Intention to participate in a COVID-19 vaccine clinical trial and to get vaccinated against COVID-19 in France during the pandemic.
    Vaccine. 2020 Sep 17. pii: S0264-410X(20)31201.
    PubMed     Abstract available

  1079. HE Y, Wang M, Chen S, Cheng A, et al
    The role of capsid in the flaviviral life cycle and perspectives for vaccine development.
    Vaccine. 2020 Sep 16. pii: S0264-410X(20)31094.
    PubMed     Abstract available

  1080. ALHALASEH L, Fayoumi H, Khalil B
    The Health Belief Model in predicting healthcare workers' intention for influenza vaccine uptake in Jordan.
    Vaccine. 2020 Sep 16. pii: S0264-410X(20)31128.
    PubMed     Abstract available

  1081. DEAN NE, Pastore Y Piontti A, Madewell ZJ, Cummings DAT, et al
    Ensemble forecast modeling for the design of COVID-19 vaccine efficacy trials.
    Vaccine. 2020 Sep 15. pii: S0264-410X(20)31191.
    PubMed     Abstract available

  1082. MCMAHON M, Strohmeier S, Rajendran M, Capuano C, et al
    Correctly folded - but not necessarily functional - influenza virus neuraminidase is required to induce protective antibody responses in mice.
    Vaccine. 2020 Sep 15. pii: S0264-410X(20)31119.
    PubMed     Abstract available

  1083. BAUER KA, Johnson K, Stephenson JJ, Visaria J, et al
    Rate of preventative vaccine use and vaccine beliefs among a commercially insured population.
    Vaccine. 2020 Sep 14. pii: S0264-410X(20)31127.
    PubMed     Abstract available

  1084. DADARI I, Ssenyonjo J, Anga J
    Effective vaccine management through social behavior change communication: Exploring solutions using a participatory action research approach in the Solomon Islands.
    Vaccine. 2020 Sep 14. pii: S0264-410X(20)31109.
    PubMed     Abstract available

  1085. SHOME R, Kilari S, Sahare A, Kalleshamurthy T, et al
    Evaluation of the immune responses against reduced doses of Brucella abortus S19 (calfhood) vaccine in water buffaloes (Bubalus bubalis), India.
    Vaccine. 2020 Sep 14. pii: S0264-410X(20)31152.
    PubMed     Abstract available

  1086. WANG K, Wong ELY, Ho KF, Cheung AWL, et al
    Intention of nurses to accept coronavirus disease 2019 vaccination and change of intention to accept seasonal influenza vaccination during the coronavirus disease 2019 pandemic: A cross-sectional survey.
    Vaccine. 2020 Sep 10. pii: S0264-410X(20)31175.
    PubMed     Abstract available

    August 2020
  1087. HOWE AS, Pointon L, Gauld N, Paynter J, et al
    Pertussis and influenza immunisation coverage of pregnant women in New Zealand.
    Vaccine. 2020 Aug 28. pii: S0264-410X(20)31071.
    PubMed     Abstract available

    July 2020
  1088. SKARLUPKA AL, Handel A, Ross TM
    Influenza hemagglutinin antigenic distance measures capture trends in HAI differences and infection outcomes, but are not suitable predictive tools.
    Vaccine. 2020 Jul 15. pii: S0264-410X(20)30828.
    PubMed     Abstract available

  1089. MELIDOU A, Hungnes O, Pereyaslov D, Adlhoch C, et al
    Predominance of influenza virus A(H3N2) 3C.2a1b and A(H1N1)pdm09 6B.1A5A genetic subclades in the WHO European Region, 2018-2019.
    Vaccine. 2020 Jul 2. pii: S0264-410X(20)30804.
    PubMed     Abstract available

    June 2020
  1090. PARIZE P, Poujol P, Morineau Le Houssine P, Goesch J, et al
    Immune response to rabies post-exposure prophylaxis in patients with non-HIV secondary immunodeficiencies.
    Vaccine. 2020 Jun 22. pii: S0264-410X(20)30823.
    PubMed     Abstract available

  1091. GRIECO L, Panovska-Griffiths J, van Leeuwen E, Grove P, et al
    Exploring the role of mass immunisation in influenza pandemic preparedness: A modelling study for the UK context.
    Vaccine. 2020 Jun 20. pii: S0264-410X(20)30805.
    PubMed     Abstract available

  1092. YANG TU, Jung CW, Kim D, Park HA, et al
    Impact of the National Perinatal Hepatitis B Prevention Programme in the Republic of Korea: A retrospective registry-based cohort study.
    Vaccine. 2020 Jun 12. pii: S0264-410X(20)30689.
    PubMed     Abstract available

    May 2020
  1093. NOGAREDA F, Gunregjav N, Sarankhuu A, Munkhbat E, et al
    Measles and rubella IgG seroprevalence in persons 6 month-35 years of age, Mongolia, 2016.
    Vaccine. 2020;38:4200-4208.
    PubMed     Abstract available

  1094. ANDRE GO, Assoni L, Rodriguez D, Leite LCC, et al
    Immunization with PhtD truncated fragments reduces nasopharyngeal colonization by Streptococcus pneumoniae.
    Vaccine. 2020;38:4146-4153.
    PubMed     Abstract available

  1095. BREAKWELL L, Anga J, Cooley G, Ropiti L, et al
    Seroprevalence of chronic hepatitis B virus infection and immunity to measles, rubella, tetanus and diphtheria among schoolchildren aged 6-7 years old in the Solomon Islands, 2016.
    Vaccine. 2020 May 27. pii: S0264-410X(20)30648.
    PubMed     Abstract available

  1096. PLOTKIN SA, Caplan A
    Extraordinary diseases require extraordinary solutions.
    Vaccine. 2020;38:3987-3988.

  1097. CUI A, Zhang Y, Zhu Z, Wang H, et al
    Classification of measles cases from 2014 to 2018: Implications for progress towards measles elimination in China.
    Vaccine. 2020;38:3832-3838.
    PubMed     Abstract available

  1098. WRAITH S, Nachbagauer R, Balmaseda A, Stadlbauer D, et al
    Antibody responses to influenza A(H1N1)pdm infection.
    Vaccine. 2020 May 7. pii: S0264-410X(20)30586.
    PubMed     Abstract available

  1099. YASUDA I, Suzuki M, Dhoubhadel BG, Terada M, et al
    The low carriage prevalence of pneumococcus among community-dwelling older people: A cross-sectional study in Japan.
    Vaccine. 2020;38:3752-3758.
    PubMed     Abstract available

    April 2020
  1100. JOE CCD, Chatterjee S, Lovrecz G, Adams TE, et al
    Glycoengineered hepatitis B virus-like particles with enhanced immunogenicity.
    Vaccine. 2020 Apr 10. pii: S0264-410X(20)30350.
    PubMed     Abstract available

  1101. HIRSCH J, Faber BW, Crowe JE Jr, Verstrepen B, et al
    E. coli production process yields stable dengue 1 virus-sized particles (VSPs).
    Vaccine. 2020;38:3305-3312.
    PubMed     Abstract available

  1102. CHEBLOUNE Y, Moussa M, Arrode-Bruses G, Ronfort C, et al
    A single lentivector DNA based immunization contains a late heterologous SIVmac251 mucosal challenge infection.
    Vaccine. 2020 Apr 8. pii: S0264-410X(20)30442.
    PubMed     Abstract available

    March 2020
  1103. JIANG Y, Cheng X, Zhao X, Yu Y, et al
    Recombinant infectious bronchitis coronavirus H120 with the spike protein S1 gene of the nephropathogenic IBYZ strain remains attenuated but induces protective immunity.
    Vaccine. 2020;38:3157-3168.
    PubMed     Abstract available

  1104. STEPANEK L, Nakladalova M, Borikova A, Horakova D, et al
    Measles immunity in a Czech tertiary care hospital.
    Vaccine. 2020;38:2889-2892.
    PubMed     Abstract available

  1105. HOANG HH, Wang PC, Chen SC
    The protective efficacy of recombinant hypoxic response protein 1 of Nocardia seriolae in largemouth bass (Micropterus salmoides).
    Vaccine. 2020;38:2925-2936.
    PubMed     Abstract available

  1106. LIU FJ, Shi DY, Mao YY, Xiong XH, et al
    Immunological characterisation and immunoprotective efficacy of functional domain antigens of botulinum neurotoxin serotype A.
    Vaccine. 2020;38:2978-2983.
    PubMed     Abstract available

  1107. CHOE YJ, Jee Y, Takashima Y, Lee JK, et al
    Japanese encephalitis in the Western Pacific Region: Implication from the Republic of Korea.
    Vaccine. 2020;38:2760-2763.
    PubMed     Abstract available

  1108. COULBORN RM, Nackers F, Bachy C, Porten K, et al
    Field challenges to measles elimination in the Democratic Republic of the Congo.
    Vaccine. 2020;38:2800-2807.
    PubMed     Abstract available

  1109. HVASS AMF, Norredam M, Sodemann M, Thomsen MK, et al
    Are refugees arriving in Denmark an under-immunised group for measles? A cross-sectional serology study.
    Vaccine. 2020;38:2788-2794.
    PubMed     Abstract available

  1110. VOS RA, Pasmans H, Tymchenko L, Janga-Jansen AVA, et al
    High seroprevalence of multiple high-risk human papillomavirus types among the general population of Bonaire, St. Eustatius and Saba, Caribbean Netherlands.
    Vaccine. 2020;38:2816-2826.
    PubMed     Abstract available

  1111. LAI JI, Eszterhas SK, Brooks SA, Guo C, et al
    Induction of cross-reactive HIV-1 specific antibody responses by engineered V1V2 immunogens with reduced conformational plasticity.
    Vaccine. 2020 Mar 16. pii: S0264-410X(20)30354.
    PubMed     Abstract available

  1112. ASTON-DEAVILLE S, Carlsson E, Saleem M, Thistlethwaite A, et al
    An assessment of the use of Hepatitis B Virus core protein virus-like particles to display heterologous antigens from Neisseria meningitidis.
    Vaccine. 2020 Mar 13. pii: S0264-410X(20)30327.
    PubMed     Abstract available

  1113. BASU R, Zhai L, Rosso B, Tumban E, et al
    Bacteriophage Qbeta virus-like particles displaying Chikungunya virus B-cell epitopes elicit high-titer E2 protein antibodies but fail to neutralize a Thailand strain of Chikungunya virus.
    Vaccine. 2020;38:2542-2550.
    PubMed     Abstract available

    February 2020
  1114. MOGASALE V, Kanungo S, Pati S, Lynch J, et al
    The history of OCV in India and barriers remaining to programmatic introduction.
    Vaccine. 2020;38 Suppl 1:A41-A45.
    PubMed     Abstract available

  1115. HOLMGREN J
    Vaccine. 2020;38 Suppl 1:A1-A3.

  1116. GUPTA SS, Gupta SK
    Social mobilization for cholera prevention & control in India: Building on the existing framework.
    Vaccine. 2020;38 Suppl 1:A181-A183.
    PubMed     Abstract available

  1117. HALDAR P
    Programmatic Preparations and challenges for OCV introduction in India.
    Vaccine. 2020;38 Suppl 1:A175-A177.
    PubMed     Abstract available

  1118. GUPTA SS, Ganguly NK
    Opportunities and challenges for cholera control in India.
    Vaccine. 2020;38 Suppl 1:A25-A27.
    PubMed     Abstract available

  1119. SEKHAR A, Kang G
    Pathways to a policy for cholera control in India.
    Vaccine. 2020;38 Suppl 1:A157-A159.
    PubMed     Abstract available

  1120. AZMAN AS, Moore SM, Lessler J
    Surveillance and the global fight against cholera: Setting priorities and tracking progress.
    Vaccine. 2020;38 Suppl 1:A28-A30.

  1121. POLAND GA
    Another coronavirus, another epidemic, another warning.
    Vaccine. 2020;38:v-vi.

  1122. HUNEYCUTT B, Lurie N, Rotenberg S, Wilder R, et al
    Finding equipoise: CEPI revises its equitable access policy.
    Vaccine. 2020;38:2144-2148.
    PubMed     Abstract available

  1123. ANGELIDOU A, Conti MG, Diray-Arce J, Benn CS, et al
    Licensed Bacille Calmette-Guerin (BCG) formulations differ markedly in bacterial viability, RNA content and innate immune activation.
    Vaccine. 2020;38:2229-2240.
    PubMed     Abstract available

  1124. PERRETT KP, Halperin SA, Nolan T, Martinez Pancorbo C, et al
    Immunogenicity, transplacental transfer of pertussis antibodies and safety following pertussis immunization during pregnancy: Evidence from a randomized, placebo-controlled trial.
    Vaccine. 2020;38:2095-2104.
    PubMed     Abstract available

  1125. PERRETT KP, Halperin SA, Nolan T, Carmona Martinez A, et al
    Impact of tetanus-diphtheria-acellular pertussis immunization during pregnancy on subsequent infant immunization seroresponses: follow-up from a large randomized placebo-controlled trial.
    Vaccine. 2020;38:2105-2114.
    PubMed     Abstract available

  1126. ADAMSON PJ, Wang JJ, Anosova NG, Colella AD, et al
    Proteomic profiling of precipitated Clostridioides difficile toxin A and B antibodies.
    Vaccine. 2020;38:2077-2087.
    PubMed     Abstract available

  1127. NATH B, Vandna, Saini HM, Prasad M, et al
    Evaluation of Japanese encephalitis virus E and NS1 proteins immunogenicity using a recombinant Newcastle disease virus in mice.
    Vaccine. 2020;38:1860-1868.
    PubMed     Abstract available

  1128. GORAIN C, Singh A, Bhattacharyya S, Kundu A, et al
    Mucosal delivery of live Lactococcus lactis expressing functionally active JlpA antigen induces potent local immune response and prevent enteric colonization of Campylobacter jejuni in chickens.
    Vaccine. 2020;38:1630-1642.
    PubMed     Abstract available

  1129. ANYIWE K, Richardson M, Brophy J, Sander B, et al
    Assessing adolescent immunization options for pertussis in Canada: A cost-utility analysis.
    Vaccine. 2020;38:1825-1833.
    PubMed     Abstract available

  1130. SICCA F, Martinuzzi D, Montomoli E, Huckriede A, et al
    Comparison of influenza-specific neutralizing antibody titers determined using different assay readouts and hemagglutination inhibition titers: good correlation but poor agreement.
    Vaccine. 2020 Feb 7. pii: S0264-410X(20)30141.
    PubMed     Abstract available

    January 2020
  1131. LIU J, Clayton K, Gao W, Li Y, et al
    Trimeric HIV-1 gp140 fused with APRIL, BAFF, and CD40L on the mucosal gp140-specific antibody responses in mice.
    Vaccine. 2020 Jan 31. pii: S0264-410X(20)30076.
    PubMed     Abstract available

  1132. CUTTS FT, Dansereau E, Ferrari MJ, Hanson M, et al
    Using models to shape measles control and elimination strategies in low- and middle-income countries: A review of recent applications.
    Vaccine. 2020;38:979-992.
    PubMed     Abstract available

  1133. SHILLING H, Murray G, Brotherton JML, Hawkes D, et al
    Monitoring human papillomavirus prevalence among young Australian women undergoing routine chlamydia screening.
    Vaccine. 2020;38:1186-1193.
    PubMed     Abstract available

  1134. FORSTNER C, Kolditz M, Kesselmeier M, Ewig S, et al
    Pneumococcal conjugate serotype distribution and predominating role of serotype 3 in German adults with community-acquired pneumonia.
    Vaccine. 2020;38:1129-1136.
    PubMed     Abstract available

  1135. FEDERIZON J, Frye A, Huang WC, Hart TM, et al
    Immunogenicity of the Lyme disease antigen OspA, particleized by cobalt porphyrin-phospholipid liposomes.
    Vaccine. 2020;38:942-950.
    PubMed     Abstract available

  1136. ZHANG L, Sun M, Zhang Q, Wang J, et al
    Long-term passage of duck Tembusu virus in BHK-21 cells generates a completely attenuated and immunogenic population with increased genetic diversity.
    Vaccine. 2020;38:933-941.
    PubMed     Abstract available

  1137. GOETTLER D, Streng A, Kemmling D, Schoen C, et al
    Increase in Streptococcus pneumoniae serotype 3 associated parapneumonic pleural effusion/empyema after the introduction of PCV13 in Germany.
    Vaccine. 2020;38:570-577.
    PubMed     Abstract available

  1138. SISTERE-ORO M, Martinez-Pulgarin S, Solanes D, Veljkovic V, et al
    Conserved HA-peptides expressed along with flagellin in Trichoplusia ni larvae protects chicken against intranasal H7N1 HPAIV challenge.
    Vaccine. 2020;38:416-422.
    PubMed     Abstract available

  1139. MCENTEE CP, Moran HBT, Munoz-Wolf N, Liddicoat AM, et al
    Type I IFN signalling is required for cationic adjuvant formulation (CAF)01-induced cellular immunity and mucosal priming.
    Vaccine. 2020;38:635-643.
    PubMed     Abstract available

  1140. BERENSON AB, Hirth JM, Southerland JH
    Knowledge of human papillomavirus among dental providers: A mixed methods study.
    Vaccine. 2020;38:423-426.
    PubMed     Abstract available

  1141. HARRIS A, Lazzaro T, Crawford NW
    Blistering post 4-year old Infanrix(R) IPV.
    Vaccine. 2020;38:705-706.

  1142. BROUSSEAU N, Skowronski DM, Bellemare D, Amini R, et al
    Impact of the adolescent pertussis booster dose on the incidence of pertussis in British Columbia and Quebec, Canada.
    Vaccine. 2020;38:427-432.
    PubMed     Abstract available

  1143. RUSSO AT, Berhanu A, Bigger CB, Prigge J, et al
    Co-administration of tecovirimat and ACAM2000 in non-human primates: Effect of tecovirimat treatment on ACAM2000 immunogenicity and efficacy versus lethal monkeypox virus challenge.
    Vaccine. 2020;38:644-654.
    PubMed     Abstract available

  1144. RITSCHER AM, LeClair-Netzel M, Friedlander NJ, Howard Stewart DN, et al
    Cross-sectional study of hepatitis B antibody status in health care workers immunized as children at an academic medical center in Wisconsin.
    Vaccine. 2020 Jan 16. pii: S0264-410X(19)31678.
    PubMed     Abstract available

  1145. RAINISCH G, Adhikari B, Meltzer MI, Langley G, et al
    Estimating the impact of multiple immunization products on medically-attended respiratory syncytial virus (RSV) infections in infants.
    Vaccine. 2020;38:251-257.
    PubMed     Abstract available

  1146. HARBECKE R, Jensen NJ, Depledge DP, Johnson GR, et al
    Recurrent herpes zoster in the Shingles Prevention Study: Are second episodes caused by the same varicella-zoster virus strain?
    Vaccine. 2020;38:150-157.
    PubMed     Abstract available

  1147. CHUN JY, Park WB, Kim NJ, Choi EH, et al
    Estimating contact-adjusted immunity levels against measles in South Korea and prospects for maintaining elimination status.
    Vaccine. 2020;38:107-111.
    PubMed     Abstract available

  1148. DOWALL SD, Kempster S, Findlay-Wilson S, Mattiuzzo G, et al
    Towards quantification of protective antibody responses by passive transfer of the 1st WHO International Standard for Ebola virus antibody in a guinea pig model.
    Vaccine. 2020;38:345-349.
    PubMed     Abstract available

  1149. ZAHRAEI SM, Mokhtari-Azad T, Izadi S, Mohammadi M, et al
    Seroprevalence of anti-rubella and anti-measles antibodies in women at the verge of marriage in Iran.
    Vaccine. 2020;38:235-241.
    PubMed     Abstract available

  1150. NEAL EFG, Flasche S, Nguyen CD, Ratu FT, et al
    Associations between ethnicity, social contact, and pneumococcal carriage three years post-PCV10 in Fiji.
    Vaccine. 2020;38:202-211.
    PubMed     Abstract available

  1151. CAVALLI A, Desario C, Marinaro M, Losurdo M, et al
    Oral administration of modified live canine parvovirus type 2b induces systemic immune response.
    Vaccine. 2020;38:115-118.
    PubMed     Abstract available

  1152. CHIU ML, Luo ST, Chen YY, Chung WY, et al
    Establishment of Asia-Pacific Network for Enterovirus Surveillance.
    Vaccine. 2020;38:1-9.
    PubMed     Abstract available

    November 2019
  1153. CHOE YJ, Son H
    The changing gender differences in hepatitis a incidence in South Korea.
    Vaccine. 2019 Nov 28. pii: S0264-410X(19)31590.
    PubMed     Abstract available

  1154. FOUDA GG, De Paris K, Levy O, Marchant A, et al
    Immunological mechanisms of inducing HIV immunity in infants.
    Vaccine. 2019 Nov 21. pii: S0264-410X(19)31518.
    PubMed     Abstract available

  1155. SMATTI MK, Nasrallah GK, Al Thani AA, Yassine HM, et al
    Measuring influenza hemagglutinin (HA) stem-specific antibody-dependent cellular cytotoxicity (ADCC) in human sera using novel stabilized stem nanoparticle probes.
    Vaccine. 2019 Nov 14. pii: S0264-410X(19)31493.
    PubMed     Abstract available

  1156. XU WB, Li Y, Li D, Fang Y, et al
    Investigation and analysis of antibody levels of hepatitis A among children before and after implementing the Expanded National Immunization Program in China.
    Vaccine. 2019 Nov 14. pii: S0264-410X(19)31475.
    PubMed     Abstract available

  1157. KLAUSBERGER M, Leneva IA, Egorov A, Strobl F, et al
    Off-target effects of an insect cell-expressed influenza HA-pseudotyped Gag-VLP preparation in limiting postinfluenza Staphylococcus aureus infections.
    Vaccine. 2019 Nov 9. pii: S0264-410X(19)31472.
    PubMed     Abstract available

    October 2019
  1158. BUFFIN S, Peubez I, Barriere F, Nicolai MC, et al
    Influenza A and B virus-like particles produced in mammalian cells are highly immunogenic and induce functional antibodies.
    Vaccine. 2019 Oct 4. pii: S0264-410X(19)31281.
    PubMed     Abstract available

    September 2019
  1159. RUDICELL RS, Garinot M, Kanekiyo M, Kamp HD, et al
    Comparison of adjuvants to optimize influenza neutralizing antibody responses.
    Vaccine. 2019;37:6208-6220.
    PubMed     Abstract available

  1160. FU M, Hu K, Hu H, Ni F, et al
    Antigenicity and immunogenicity of HIV-1 gp140 with different combinations of glycan mutation and V1/V2 region or V3 crown deletion.
    Vaccine. 2019 Sep 26. pii: S0264-410X(19)31301.
    PubMed     Abstract available

  1161. OKENWA UJ, Dairo MD, Uba B, Ajumobi O, et al
    Maternal reasons for non-receipt of valid Hepatitis B birth dose among mother-infant pairs attending routine immunization clinics, South-east, Nigeria.
    Vaccine. 2019 Sep 24. pii: S0264-410X(19)31280.
    PubMed     Abstract available

  1162. HONEMANN M, Martin D, Pietsch C, Maier M, et al
    Influenza B virus infections in Western Saxony, Germany in three consecutive seasons between 2015 and 2018: Analysis of molecular and clinical features.
    Vaccine. 2019 Sep 11. pii: S0264-410X(19)31091.
    PubMed     Abstract available

  1163. LOPES JLS, Oliveira DCA, Utescher CLA, Quintilio W, et al
    Antigenic and physicochemical characterization of Hepatitis B surface protein under extreme temperature and pH conditions.
    Vaccine. 2019 Sep 10. pii: S0264-410X(19)31193.
    PubMed     Abstract available

    August 2019
  1164. NGUYEN TT, Choi JA, Kim JS, Park H, et al
    Skin immunization with third-generation hepatitis B surface antigen using microneedles.
    Vaccine. 2019 Aug 26. pii: S0264-410X(19)31100.
    PubMed     Abstract available

  1165. BEUN AJ, Grammens T, Hainaut M, Barlow P, et al
    High rate of rubella seronegativity in perinatally-infected HIV women of childbearing age: A case-control study.
    Vaccine. 2019 Aug 23. pii: S0264-410X(19)31098.
    PubMed     Abstract available

  1166. TZENG TT, Lai CC, Weng TC, Cyue MH, et al
    The stability and immunogenicity of inactivated MDCK cell-derived influenza H7N9 viruses.
    Vaccine. 2019 Aug 2. pii: S0264-410X(19)30346.
    PubMed     Abstract available

  1167. PRIVATT SR, Bullard BL, Weaver EA, Wood C, et al
    Longitudinal quantification of adenovirus neutralizing responses in Zambian mother-infant pairs: Impact of HIV-1 infection and its treatment.
    Vaccine. 2019 Aug 1. pii: S0264-410X(19)30995.
    PubMed     Abstract available

    July 2019
  1168. JANEWONGWIROT P, Jantarabenjakul W, Anugulruengkitt S, Anunsittichai O, et al
    A randomized open-label trial of 2-dose or 3-dose pre-exposure rabies prophylaxis among Thai children.
    Vaccine. 2019 Jul 26. pii: S0264-410X(19)30953.
    PubMed     Abstract available

  1169. VENEREO-SANCHEZ A, Fulton K, Koczka K, Twine S, et al
    Characterization of influenza H1N1 Gag virus-like particles and extracellular vesicles co-produced in HEK-293SF.
    Vaccine. 2019 Jul 26. pii: S0264-410X(19)30955.
    PubMed     Abstract available

  1170. TATEISHI K, Fujihashi K, Yamamoto N, Hasegawa H, et al
    CpG ODN G9.1 as a novel nasal ODN adjuvant elicits complete protection from influenza virus infection without causing inflammatory immune responses.
    Vaccine. 2019 Jul 22. pii: S0264-410X(19)30923.
    PubMed     Abstract available

  1171. LEMIEUX M, Lorbetskie B, Luebbert CC, Walrond L, et al
    The differential effect of sub-micron level HA aggregates on influenza potency assays.
    Vaccine. 2019 Jul 20. pii: S0264-410X(19)30948.
    PubMed     Abstract available

  1172. EICKHOFF CS, Terry FE, Peng L, Meza KA, et al
    Highly conserved influenza T cell epitopes induce broadly protective immunity.
    Vaccine. 2019 Jul 19. pii: S0264-410X(19)30924.
    PubMed     Abstract available

  1173. TRABELSI K, Ben Zakour M, Kallel H
    Purification of rabies virus produced in Vero cells grown in serum free medium.
    Vaccine. 2019 Jul 9. pii: S0264-410X(19)30849.
    PubMed     Abstract available

  1174. KINGSTAD-BAKKE BA, Chandrasekar SS, Phanse Y, Ross KA, et al
    Effective mosaic-based nanovaccines against avian influenza in poultry.
    Vaccine. 2019 Jul 9. pii: S0264-410X(19)30854.
    PubMed     Abstract available

    June 2019
  1175. CORONEL J, Behrendt I, Burgin T, Anderlei T, et al
    Influenza A virus production in a single-use orbital shaken bioreactor with ATF or TFF perfusion systems.
    Vaccine. 2019 Jun 29. pii: S0264-410X(19)30764.
    PubMed     Abstract available

  1176. NAYYAR A, Privor-Dumm L
    Cholera control and prevention: Role of evidence-based advocacy and communications.
    Vaccine. 2019 Jun 28. pii: S0264-410X(19)30804.
    PubMed     Abstract available

  1177. DE OLIVEIRA BERNARDO C, Gonzalez-Chica DA, Chilver M, Stocks N, et al
    Influenza immunisation coverage from 2015 to 2017: A national study of adult patients from Australian general practice.
    Vaccine. 2019 Jun 25. pii: S0264-410X(19)30819.
    PubMed     Abstract available

  1178. ROUROU S, Ben Zakkour M, Kallel H
    Adaptation of Vero cells to suspension growth for rabies virus production in different serum free media.
    Vaccine. 2019 Jun 11. pii: S0264-410X(19)30749.
    PubMed     Abstract available

    April 2019
  1179. BISSINGER T, Fritsch J, Mihut A, Wu Y, et al
    Semi-perfusion cultures of suspension MDCK cells enable high cell concentrations and efficient influenza A virus production.
    Vaccine. 2019 Apr 29. pii: S0264-410X(19)30528.
    PubMed     Abstract available

  1180. GRANICHER G, Coronel J, Pralow A, Marichal-Gallardo P, et al
    Efficient influenza A virus production in high cell density using the novel porcine suspension cell line PBG.PK2.1.
    Vaccine. 2019 Apr 17. pii: S0264-410X(19)30481.
    PubMed     Abstract available

    June 2017
  1181. GOTTLIEB SL, Giersing B, Boily MC, Chesson H, et al
    Modelling efforts needed to advance herpes simplex virus (HSV) vaccine development: Key findings from the World Health Organization Consultation on HSV Vaccine Impact Modelling.
    Vaccine. 2017 Jun 21. pii: S0264-410X(17)30408.
    PubMed     Abstract available

    December 2016
  1182. VANNICE KS, Giersing BK, Kaslow DC, Griffiths E, et al
    Meeting Report: WHO consultation on considerations for regulatory expectations of Zika virus vaccines for use during an emergency.
    Vaccine. 2016 Dec 1. pii: S0264-410X(16)30969.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Vaccines is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.